Reactive	O
oxygen	O
intermediate-dependent	O
NF-kappaB	B-protein
activation	O
by	O
interleukin-1beta	B-protein
requires	O
5-lipoxygenase	B-protein
or	O
NADPH	O
oxidase	O
activity	O
.	O

We	O
previously	O
reported	O
that	O
the	O
role	O
of	O
reactive	O
oxygen	O
intermediates	O
(	O
ROIs	O
)	O
in	O
NF-kappaB	B-protein
activation	O
by	O
proinflammatory	B-protein
cytokines	I-protein
was	O
cell	O
specific	O
.	O

However	O
,	O
the	O
sources	O
for	O
ROIs	O
in	O
various	O
cell	O
types	O
are	O
yet	O
to	O
be	O
determined	O
and	O
might	O
include	O
5-lipoxygenase	B-protein
(	O
5-LOX	B-protein
)	O
and	O
NADPH	O
oxidase	O
.	O

5-LOX	B-protein
and	O
5-LOX	B-protein
activating	I-protein
protein	I-protein
(	O
FLAP	B-protein
)	O
are	O
coexpressed	O
in	O
lymphoid	B-cell_type
cells	I-cell_type
but	O
not	O
in	O
monocytic	B-cell_type
or	I-cell_type
epithelial	I-cell_type
cells	I-cell_type
.	O

Stimulation	O
of	O
lymphoid	B-cell_type
cells	I-cell_type
with	O
interleukin-1beta	B-protein
(	O
IL-1beta	B-protein
)	O
led	O
to	O
ROI	O
production	O
and	O
NF-kappaB	B-protein
activation	O
,	O
which	O
could	O
both	O
be	O
blocked	O
by	O
antioxidants	O
or	O
FLAP	B-protein
inhibitors	O
,	O
confirming	O
that	O
5-LOX	B-protein
was	O
the	O
source	O
of	O
ROIs	O
and	O
was	O
required	O
for	O
NF-kappaB	B-protein
activation	O
in	O
these	O
cells	O
.	O

IL-1beta	B-protein
stimulation	O
of	O
epithelial	B-cell_type
cells	I-cell_type
did	O
not	O
generate	O
any	O
ROIs	O
and	O
NF-kappaB	B-protein
induction	O
was	O
not	O
influenced	O
by	O
5-LOX	B-protein
inhibitors	O
.	O

However	O
,	O
reintroduction	O
of	O
a	O
functional	O
5-LOX	B-protein
system	O
in	O
these	O
cells	O
allowed	O
ROI	O
production	O
and	O
5-LOX	B-protein
-dependent	O
NF-kappaB	B-protein
activation	O
.	O

In	O
monocytic	B-cell_type
cells	I-cell_type
,	O
IL-1beta	B-protein
treatment	O
led	O
to	O
a	O
production	O
of	O
ROIs	O
which	O
is	O
independent	O
of	O
the	O
5-LOX	B-protein
enzyme	I-protein
but	O
requires	O
the	O
NADPH	O
oxidase	O
activity	O
.	O

This	O
pathway	O
involves	O
the	O
Rac1	B-protein
and	O
Cdc42	B-protein
GTPases	B-protein
,	O
two	O
enzymes	O
which	O
are	O
not	O
required	O
for	O
NF-kappaB	B-protein
activation	O
by	O
IL-1beta	B-protein
in	O
epithelial	B-cell_type
cells	I-cell_type
.	O

In	O
conclusion	O
,	O
three	O
different	O
cell-specific	O
pathways	O
lead	O
to	O
NF-kappaB	B-protein
activation	O
by	O
IL-1beta	B-protein
:	O
a	O
pathway	O
dependent	O
on	O
ROI	O
production	O
by	O
5-LOX	B-protein
in	O
lymphoid	B-cell_type
cells	I-cell_type
,	O
an	O
ROI-	O
and	O
5-LOX	B-protein
-independent	O
pathway	O
in	O
epithelial	B-cell_type
cells	I-cell_type
,	O
and	O
a	O
pathway	O
requiring	O
ROI	O
production	O
by	O
NADPH	B-protein
oxidase	I-protein
in	O
monocytic	B-cell_type
cells	I-cell_type
.	O

MoLEcULAR	NULL
AND	NULL
CELLULAR	NULL
BroLoGY	NULL
,	NULL
Mar	NULL
.	NULL

1999	NULL
,	NULL
p.	NULL
1950-1960	NULL
0270-7306/99/	NULL
$	NULL
04.00+0	NULL
Vol	NULL
.	NULL

19	NULL
,	NULL
No	NULL
.	NULL

3	NULL
Copyright	NULL
©	NULL
1999	NULL
,	NULL
American	NULL
Society	NULL
for	NULL
Microbiology	NULL
.	NULL

All	NULL
Rights	NULL
Reserved	NULL
.	NULL

Reactive	NULL
Oxygen	NULL
Intermediate-Dependent	NULL
NF-	NULL
«	NULL
kB	NULL
Activation	NULL
by	NULL
Interleukin-1B	NULL
Requires	NULL
5-Lipoxygenase	NULL
or	NULL
NADPH	NULL
Oxidase	NULL
Activity	NULL
GIUSEPPINA	NULL
BONIZZI	NULL
,	NULL
'	NULL
JACQUES	NULL
PIETTE	NULL
,	NULL
``	NULL
SONIA	NULL
SCHOONBROODT,2	NULL
ROLAND	NULL
GREIMERS	NULL
,	NULL
``	NULL
LAURENCE	NULL
HAVARD	NULL
,	NULL
'	NULL
MARIE-PAULE	NULL
MERVILLE	NULL
,	NULL
*	NULL
anp	NULL
VINCENT	NULL
BOURS	NULL
!	NULL

*	NULL
Laboratory	NULL
of	NULL
Medical	NULL
Chemistry/Medical	NULL
Oncology	NULL
,	NULL
``	NULL
Laboratory	NULL
of	NULL
Fundamental	NULL
Virology	NULL
,	NULL
``	NULL
and	NULL
Laboratory	NULL
of	NULL
Pathology	NULL
,	NULL
``	NULL
University	NULL
of	NULL
Liege	NULL
,	NULL
Liege	NULL
,	NULL
Belgium	NULL
Received	NULL
16	NULL
July	NULL
1998/Returned	NULL
for	NULL
modification	NULL
26	NULL
August	NULL
1998/Accepted	NULL
30	NULL
November	NULL
1998	NULL
We	NULL
previously	NULL
reported	NULL
that	NULL
the	NULL
role	NULL
of	NULL
reactive	NULL
oxygen	NULL
intermediates	NULL
(	NULL
ROIs	NULL
)	NULL
in	NULL
NF-KB	NULL
activation	NULL
by	NULL
proinflammatory	NULL
cytokines	NULL
was	NULL
cell	NULL
specific	NULL
.	NULL

However	NULL
,	NULL
the	NULL
sources	NULL
for	NULL
ROIs	NULL
in	NULL
various	NULL
cell	NULL
types	NULL
are	NULL
yet	NULL
to	NULL
be	NULL
determined	NULL
and	NULL
might	NULL
include	NULL
S-lipoxygenase	NULL
(	NULL
5-LOX	NULL
)	NULL
and	NULL
NADPH	NULL
oxidase	NULL
.	NULL

5-LOX	NULL
and	NULL
5-LOX	NULL
activating	NULL
protein	NULL
(	NULL
FLAP	NULL
)	NULL
are	NULL
coexpressed	NULL
in	NULL
lymphoid	NULL
cells	NULL
but	NULL
not	NULL
in	NULL
monocytic	NULL
or	NULL
epithelial	NULL
cells	NULL
.	NULL

Stimulation	NULL
of	NULL
lymphoid	NULL
cells	NULL
with	NULL
led	NULL
to	NULL
ROI	NULL
production	NULL
and	NULL
NF-KB	NULL
activation	NULL
,	NULL
which	NULL
could	NULL
both	NULL
be	NULL
blocked	NULL
by	NULL
antioxidants	NULL
or	NULL
FLAP	NULL
inhibitors	NULL
,	NULL
confirming	NULL
that	NULL
5-LOX	NULL
was	NULL
the	NULL
source	NULL
of	NULL
ROIs	NULL
and	NULL
was	NULL
required	NULL
for	NULL
NF-B	NULL
activation	NULL
in	NULL
these	NULL
cells	NULL
.	NULL

IL-1B	NULL
stimulation	NULL
of	NULL
epithelial	NULL
cells	NULL
did	NULL
not	NULL
generate	NULL
any	NULL
ROIs	NULL
and	NULL
NF-KB	NULL
induction	NULL
was	NULL
not	NULL
influenced	NULL
by	NULL
5-LOX	NULL
inhibitors	NULL
.	NULL

However	NULL
,	NULL
reintroduction	NULL
of	NULL
a	NULL
functional	NULL
5-LOX	NULL
system	NULL
in	NULL
these	NULL
cells	NULL
allowed	NULL
ROI	NULL
production	NULL
and	NULL
5-LOX-dependent	NULL
NF-KB	NULL
activation	NULL
.	NULL

In	NULL
monocytic	NULL
cells	NULL
,	NULL
IL-1f	NULL
treatment	NULL
led	NULL
to	NULL
a	NULL
production	NULL
of	NULL
ROIs	NULL
which	NULL
is	NULL
independent	NULL
of	NULL
the	NULL
5-LOX	NULL
enzyme	NULL
but	NULL
requires	NULL
the	NULL
NADPH	NULL
oxidase	NULL
activity	NULL
.	NULL

This	NULL
pathway	NULL
involves	NULL
the	NULL
Racl	NULL
and	NULL
Cdcd42	NULL
GTPases	NULL
,	NULL
two	NULL
enzymes	NULL
which	NULL
are	NULL
not	NULL
required	NULL
for	NULL
NF-KB	NULL
activation	NULL
by	NULL
IL-1	NULL
in	NULL
epithelial	NULL
cells	NULL
.	NULL

In	NULL
conclusion	NULL
,	NULL
three	NULL
different	NULL
cell-specific	NULL
pathways	NULL
lead	NULL
to	NULL
NF-KB	NULL
activation	NULL
by	NULL
a	NULL
pathway	NULL
dependent	NULL
on	NULL
ROI	NULL
production	NULL
by	NULL
5-LOX	NULL
in	NULL
lymphoid	NULL
cells	NULL
,	NULL
an	NULL
ROI-	NULL
and	NULL
5-LOX-independent	NULL
pathway	NULL
in	NULL
epithelial	NULL
cells	NULL
,	NULL
and	NULL
a	NULL
pathway	NULL
requiring	NULL
ROI	NULL
production	NULL
by	NULL
NADPH	NULL
oxidase	NULL
in	NULL
monocytic	NULL
cells	NULL
.	NULL

The	NULL
interaction	NULL
of	NULL
interleukin-16	NULL
(	NULL
IL-1B	NULL
)	NULL
with	NULL
its	NULL
type	NULL
1	NULL
cell	NULL
surface	NULL
receptor	NULL
initiates	NULL
a	NULL
cascade	NULL
of	NULL
intracellular	NULL
reactions	NULL
leading	NULL
to	NULL
the	NULL
activation	NULL
of	NULL
transcription	NULL
factors	NULL
and	NULL
the	NULL
expression	NULL
of	NULL
target	NULL
genes	NULL
.	NULL

One	NULL
of	NULL
the	NULL
major	NULL
transcription	NULL
factors	NULL
mediating	NULL
IL-1B	NULL
biological	NULL
activities	NULL
is	NULL
NF-KB	NULL
(	NULL
for	NULL
reviews	NULL
,	NULL
see	NULL
references	NULL
2	NULL
,	NULL
3	NULL
,	NULL
and	NULL
22	NULL
)	NULL
.	NULL

This	NULL
factor	NULL
is	NULL
sequestered	NULL
in	NULL
the	NULL
cytoplasm	NULL
by	NULL
an	NULL
inhibitor	NULL
from	NULL
the	NULL
IxB	NULL
family	NULL
.	NULL

IL-16	NULL
cellular	NULL
stimulation	NULL
leads	NULL
to	NULL
a	NULL
rapid	NULL
phosphorylation	NULL
and	NULL
degradation	NULL
of	NULL
IxBa	NULL
,	NULL
the	NULL
most	NULL
common	NULL
NF-	NULL
«	NULL
B	NULL
inhibitor	NULL
.	NULL

This	NULL
reaction	NULL
allows	NULL
NF-	NULL
«	NULL
B	NULL
to	NULL
translocate	NULL
to	NULL
the	NULL
nucleus	NULL
,	NULL
to	NULL
bind	NULL
DNA	NULL
,	NULL
and	NULL
to	NULL
activate	NULL
the	NULL
transcription	NULL
of	NULL
specific	NULL
genes	NULL
(	NULL
2	NULL
,	NULL
55	NULL
)	NULL
.	NULL

Following	NULL
its	NULL
interaction	NULL
with	NULL
IL-1	NULL
,	NULL
the	NULL
type	NULL
1	NULL
IL-1	NULL
receptor	NULL
recruits	NULL
the	NULL
IL-1	NULL
receptor-associated	NULL
kinase	NULL
(	NULL
IRAK	NULL
)	NULL
protein	NULL
,	NULL
which	NULL
subsequently	NULL
interacts	NULL
with	NULL
the	NULL
TRAF6	NULL
adapter	NULL
protein	NULL
(	NULL
15	NULL
,	NULL
16	NULL
,	NULL
30	NULL
,	NULL
61	NULL
,	NULL
62	NULL
,	NULL
65	NULL
)	NULL
.	NULL

TRAF6	NULL
is	NULL
required	NULL
for	NULL
IL-1B-induced	NULL
NF-	NULL
«	NULL
B	NULL
activation	NULL
,	NULL
as	NULL
demonstrated	NULL
in	NULL
293	NULL
cells	NULL
(	NULL
16	NULL
)	NULL
.	NULL

However	NULL
,	NULL
the	NULL
signaling	NULL
pathways	NULL
leading	NULL
to	NULL
NF-kB	NULL
activation	NULL
from	NULL
the	NULL
IL-1B	NULL
receptors	NULL
are	NULL
still	NULL
controversial	NULL
.	NULL

It	NULL
has	NULL
been	NULL
demonstrated	NULL
that	NULL
TRAF6	NULL
interacts	NULL
with	NULL
a	NULL
MAP	NULL
kinase	NULL
kinase	NULL
kinase	NULL
(	NULL
MAPKKK	NULL
)	NULL
known	NULL
as	NULL
NIK	NULL
and	NULL
that	NULL
NIK	NULL
is	NULL
required	NULL
for	NULL
IL-1B-	NULL
or	NULL
tumor	NULL
necrosis	NULL
factor	NULL
alpha	NULL
(	NULL
TNF-	NULL
«	NULL
)	NULL
-dependent	NULL
NF-	NULL
«	NULL
B	NULL
activation	NULL
(	NULL
39	NULL
,	NULL
56	NULL
)	NULL
.	NULL

Large	NULL
(	NULL
500	NULL
to	NULL
900	NULL
kDa	NULL
)	NULL
multimeric	NULL
protein	NULL
kinase	NULL
complexes	NULL
have	NULL
been	NULL
purified	NULL
from	NULL
HeLa	NULL
cells	NULL
and	NULL
transmit	NULL
the	NULL
signal	NULL
from	NULL
the	NULL
TNF	NULL
receptor	NULL
type	NULL
1	NULL
(	NULL
TNFR-1	NULL
)	NULL
and	NULL
type	NULL
1	NULL
IL-1	NULL
receptors	NULL
to	NULL
the	NULL
cytoplasmic	NULL
complex	NULL
(	NULL
17	NULL
,	NULL
20	NULL
,	NULL
33	NULL
,	NULL
41	NULL
)	NULL
.	NULL

From	NULL
these	NULL
complexes	NULL
three	NULL
IxB	NULL
kinases	NULL
,	NULL
IKK-	NULL
«	NULL
@	NULL
,	NULL
IKK-B	NULL
,	NULL
and	NULL
IKK-y	NULL
,	NULL
have	NULL
been	NULL
purified	NULL
,	NULL
and	NULL
their	NULL
genes	NULL
were	NULL
cloned	NULL
(	NULL
20	NULL
,	NULL
42	NULL
,	NULL
49	NULL
,	NULL
66	NULL
)	NULL
.	NULL

Other	NULL
investiga-	NULL
*	NULL
Corresponding	NULL
author	NULL
.	NULL

Mailing	NULL
address	NULL
:	NULL
Medical	NULL
Oncology	NULL
,	NULL
CHU	NULL
B35	NULL
,	NULL
Sart-Tilman	NULL
,	NULL
Université	NULL
de	NULL
Liege	NULL
,	NULL
4000	NULL
Liege	NULL
,	NULL
Belgium	NULL
.	NULL

Phone	NULL
:	NULL
32-4-3662482	NULL
.	NULL

Fax	NULL
:	NULL
32-4-3664534	NULL
.	NULL

E-mail	NULL
:	NULL
vbours	NULL
@	NULL
ulg.ac.be	NULL
.	NULL

1950	NULL
tors	NULL
have	NULL
cloned	NULL
IKK	NULL
kinases	NULL
by	NULL
virtue	NULL
of	NULL
their	NULL
association	NULL
with	NULL
the	NULL
NIK	NULL
protein	NULL
kinase	NULL
(	NULL
47	NULL
,	NULL
64	NULL
)	NULL
.	NULL

Moreover	NULL
,	NULL
inactivation	NULL
of	NULL
these	NULL
kinases	NULL
by	NULL
dominant	NULL
negative	NULL
mutants	NULL
suppresses	NULL
IL-1B	NULL
and	NULL
TNF-	NULL
«	NULL
induction	NULL
of	NULL
NF-	NULL
«	NULL
B	NULL
.	NULL

These	NULL
studies	NULL
indicate	NULL
that	NULL
the	NULL
activated	NULL
NIK	NULL
kinase	NULL
phosphorylates	NULL
and	NULL
activates	NULL
the	NULL
IKK	NULL
protein	NULL
kinases	NULL
.	NULL

IKK	NULL
protein	NULL
kinases	NULL
can	NULL
in	NULL
turn	NULL
phosphorylate	NULL
the	NULL
IxBa	NULL
protein	NULL
on	NULL
serines	NULL
located	NULL
at	NULL
positions	NULL
32	NULL
and	NULL
36	NULL
,	NULL
a	NULL
reaction	NULL
which	NULL
targets	NULL
IxBa	NULL
for	NULL
ubiquitination	NULL
and	NULL
rapid	NULL
degradation	NULL
by	NULL
the	NULL
proteasome	NULL
(	NULL
12	NULL
,	NULL
58	NULL
,	NULL
59	NULL
)	NULL
.	NULL

These	NULL
reactions	NULL
are	NULL
extremely	NULL
rapid	NULL
,	NULL
and	NULL
the	NULL
cellular	NULL
IxBa	NULL
protein	NULL
is	NULL
completely	NULL
degraded	NULL
within	NULL
minutes	NULL
following	NULL
TNF-	NULL
«	NULL
or	NULL
IL-18	NULL
cell	NULL
stimulation	NULL
(	NULL
4	NULL
,	NULL
13	NULL
)	NULL
.	NULL

Despite	NULL
this	NULL
simplified	NULL
linear	NULL
receptor-TRAF-NIK-IKK	NULL
axis	NULL
for	NULL
IxBa	NULL
phosphorylation	NULL
and	NULL
degradation	NULL
,	NULL
other	NULL
intermediates	NULL
might	NULL
be	NULL
involved	NULL
in	NULL
NF-KB	NULL
activation	NULL
by	NULL
TNF-a	NULL
or	NULL
IL-1	NULL
.	NULL

First	NULL
,	NULL
several	NULL
components	NULL
of	NULL
the	NULL
large	NULL
signaling	NULL
complex	NULL
remain	NULL
to	NULL
be	NULL
identified	NULL
,	NULL
as	NULL
the	NULL
three	NULL
IKK	NULL
protein	NULL
kinases	NULL
do	NULL
not	NULL
account	NULL
for	NULL
the	NULL
molecular	NULL
weight	NULL
of	NULL
the	NULL
whole	NULL
complex	NULL
.	NULL

Sec-ond	NULL
,	NULL
a	NULL
large	NULL
number	NULL
of	NULL
studies	NULL
,	NULL
some	NULL
of	NULL
them	NULL
being	NULL
a	NULL
matter	NULL
of	NULL
controversy	NULL
,	NULL
have	NULL
identified	NULL
other	NULL
intermediates	NULL
which	NULL
seem	NULL
to	NULL
be	NULL
required	NULL
for	NULL
TNF-	NULL
«	NULL
-	NULL
or	NULL
IL-1B-mediated	NULL
NF-	NULL
«	NULL
B	NULL
activation	NULL
.	NULL

These	NULL
intermediates	NULL
are	NULL
Raf-1	NULL
,	NULL
MAP	NULL
kinases	NULL
,	NULL
the	NULL
PKC	NULL
{	NULL
and	NULL
A/v	NULL
isoforms	NULL
,	NULL
Rho	NULL
and	NULL
Rac	NULL
proteins	NULL
,	NULL
and	NULL
ceramide	NULL
or	NULL
reactive	NULL
oxygen	NULL
intermediates	NULL
(	NULL
ROIs	NULL
)	NULL
(	NULL
19	NULL
,	NULL
24	NULL
,	NULL
25	NULL
,	NULL
32	NULL
,	NULL
33	NULL
,	NULL
38	NULL
,	NULL
46	NULL
,	NULL
50-53	NULL
,	NULL
57	NULL
)	NULL
.	NULL

Such	NULL
a	NULL
large	NULL
number	NULL
of	NULL
controversial	NULL
studies	NULL
might	NULL
be	NULL
explained	NULL
by	NULL
cell	NULL
type	NULL
specificities	NULL
.	NULL

Indeed	NULL
,	NULL
most	NULL
of	NULL
these	NULL
studies	NULL
were	NULL
performed	NULL
with	NULL
a	NULL
single	NULL
cell	NULL
line	NULL
,	NULL
although	NULL
as	NULL
we	NULL
reported	NULL
the	NULL
roles	NULL
of	NULL
sphingomyelinases	NULL
,	NULL
PKC	NULL
A/	NULL
,	NULL
and	NULL
ROIs	NULL
in	NULL
NF-	NULL
«	NULL
B	NULL
activation	NULL
by	NULL
IL-1B	NULL
were	NULL
cell	NULL
specific	NULL
(	NULL
6-8	NULL
)	NULL
.	NULL

We	NULL
reported	NULL
that	NULL
an	NULL
oxidative	NULL
stress	NULL
favored	NULL
replication	NULL
of	NULL
the	NULL
human	NULL
immunodeficiency	NULL
virus	NULL
type	NULL
1	NULL
(	NULL
HIV-1	NULL
)	NULL
containing	NULL
a	NULL
tandem	NULL
KB	NULL
site	NULL
in	NULL
its	NULL
long	NULL
terminal	NULL
repeat	NULL
(	NULL
LTR	NULL
)	NULL
(	NULL
35	NULL
)	NULL
.	NULL

Later	NULL
on	NULL
,	NULL
the	NULL
authors	NULL
of	NULL
several	NULL
studies	NULL
proposed	NULL
that	NULL
ROIs	NULL
were	NULL
Vor	NULL
.	NULL

19	NULL
,	NULL
1999	NULL
produced	NULL
by	NULL
all	NULL
agents	NULL
and	NULL
were	NULL
required	NULL
for	NULL
NF-kB	NULL
activation	NULL
(	NULL
50-52	NULL
)	NULL
.	NULL

So	NULL
far	NULL
,	NULL
however	NULL
,	NULL
the	NULL
IB	NULL
kinases	NULL
activated	NULL
by	NULL
ROIs	NULL
have	NULL
not	NULL
yet	NULL
been	NULL
identified	NULL
.	NULL

More	NULL
recently	NULL
,	NULL
however	NULL
,	NULL
it	NULL
was	NULL
reported	NULL
that	NULL
the	NULL
effects	NULL
of	NULL
oxidants	NULL
and	NULL
antioxidants	NULL
on	NULL
NF-	NULL
«	NULL
B	NULL
activation	NULL
were	NULL
dependent	NULL
on	NULL
the	NULL
cell	NULL
line	NULL
and	NULL
on	NULL
the	NULL
applied	NULL
stimulus	NULL
(	NULL
10	NULL
,	NULL
11	NULL
)	NULL
.	NULL

We	NULL
also	NULL
reported	NULL
that	NULL
IL-18	NULL
induced	NULL
NF-kB	NULL
through	NULL
the	NULL
production	NULL
of	NULL
ROIs	NULL
in	NULL
lymphoid	NULL
cells	NULL
but	NULL
independently	NULL
of	NULL
any	NULL
ROI	NULL
production	NULL
in	NULL
epithelial	NULL
cells	NULL
(	NULL
6	NULL
)	NULL
.	NULL

These	NULL
data	NULL
indicate	NULL
that	NULL
the	NULL
role	NULL
of	NULL
ROIs	NULL
in	NULL
activation	NULL
is	NULL
probably	NULL
cell	NULL
specific	NULL
.	NULL

The	NULL
sources	NULL
of	NULL
ROIs	NULL
following	NULL
TNF-	NULL
«	NULL
or	NULL
IL-1B	NULL
treatment	NULL
are	NULL
still	NULL
largely	NULL
unknown	NULL
.	NULL

CD28	NULL
stimulation	NULL
of	NULL
T	NULL
lymphocytes	NULL
induces	NULL
ROI	NULL
production	NULL
through	NULL
an	NULL
increase	NULL
of	NULL
the	NULL
activity	NULL
of	NULL
5-lipoxygenase	NULL
(	NULL
5-LOX	NULL
)	NULL
(	NULL
37	NULL
)	NULL
,	NULL
an	NULL
enzyme	NULL
which	NULL
is	NULL
also	NULL
required	NULL
for	NULL
NF-	NULL
«	NULL
xB-dependent	NULL
transcription	NULL
induced	NULL
by	NULL
IL-18	NULL
in	NULL
endothelial	NULL
cells	NULL
(	NULL
34	NULL
)	NULL
.	NULL

The	NULL
5-LOX	NULL
enzyme	NULL
catalyzes	NULL
the	NULL
production	NULL
of	NULL
leukotrienes	NULL
and	NULL
ROIs	NULL
from	NULL
arachidonic	NULL
acid	NULL
(	NULL
29	NULL
,	NULL
36	NULL
)	NULL
.	NULL

Its	NULL
activity	NULL
requires	NULL
FLAP	NULL
(	NULL
5-LOX	NULL
activating	NULL
protein	NULL
)	NULL
,	NULL
which	NULL
transports	NULL
5-LOX	NULL
to	NULL
the	NULL
nuclear	NULL
membrane	NULL
(	NULL
23	NULL
,	NULL
43	NULL
,	NULL
48	NULL
,	NULL
63	NULL
)	NULL
.	NULL

Recently	NULL
,	NULL
we	NULL
reported	NULL
that	NULL
the	NULL
inhibition	NULL
of	NULL
5-LOX	NULL
in	NULL
lymphoid	NULL
cells	NULL
blocked	NULL
NF-	NULL
«	NULL
B	NULL
activation	NULL
after	NULL
IL-1B	NULL
or	NULL
arachidonic	NULL
acid	NULL
stimulation	NULL
(	NULL
7	NULL
)	NULL
.	NULL

Similarly	NULL
,	NULL
according	NULL
to	NULL
our	NULL
previous	NULL
data	NULL
,	NULL
the	NULL
absence	NULL
of	NULL
ROI	NULL
induction	NULL
in	NULL
IL-1B-treated	NULL
epithelial	NULL
cells	NULL
might	NULL
be	NULL
due	NULL
to	NULL
low	NULL
5-LOX	NULL
and	NULL
high	NULL
catalase	NULL
activities	NULL
(	NULL
7	NULL
)	NULL
.	NULL

However	NULL
,	NULL
there	NULL
are	NULL
other	NULL
sources	NULL
of	NULL
cellular	NULL
ROIs	NULL
,	NULL
including	NULL
the	NULL
NADPH	NULL
oxidase	NULL
which	NULL
is	NULL
expressed	NULL
not	NULL
only	NULL
in	NULL
mono-cytes/macrophages	NULL
and	NULL
polymorphonuclear	NULL
neutrophils	NULL
but	NULL
also	NULL
in	NULL
lymphocytes	NULL
(	NULL
54	NULL
)	NULL
.	NULL

In	NULL
the	NULL
present	NULL
study	NULL
,	NULL
we	NULL
investigated	NULL
the	NULL
roles	NULL
of	NULL
5-LOX	NULL
,	NULL
FLAP	NULL
,	NULL
and	NULL
NADPH	NULL
oxidase	NULL
in	NULL
the	NULL
IL-1B-induced	NULL
ROI	NULL
production	NULL
and	NULL
NF-B	NULL
activation	NULL
in	NULL
different	NULL
cell	NULL
types	NULL
.	NULL

MATERIALS	NULL
AND	NULL
METHODS	NULL
Cell	NULL
culture	NULL
and	NULL
biological	NULL
reagents	NULL
.	NULL

The	NULL
cell	NULL
lines	NULL
HL-60	NULL
,	NULL
U937	NULL
,	NULL
Jurkat	NULL
,	NULL
EL-4	NULL
,	NULL
Raji	NULL
,	NULL
OVCAR-3	NULL
,	NULL
SKOV-3	NULL
,	NULL
MCF7	NULL
A/Z	NULL
,	NULL
HCT-116	NULL
,	NULL
HT-29	NULL
,	NULL
and	NULL
HTM-29	NULL
were	NULL
grown	NULL
in	NULL
RPMI	NULL
1640	NULL
medium	NULL
(	NULL
Life	NULL
Technologies	NULL
)	NULL
supplemented	NULL
with	NULL
1	NULL
%	NULL
antibiotics	NULL
,	NULL
1	NULL
%	NULL
glutamine	NULL
,	NULL
and	NULL
10	NULL
%	NULL
fetal	NULL
bovine	NULL
serum	NULL
.	NULL

The	NULL
mouse	NULL
pre-B-cell	NULL
line	NULL
70Z/3	NULL
was	NULL
grown	NULL
in	NULL
RPMI	NULL
1640	NULL
medium	NULL
supplemented	NULL
with	NULL
10	NULL
%	NULL
fetal	NULL
bovine	NULL
serum	NULL
,	NULL
1	NULL
%	NULL
antibiotics	NULL
,	NULL
1	NULL
%	NULL
glutamine	NULL
,	NULL
and	NULL
10	NULL
mM	NULL
B-mercaptocthanol	NULL
.	NULL

Before	NULL
stimulation	NULL
,	NULL
70Z	NULL
,	NULL
/3	NULL
cells	NULL
were	NULL
grown	NULL
for	NULL
one	NULL
day	NULL
in	NULL
medium	NULL
without	NULL
B-mercaptocthanol	NULL
.	NULL

The	NULL
breast	NULL
cancer	NULL
cell	NULL
line	NULL
MCF7	NULL
A/Z	NULL
was	NULL
a	NULL
generous	NULL
gift	NULL
from	NULL
M.	NULL
Mareel	NULL
(	NULL
University	NULL
of	NULL
Ghent	NULL
,	NULL
Belgium	NULL
)	NULL
.	NULL

IL-16	NULL
treatment	NULL
was	NULL
carried	NULL
out	NULL
at	NULL
a	NULL
50-U/ml	NULL
concentration	NULL
(	NULL
specific	NULL
activity	NULL
,	NULL
>	NULL
5	NULL
X	NULL
10	NULL
``	NULL
U/mg	NULL
;	NULL
Boehringer	NULL
,	NULL
Mannheim	NULL
,	NULL
Germany	NULL
)	NULL
.	NULL

N-Acetyl-cysteine	NULL
(	NULL
NAC	NULL
)	NULL
or	NULL
pyrrolidine-9-dithiocarbamate	NULL
(	NULL
PDTC	NULL
)	NULL
was	NULL
added	NULL
to	NULL
the	NULL
medium	NULL
150	NULL
min	NULL
before	NULL
IL-1	NULL
$	NULL
stimulation	NULL
.	NULL

Cells	NULL
were	NULL
incubated	NULL
with	NULL
the	NULL
FLAP	NULL
inhibitor	NULL
MK-886	NULL
,	NULL
a	NULL
generous	NULL
gift	NULL
from	NULL
J.	NULL
Evans	NULL
(	NULL
Merck	NULL
Frosst	NULL
Centre	NULL
for	NULL
Therapeutic	NULL
Research	NULL
,	NULL
Quebec	NULL
,	NULL
Canada	NULL
)	NULL
(	NULL
40	NULL
)	NULL
,	NULL
for	NULL
10	NULL
min	NULL
before	NULL
IL-1B	NULL
stimulation	NULL
,	NULL
with	NULL
phenylarsine	NULL
oxide	NULL
(	NULL
PAQ	NULL
;	NULL
Sigma	NULL
)	NULL
for	NULL
1	NULL
h	NULL
prior	NULL
to	NULL
IL-1B	NULL
treatment	NULL
,	NULL
or	NULL
with	NULL
diphenylenciodo-nium	NULL
chloride	NULL
(	NULL
DPI	NULL
;	NULL
Sigma	NULL
)	NULL
or	NULL
eicosatetraynoic	NULL
acid	NULL
(	NULL
ETYA	NULL
;	NULL
Sigma	NULL
)	NULL
for	NULL
40	NULL
min	NULL
before	NULL
IL-1	NULL
$	NULL
stimulation	NULL
.	NULL

Immunoblots	NULL
.	NULL

Protein	NULL
extracts	NULL
(	NULL
30	NULL
mg	NULL
)	NULL
obtained	NULL
by	NULL
sodium	NULL
dodecyl	NULL
sulfate	NULL
(	NULL
SDS	NULL
)	NULL
lysis	NULL
were	NULL
separated	NULL
on	NULL
a	NULL
10	NULL
%	NULL
SDS-polyacrylamide	NULL
gel	NULL
electrophoresis	NULL
(	NULL
PAGE	NULL
)	NULL
gel	NULL
.	NULL

After	NULL
transfer	NULL
to	NULL
a	NULL
nylon	NULL
membrane	NULL
(	NULL
Immobilon-P	NULL
;	NULL
Millipore	NULL
,	NULL
Bedford	NULL
,	NULL
Mass	NULL
.	NULL
)	NULL

and	NULL
overnight	NULL
blocking	NULL
at	NULL
4°C	NULL
with	NULL
Tris-buffered	NULL
saline-Tween	NULL
(	NULL
20	NULL
mM	NULL
Tris	NULL
[	NULL
pH	NULL
7.5	NULL
]	NULL
,	NULL
500	NULL
mM	NULL
NaCl	NULL
,	NULL
0.2	NULL
%	NULL
Tween	NULL
20	NULL
plus	NULL
5	NULL
%	NULL
dry	NULL
milk	NULL
)	NULL
,	NULL
the	NULL
membranes	NULL
were	NULL
incubated	NULL
for	NULL
1	NULL
h	NULL
with	NULL
specific	NULL
antibodies	NULL
directed	NULL
against	NULL
human	NULL
5-LOX	NULL
and	NULL
FLAP	NULL
(	NULL
Merck	NULL
Frosst	NULL
Centre	NULL
for	NULL
Therapeutic	NULL
Research	NULL
)	NULL
,	NULL
washed	NULL
,	NULL
and	NULL
then	NULL
incubated	NULL
with	NULL
the	NULL
second	NULL
peroxidase-conjugated	NULL
antibody	NULL
.	NULL

The	NULL
reaction	NULL
was	NULL
revealed	NULL
by	NULL
the	NULL
enhanced	NULL
chemiluminescence	NULL
detection	NULL
method	NULL
(	NULL
ECL	NULL
kit	NULL
;	NULL
Amersham	NULL
,	NULL
Little	NULL
Chalfont	NULL
,	NULL
Buckinghamshire	NULL
,	NULL
United	NULL
King-dom	NULL
)	NULL
.	NULL

Fluorescence	NULL
measurement	NULL
of	NULL
intracellular	NULL
ROIs	NULL
.	NULL

Formation	NULL
of	NULL
ROIs	NULL
was	NULL
measured	NULL
using	NULL
dichlorofluorescein	NULL
diacetate	NULL
(	NULL
DFCH	NULL
)	NULL
(	NULL
6	NULL
)	NULL
.	NULL

The	NULL
cells	NULL
were	NULL
incubated	NULL
in	NULL
175-cm*	NULL
flasks	NULL
with	NULL
20	NULL
wM	NULL
DCFH	NULL
in	NULL
phenol	NULL
red-free	NULL
medium	NULL
199	NULL
.	NULL

After	NULL
15	NULL
min	NULL
,	NULL
the	NULL
medium	NULL
was	NULL
removed	NULL
and	NULL
the	NULL
cells	NULL
were	NULL
washed	NULL
and	NULL
incubated	NULL
with	NULL
IL-18	NULL
or	NULL
H	NULL
,	NULL
O	NULL
,	NULL
for	NULL
15	NULL
min	NULL
.	NULL

Fluorescence	NULL
was	NULL
measured	NULL
by	NULL
spectrofluorometry	NULL
with	NULL
excitation	NULL
at	NULL
505	NULL
nm	NULL
and	NULL
detection	NULL
of	NULL
light	NULL
emission	NULL
at	NULL
525	NULL
nm	NULL
.	NULL

ROI	NULL
concentrations	NULL
in	NULL
cytoplasmic	NULL
extracts	NULL
were	NULL
measured	NULL
as	NULL
previously	NULL
described	NULL
(	NULL
6	NULL
)	NULL
and	NULL
expressed	NULL
as	NULL
a	NULL
function	NULL
of	NULL
the	NULL
protein	NULL
content	NULL
in	NULL
nuclear	NULL
extracts	NULL
from	NULL
the	NULL
same	NULL
cells	NULL
.	NULL

The	NULL
measurements	NULL
were	NULL
performed	NULL
on	NULL
3	NULL
X	NULL
10°	NULL
cells	NULL
for	NULL
all	NULL
cell	NULL
types	NULL
with	NULL
the	NULL
exception	NULL
of	NULL
selected	NULL
CD20-positive	NULL
cells	NULL
,	NULL
for	NULL
which	NULL
measurements	NULL
were	NULL
made	NULL
on	NULL
1.2	NULL
x	NULL
10°	NULL
cells	NULL
.	NULL

NF-	NULL
«	NULL
B	NULL
ACTIVATION	NULL
BY	NULL
REACTIVE	NULL
OXYGEN	NULL
INTERMEDIATES	NULL
-	NULL
1951	NULL
3	NULL
n	NULL
3	NULL
mo	NULL
®	NULL
ps	NULL
a	NULL
1	NULL
S	NULL
ﬁggégggﬁé	NULL
3	NULL
s	NULL
4	NULL
&	NULL
H	NULL
3	NULL
3	NULL
4	NULL
§	NULL
a	NULL
E	NULL
R	NULL
rp	NULL
we	NULL
~-	NULL
A	NULL
<	NULL
me	NULL
«	NULL
owen	NULL
FIG	NULL
.	NULL

1	NULL
.	NULL

5-LOX	NULL
and	NULL
FLAP	NULL
expression	NULL
in	NULL
cell	NULL
lines	NULL
.	NULL

Protein	NULL
extracts	NULL
from	NULL
various	NULL
cell	NULL
lines	NULL
were	NULL
prepared	NULL
and	NULL
analyzed	NULL
for	NULL
5-LOX	NULL
(	NULL
A	NULL
)	NULL
and	NULL
FLAP	NULL
(	NULL
B	NULL
)	NULL
expression	NULL
by	NULL
immunoblots	NULL
revealed	NULL
with	NULL
specific	NULL
antibodies	NULL
.	NULL

The	NULL
5-LOX	NULL
antibody	NULL
was	NULL
directed	NULL
against	NULL
the	NULL
human	NULL
protein	NULL
and	NULL
could	NULL
not	NULL
detect	NULL
the	NULL
murine	NULL
enzyme	NULL
in	NULL
EL-4	NULL
and	NULL
70Z/3	NULL
cells	NULL
.	NULL

The	NULL
FLAP	NULL
antibody	NULL
could	NULL
recognize	NULL
both	NULL
the	NULL
human	NULL
and	NULL
the	NULL
murine	NULL
proteins	NULL
,	NULL
and	NULL
the	NULL
murine	NULL
protein	NULL
gave	NULL
a	NULL
faint	NULL
and	NULL
more	NULL
slowly	NULL
migrating	NULL
band	NULL
in	NULL
EL-4	NULL
and	NULL
70Z/3	NULL
cells	NULL
,	NULL
which	NULL
is	NULL
visible	NULL
after	NULL
longer	NULL
exposures	NULL
of	NULL
the	NULL
gel	NULL
.	NULL

Nuclear	NULL
protein	NULL
extraction	NULL
and	NULL
EMSA	NULL
.	NULL

Nuclear	NULL
protein	NULL
extracts	NULL
were	NULL
prepared	NULL
as	NULL
described	NULL
(	NULL
7	NULL
)	NULL
.	NULL

Briefly	NULL
,	NULL
the	NULL
pelleted	NULL
nuclei	NULL
were	NULL
resuspended	NULL
in	NULL
nuclear	NULL
buffer	NULL
(	NULL
20	NULL
mM	NULL
HEPES	NULL
[	NULL
pH	NULL
7.9	NULL
]	NULL
,	NULL
1.5	NULL
mM	NULL
MgCl	NULL
,	NULL
,	NULL
0.2	NULL
mM	NULL
EDTA	NULL
,	NULL
0.63	NULL
M	NULL
NaCl	NULL
,	NULL
25	NULL
%	NULL
glycerol	NULL
,	NULL
protease	NULL
inhibitors	NULL
[	NULL
protease	NULL
inhibitor	NULL
kit	NULL
;	NULL
Bochringer	NULL
]	NULL
)	NULL
,	NULL
incubated	NULL
for	NULL
20	NULL
min	NULL
at	NULL
4°C	NULL
,	NULL
and	NULL
centrifuged	NULL
for	NULL
30	NULL
min	NULL
at	NULL
14,000	NULL
rpm	NULL
in	NULL
an	NULL
Eppendorf	NULL
5415C	NULL
centrifuge	NULL
.	NULL

Protein	NULL
amounts	NULL
were	NULL
quantified	NULL
with	NULL
the	NULL
Micro	NULL
BCA	NULL
Protein	NULL
Assay	NULL
Reagent	NULL
kit	NULL
(	NULL
Pierce	NULL
,	NULL
Rockford	NULL
,	NULL
III	NULL
.	NULL
)	NULL

.	NULL

Electrophoretic	NULL
mobility	NULL
shift	NULL
assays	NULL
(	NULL
EMSA	NULL
)	NULL
were	NULL
performed	NULL
as	NULL
described	NULL
(	NULL
26	NULL
)	NULL
.	NULL

The	NULL
palindromic	NULL
(	NULL
PD	NULL
)	NULL
-	NULL
«	NULL
B	NULL
probe	NULL
was	NULL
5'-TTGGCAACGGCAGGGGAATTCCCCTCTCCITTA-3	NULL
'	NULL
.	NULL

Plasmids	NULL
.	NULL

The	NULL
reporter	NULL
plasmid	NULL
HIV-	NULL
«	NULL
kB-CAT	NULL
contained	NULL
the	NULL
two	NULL
xB	NULL
sites	NULL
from	NULL
the	NULL
HIV	NULL
LTR	NULL
cloned	NULL
upstream	NULL
of	NULL
a	NULL
chloramphenicol	NULL
acetyltransferase	NULL
(	NULL
CAT	NULL
)	NULL
reporter	NULL
gene	NULL
(	NULL
9	NULL
)	NULL
.	NULL

Expression	NULL
vectors	NULL
for	NULL
wild-type	NULL
and	NULL
mutant	NULL
RhoA	NULL
,	NULL
Racl	NULL
,	NULL
and	NULL
Cdc42	NULL
were	NULL
generous	NULL
gifts	NULL
from	NULL
L.	NULL
Cross	NULL
(	NULL
National	NULL
Institutes	NULL
of	NULL
Health	NULL
,	NULL
Bethesda	NULL
,	NULL
Md	NULL
.	NULL
)	NULL

(	NULL
18	NULL
,	NULL
46	NULL
)	NULL
.	NULL

The	NULL
5-LOX	NULL
and	NULL
FLAP	NULL
expression	NULL
vectors	NULL
were	NULL
received	NULL
from	NULL
J.	NULL
Evans	NULL
(	NULL
Merck	NULL
Frosst	NULL
Centre	NULL
for	NULL
Therapeutic	NULL
Research	NULL
)	NULL
.	NULL

The	NULL
pCMV-CD20	NULL
(	NULL
cluster	NULL
of	NULL
differentiation	NULL
20	NULL
antigen	NULL
)	NULL
plasmid	NULL
was	NULL
kindly	NULL
provided	NULL
by	NULL
Jim	NULL
Koh	NULL
(	NULL
Laboratory	NULL
of	NULL
Molecular	NULL
Oncology	NULL
,	NULL
Massachusetts	NULL
General	NULL
Hospital	NULL
and	NULL
Harvard	NULL
Medical	NULL
School	NULL
,	NULL
Cambridge	NULL
,	NULL
Mass	NULL
.	NULL
)	NULL

.	NULL

Transfections	NULL
.	NULL

Expression	NULL
vectors	NULL
(	NULL
1	NULL
pg	NULL
)	NULL
and	NULL
the	NULL
HIV-	NULL
«	NULL
B-CAT	NULL
reporter	NULL
plasmid	NULL
(	NULL
4	NULL
pg	NULL
)	NULL
were	NULL
transfected	NULL
into	NULL
HCT-116	NULL
and	NULL
MCF7	NULL
A/Z	NULL
cells	NULL
by	NULL
using	NULL
the	NULL
DOTAP	NULL
liposomal	NULL
transfection	NULL
reagent	NULL
(	NULL
Boehringer	NULL
Mannheim	NULL
)	NULL
.	NULL

After	NULL
6	NULL
h	NULL
,	NULL
the	NULL
DNA-containing	NULL
medium	NULL
was	NULL
removed	NULL
and	NULL
replaced	NULL
by	NULL
fresh	NULL
medium	NULL
.	NULL

Cells	NULL
were	NULL
then	NULL
left	NULL
untreated	NULL
or	NULL
were	NULL
stimulated	NULL
with	NULL
50	NULL
U	NULL
of	NULL
IL-18/ml	NULL
for	NULL
6	NULL
h.	NULL
Cellular	NULL
extracts	NULL
were	NULL
prepared	NULL
and	NULL
CAT	NULL
activity	NULL
was	NULL
determined	NULL
as	NULL
described	NULL
previously	NULL
(	NULL
9	NULL
)	NULL
.	NULL

U937	NULL
and	NULL
THP-1	NULL
cells	NULL
were	NULL
transfected	NULL
with	NULL
DEAE-dextran	NULL
(	NULL
Amersham	NULL
}	NULL
.	NULL

Cells	NULL
(	NULL
8	NULL
X	NULL
10°	NULL
cells	NULL
)	NULL
were	NULL
incubated	NULL
for	NULL
90	NULL
min	NULL
at	NULL
37°C	NULL
in	NULL
1	NULL
ml	NULL
of	NULL
Tris-buffered	NULL
saline	NULL
(	NULL
pH	NULL
7.6	NULL
)	NULL
containing	NULL
5	NULL
pg	NULL
of	NULL
total	NULL
DNA	NULL
and	NULL
400	NULL
ug	NULL
of	NULL
DEAE-dextran	NULL
.	NULL

After	NULL
10	NULL
%	NULL
dimethyl	NULL
sulfoxide	NULL
was	NULL
added	NULL
for	NULL
2	NULL
min	NULL
,	NULL
15	NULL
ml	NULL
of	NULL
Tris-buffered	NULL
saline	NULL
was	NULL
added	NULL
.	NULL

Cells	NULL
were	NULL
centrifuged	NULL
and	NULL
resuspended	NULL
in	NULL
1	NULL
ml	NULL
of	NULL
culture	NULL
medium	NULL
for	NULL
24	NULL
b	NULL
.	NULL

The	NULL
IL-1	NULL
$	NULL
stimulation	NULL
was	NULL
then	NULL
performed	NULL
after	NULL
the	NULL
addition	NULL
of	NULL
2	NULL
ml	NULL
of	NULL
fresh	NULL
medium	NULL
.	NULL

For	NULL
stable	NULL
transfections	NULL
,	NULL
MCF7	NULL
A/Z	NULL
cells	NULL
were	NULL
transfected	NULL
with	NULL
the	NULL
linearized	NULL
peDNA3	NULL
(	NULL
10	NULL
pg	NULL
)	NULL
empty	NULL
vector	NULL
or	NULL
with	NULL
the	NULL
5-LOX	NULL
expression	NULL
vector	NULL
(	NULL
10	NULL
pg	NULL
)	NULL
(	NULL
MCF7	NULL
A/Z	NULL
LOX	NULL
)	NULL
by	NULL
using	NULL
the	NULL
DOTAP	NULL
system	NULL
(	NULL
Bochringer	NULL
Mannheim	NULL
)	NULL
.	NULL

Forty-eight	NULL
hours	NULL
later	NULL
,	NULL
transfected	NULL
cells	NULL
were	NULL
selected	NULL
in	NULL
a	NULL
medium	NULL
containing	NULL
G418	NULL
at	NULL
0.5	NULL
mg/ml	NULL
.	NULL

After	NULL
15	NULL
days	NULL
of	NULL
selection	NULL
,	NULL
10	NULL
G418-resistant	NULL
colonies	NULL
were	NULL
isolated	NULL
,	NULL
grown	NULL
separately	NULL
,	NULL
and	NULL
selected	NULL
for	NULL
5-LOX	NULL
expression	NULL
by	NULL
immunoblotting	NULL
.	NULL

Positive	NULL
selection	NULL
of	NULL
CD20-positive	NULL
cells	NULL
.	NULL

Cells	NULL
transfected	NULL
with	NULL
the	NULL
CD20	NULL
expression	NULL
vectors	NULL
were	NULL
washed	NULL
,	NULL
incubated	NULL
in	NULL
the	NULL
presence	NULL
of	NULL
a	NULL
fluorescein	NULL
isothiocyanate	NULL
(	NULL
FITC	NULL
)	NULL
-conjugated	NULL
anti-CD20	NULL
monoclonal	NULL
antibody	NULL
(	NULL
Sanver	NULL
Tech	NULL
,	NULL
Boechout	NULL
,	NULL
Belgium	NULL
)	NULL
for	NULL
30	NULL
min	NULL
,	NULL
washed	NULL
again	NULL
,	NULL
and	NULL
then	NULL
incubated	NULL
with	NULL
magnetic	NULL
beads	NULL
coated	NULL
with	NULL
a	NULL
monoclonal	NULL
anti-FITC	NULL
antibody	NULL
(	NULL
Miltenyi	NULL
Biotec	NULL
,	NULL
Germany	NULL
)	NULL
.	NULL

The	NULL
beads	NULL
were	NULL
loaded	NULL
on	NULL
columns	NULL
in	NULL
a	NULL
magnetic	NULL
field	NULL
,	NULL
and	NULL
positive	NULL
cells	NULL
were	NULL
finally	NULL
eluted	NULL
in	NULL
culture	NULL
medium	NULL
.	NULL

1952	NULL
BONIZZI	NULL
ET	NULL
AL	NULL
.	NULL

Mor	NULL
.	NULL

CELL	NULL
.	NULL

BroL	NULL
.	NULL

A	NULL
:	NULL
RAJI	NULL
B	NULL
:	NULL
U937	NULL
B	NULL
=	NULL
d	NULL
s	NULL
in	NULL
#	NULL
=	NULL
&	NULL
4	NULL
&	NULL
a	NULL
11012	NULL
13	NULL
14	NULL
IL-I1B	NULL
.	NULL
}	NULL

4	NULL
4	NULL
4	NULL
4	NULL
o	NULL
o-	NULL
+0	NULL
¢	NULL
4	NULL
0o-HjOQp	NULL
-	NULL
>	NULL
>	NULL
&	NULL
o	NULL
>	NULL
>	NULL
>	NULL
>	NULL
>	NULL
*	NULL
8060+	NULL
so	NULL
8k	NULL
k	NULL
e	NULL
kk	NULL
k	NULL
8	NULL
#	NULL
mon	NULL
n	NULL
*	NULL
N_	NULL
__P_	NULL
MK	NULL
ETYA	NULL
N	NULL
P__	NULL
_MK	NULL
ETYA	NULL
C	NULL
:	NULL
THP-1	NULL
D	NULL
:	NULL
MCF7A/Z	NULL
E	NULL
:	NULL
HCT-116	NULL
1,5	NULL
1,5	NULL
&	NULL
=	NULL
wn	NULL
C	NULL
\n	NULL
®	NULL
&	NULL
&	NULL
4	NULL
R	NULL
@	NULL
0	NULL
102	NULL
3	NULL
4	NULL
5	NULL
6	NULL
7	NULL
8	NULL
9	NULL
10	NULL
100	NULL
2003	NULL
4	NULL
IL-1B	NULL
|	NULL
-	NULL
.	NULL

4	NULL
404	NULL
#	NULL
#	NULL
4	NULL
40	NULL
.	NULL

+0	NULL
40+	NULL
o-	NULL
200k	NULL
0	NULL
0	NULL
%	NULL
80k	NULL
0	NULL
#	NULL
00	NULL
>	NULL
-	NULL
>	NULL
>	NULL
6	NULL
>	NULL
>	NULL
6	NULL
>	NULL
>	NULL
0+	NULL
20	NULL
.	NULL

020+	NULL
200k	NULL
2	NULL
+	NULL
#	NULL
200k	NULL
00k	NULL
0	NULL
+	NULL
N	NULL
P	NULL
MK	NULL
ETYA	NULL
FIG	NULL
.	NULL

2	NULL
.	NULL

Production	NULL
of	NULL
ROIs	NULL
following	NULL
stimulation	NULL
.	NULL

Formation	NULL
of	NULL
ROIs	NULL
was	NULL
measured	NULL
using	NULL
a	NULL
DFCH	NULL
probe	NULL
in	NULL
unstimulated	NULL
and	NULL
IL-1	NULL
6-stimulated	NULL
cells	NULL
.	NULL

Panels	NULL
A	NULL
,	NULL
B	NULL
,	NULL
and	NULL
C	NULL
show	NULL
the	NULL
relative	NULL
fluorescence	NULL
emission	NULL
at	NULL
525	NULL
nm	NULL
of	NULL
the	NULL
DFCH	NULL
probe	NULL
in	NULL
Raji	NULL
,	NULL
U937	NULL
,	NULL
and	NULL
THP-1	NULL
cells	NULL
.	NULL

Columns	NULL
1	NULL
,	NULL
background	NULL
(	NULL
no	NULL
DFCH	NULL
probe	NULL
)	NULL
;	NULL
columns	NULL
2	NULL
,	NULL
unstimulated	NULL
cells	NULL
;	NULL
columns	NULL
3	NULL
,	NULL
stimulation	NULL
with	NULL
IL-18	NULL
(	NULL
50	NULL
U/ml	NULL
)	NULL
;	NULL
columns	NULL
4	NULL
,	NULL
as	NULL
in	NULL
columns	NULL
3	NULL
plus	NULL
NAC	NULL
(	NULL
10	NULL
mM	NULL
)	NULL
;	NULL
columns	NULL
5	NULL
,	NULL
as	NULL
in	NULL
columns	NULL
3	NULL
plus	NULL
NAC	NULL
(	NULL
20	NULL
mM	NULL
)	NULL
;	NULL
columns	NULL
6	NULL
,	NULL
as	NULL
in	NULL
columns	NULL
3	NULL
plus	NULL
PDTC	NULL
(	NULL
60	NULL
M	NULL
)	NULL
;	NULL
columns	NULL
7	NULL
,	NULL
as	NULL
in	NULL
columns	NULL
3	NULL
plus	NULL
PDTC	NULL
(	NULL
100	NULL
wM	NULL
)	NULL
;	NULL
columns	NULL
8	NULL
,	NULL
as	NULL
in	NULL
columns	NULL
3	NULL
plus	NULL
MK886	NULL
(	NULL
0.5	NULL
M	NULL
)	NULL
;	NULL
columns	NULL
9	NULL
,	NULL
as	NULL
in	NULL
columns	NULL
3	NULL
plus	NULL
MK886	NULL
(	NULL
1	NULL
wM	NULL
)	NULL
;	NULL
columns	NULL
11	NULL
,	NULL
stimulation	NULL
with	NULL
IL-18	NULL
(	NULL
50	NULL
U/m	NULL
!	NULL

1	NULL
)	NULL
;	NULL
columns	NULL
12	NULL
,	NULL
as	NULL
in	NULL
columns	NULL
11	NULL
plus	NULL
ETYA	NULL
(	NULL
35	NULL
M	NULL
)	NULL
;	NULL
columns	NULL
13	NULL
,	NULL
as	NULL
in	NULL
columns	NULL
11	NULL
plus	NULL
ETYA	NULL
(	NULL
65	NULL
pM	NULL
)	NULL
;	NULL
columns	NULL
10	NULL
and	NULL
14	NULL
,	NULL
stimulation	NULL
with	NULL
HO	NULL
,	NULL
(	NULL
250	NULL
M	NULL
)	NULL
.	NULL

Panels	NULL
D	NULL
and	NULL
E	NULL
show	NULL
the	NULL
relative	NULL
fluorescence	NULL
emission	NULL
at	NULL
525	NULL
nm	NULL
of	NULL
the	NULL
DFCH	NULL
probe	NULL
in	NULL
MCF7	NULL
A/Z	NULL
and	NULL
HCT-116	NULL
cells	NULL
.	NULL

Columns	NULL
1	NULL
,	NULL
background	NULL
(	NULL
no	NULL
DFCH	NULL
probe	NULL
)	NULL
;	NULL
columns	NULL
2	NULL
,	NULL
unstimulated	NULL
cells	NULL
;	NULL
columns	NULL
3	NULL
,	NULL
stimulation	NULL
with	NULL
IL-18	NULL
(	NULL
50	NULL
U/ml	NULL
)	NULL
;	NULL
columns	NULL
4	NULL
,	NULL
stimulation	NULL
with	NULL
H	NULL
,	NULL
O	NULL
,	NULL
(	NULL
250	NULL
pM	NULL
)	NULL
.	NULL

Asterisks	NULL
indicate	NULL
that	NULL
the	NULL
values	NULL
were	NULL
statistically	NULL
different	NULL
from	NULL
the	NULL
reference	NULL
values	NULL
(	NULL
A	NULL
)	NULL
.	NULL

NAC	NULL
_	NULL
PDTC	NULL
_	NULL
MK88é	NULL
ETYA	NULL
NAC	NULL
_	NULL
PDTC	NULL
_	NULL
MK88é	NULL
ETVA	NULL
3	NULL
2	NULL
<	NULL
a	NULL
5	NULL
5	NULL
«	NULL
z	NULL
o	NULL
bi	NULL
o	NULL
Li	NULL
s	NULL
a	NULL
s	NULL
§	NULL
1	NULL
3	NULL
-	NULL
#	NULL
ss	NULL
s	NULL
§	NULL
.	NULL

¢	NULL
2	NULL
#	NULL
i	NULL
lL	NULL
“	NULL
1l3-1-+++++-9-+	NULL
+o+	NULL
+	NULL
-o	NULL
t	NULL
4	NULL
4	NULL
bo	NULL
#	NULL
4	NULL
+o	NULL
+o	NULL
+	NULL
%	NULL
``	NULL
WQ	NULL
lull	NULL
)	NULL
-	NULL
sz	NULL
Wink	NULL
E	NULL
6	NULL
bb	NULL
no	NULL
$	NULL
#	NULL
B4	NULL
44	NULL
L4	NULL
l	NULL
“	NULL
.	NULL

FIG	NULL
.	NULL

3	NULL
.	NULL

ROI	NULL
or	NULL
5-LOX	NULL
inhibitors	NULL
blocked	NULL
NF-	NULL
«	NULL
B	NULL
activation	NULL
by	NULL
IL-1B	NULL
in	NULL
a	NULL
cell-specific	NULL
manner	NULL
.	NULL

Nuclear	NULL
extracts	NULL
were	NULL
prepared	NULL
from	NULL
Raji	NULL
(	NULL
A	NULL
)	NULL
,	NULL
U937	NULL
(	NULL
B	NULL
)	NULL
,	NULL
THP-1	NULL
(	NULL
C	NULL
)	NULL
,	NULL
HCT116	NULL
(	NULL
D	NULL
)	NULL
,	NULL
or	NULL
MCF7	NULL
A/Z	NULL
(	NULL
E	NULL
)	NULL
cells	NULL
,	NULL
either	NULL
untreated	NULL
or	NULL
stimulated	NULL
with	NULL
IL-1B	NULL
(	NULL
50	NULL
U/ml	NULL
)	NULL
.	NULL

The	NULL
same	NULL
cells	NULL
were	NULL
preincubated	NULL
prior	NULL
to	NULL
IL-1B	NULL
stimulation	NULL
with	NULL
increasing	NULL
concentrations	NULL
of	NULL
NAC	NULL
,	NULL
PDTC	NULL
,	NULL
MK886	NULL
,	NULL
or	NULL
ETYA	NULL
,	NULL
as	NULL
indicated	NULL
in	NULL
the	NULL
figure	NULL
.	NULL

These	NULL
extracts	NULL
were	NULL
analyzed	NULL
by	NULL
EMSA	NULL
for	NULL
binding	NULL
to	NULL
a	NULL
specific	NULL
kB	NULL
probe	NULL
.	NULL

Vou	NULL
.	NULL

19	NULL
,	NULL
1999	NULL
NF-	NULL
«	NULL
B	NULL
ACTIVATION	NULL
BY	NULL
REACTIVE	NULL
OXYGEN	NULL
INTERMEDIATES	NULL
-	NULL
1953	NULL
A	NULL
:	NULL
MCF7A/Z	NULL
B	NULL
:	NULL
MCF7A/Z	NULL
-LOX	NULL
Relative	NULL
CAT-Activity	NULL
w	NULL
to	NULL
a	NULL
tn	NULL
a	NULL
s	NULL
co	NULL
io	NULL
re	NULL
to	NULL
a	NULL
in	NULL
on	NULL
s	NULL
co	NULL
io	NULL
C	NULL
:	NULL
MCF7A/Z	NULL
D	NULL
:	NULL
MCF7A/Z	NULL
-LOX	NULL
B	NULL
C	NULL
Fd	NULL
sl	NULL
is	NULL
a	NULL
&	NULL
=	NULL
&	NULL
4	NULL
B	NULL
@	NULL
1	NULL
3	NULL
4	NULL
102	NULL
3	NULL
4	NULL
50	NULL
6	NULL
7	NULL
8	NULL
9	NULL
10	NULL
1112	NULL
13	NULL
14	NULL
15	NULL
16	NULL
FLAP	NULL
-o	NULL
o+	NULL
+	NULL
+	NULL
Kos	NULL
s	NULL
dot	NULL
tot	NULL
od	NULL
$	NULL
oto	NULL
+o	NULL
t	NULL
+o+	NULL
ILA4B	NULL
10	NULL
20	NULL
q	NULL
0	NULL
.	NULL

-k	NULL
6	NULL
$	NULL
tot	NULL
t	NULL
4	NULL
4	NULL
g	NULL
-	NULL
+o	NULL
+	NULL
+	NULL
H,0p	NULL
=	NULL
-	NULL
~	NULL
+	NULL
no	NULL
€	NULL
9	NULL
8	NULL
8	NULL
8	NULL
®	NULL
s	NULL
s	NULL
+	NULL
s	NULL
#	NULL
-o	NULL
>	NULL
+	NULL
_N___P_	NULL
MK	NULL
EIYA	NULL
FIG	NULL
.	NULL

4	NULL
.	NULL

Transfection	NULL
of	NULL
5-LOX	NULL
and	NULL
FLAP	NULL
expression	NULL
vectors	NULL
restored	NULL
ROI	NULL
production	NULL
and	NULL
ROI-dependent	NULL
NF-xB	NULL
activity	NULL
in	NULL
MCF7	NULL
A/Z	NULL
cells	NULL
.	NULL

(	NULL
A	NULL
)	NULL
MCF	NULL
A/Z	NULL
cells	NULL
were	NULL
transfected	NULL
with	NULL
the	NULL
HIV-kB-CAT	NULL
reporter	NULL
plasmid	NULL
alone	NULL
or	NULL
together	NULL
with	NULL
a	NULL
FLAP	NULL
expression	NULL
vector	NULL
,	NULL
and	NULL
CAT	NULL
activities	NULL
were	NULL
measured	NULL
in	NULL
unstimulated	NULL
cells	NULL
or	NULL
in	NULL
cells	NULL
stimulated	NULL
with	NULL
IL-16	NULL
for	NULL
6	NULL
h	NULL
(	NULL
50	NULL
U/m	NULL
!	NULL
)	NULL

,	NULL
as	NULL
indicated	NULL
in	NULL
the	NULL
figure	NULL
.	NULL

The	NULL
IL-1B	NULL
treatment	NULL
was	NULL
performed	NULL
in	NULL
the	NULL
absence	NULL
or	NULL
in	NULL
the	NULL
presence	NULL
of	NULL
either	NULL
the	NULL
FLAP	NULL
inhibitor	NULL
MK886	NULL
at	NULL
0.5	NULL
M	NULL
(	NULL
column	NULL
5	NULL
)	NULL
and	NULL
1	NULL
wM	NULL
(	NULL
column	NULL
6	NULL
)	NULL
or	NULL
the	NULL
5-LOX	NULL
inhibitor	NULL
ETYA	NULL
at	NULL
35	NULL
M	NULL
(	NULL
column	NULL
8	NULL
)	NULL
and	NULL
65	NULL
wM	NULL
(	NULL
column	NULL
9	NULL
)	NULL
.	NULL

Each	NULL
column	NULL
represents	NULL
the	NULL
mean	NULL
of	NULL
three	NULL
independent	NULL
experiments	NULL
(	NULL
+	NULL
SD	NULL
)	NULL
.	NULL

We	NULL
did	NULL
not	NULL
observe	NULL
any	NULL
statistically	NULL
significant	NULL
differences	NULL
between	NULL
cells	NULL
stimulated	NULL
by	NULL
IL-1	NULL
in	NULL
the	NULL
presence	NULL
or	NULL
absence	NULL
of	NULL
the	NULL
inhibitors	NULL
.	NULL

The	NULL
total	NULL
amount	NULL
of	NULL
transfected	NULL
DNA	NULL
was	NULL
kept	NULL
constant	NULL
throughout	NULL
the	NULL
experiment	NULL
by	NULL
addition	NULL
of	NULL
appropriate	NULL
amounts	NULL
of	NULL
the	NULL
expression	NULL
vector	NULL
without	NULL
insert	NULL
.	NULL

(	NULL
B	NULL
)	NULL
MCF	NULL
A/Z	NULL
cells	NULL
stably	NULL
transfected	NULL
with	NULL
the	NULL
5-LOX	NULL
expression	NULL
vector	NULL
(	NULL
MCF	NULL
A/Z-LOX	NULL
)	NULL
were	NULL
transfected	NULL
with	NULL
the	NULL
HIV-	NULL
«	NULL
B-CAT	NULL
reporter	NULL
plasmid	NULL
alone	NULL
or	NULL
together	NULL
with	NULL
a	NULL
FLAP	NULL
expression	NULL
vector	NULL
,	NULL
and	NULL
CAT	NULL
activities	NULL
were	NULL
measured	NULL
in	NULL
unstimulated	NULL
cells	NULL
or	NULL
in	NULL
cells	NULL
stimulated	NULL
with	NULL
IL-1B	NULL
as	NULL
described	NULL
for	NULL
panel	NULL
A.	NULL
Asterisks	NULL
indicate	NULL
that	NULL
values	NULL
were	NULL
statistically	NULL
different	NULL
from	NULL
the	NULL
reference	NULL
values	NULL
(	NULL
A	NULL
)	NULL
.	NULL

(	NULL
C	NULL
)	NULL
Formation	NULL
of	NULL
ROIs	NULL
was	NULL
measured	NULL
by	NULL
using	NULL
DFCH	NULL
in	NULL
MCF7	NULL
A/Z	NULL
cells	NULL
transiently	NULL
transfected	NULL
with	NULL
the	NULL
FLAP	NULL
expression	NULL
vector	NULL
.	NULL

Column	NULL
1	NULL
,	NULL
background	NULL
(	NULL
no	NULL
DFCH	NULL
probe	NULL
)	NULL
;	NULL
column	NULL
2	NULL
,	NULL
unstimulated	NULL
cells	NULL
;	NULL
column	NULL
3	NULL
,	NULL
stimulation	NULL
with	NULL
IL-1B	NULL
(	NULL
50	NULL
U/ml	NULL
)	NULL
;	NULL
column	NULL
4	NULL
,	NULL
stimulation	NULL
with	NULL
H	NULL
,	NULL
O	NULL
,	NULL
(	NULL
250	NULL
M	NULL
)	NULL
.	NULL

(	NULL
D	NULL
)	NULL
ROI	NULL
production	NULL
in	NULL
MCF7	NULL
A/Z-LOX	NULL
cells	NULL
either	NULL
unmodified	NULL
or	NULL
transiently	NULL
transfected	NULL
with	NULL
the	NULL
FLAP	NULL
expression	NULL
vector	NULL
.	NULL

Column	NULL
1	NULL
,	NULL
background	NULL
(	NULL
no	NULL
DFCH	NULL
probe	NULL
)	NULL
;	NULL
column	NULL
2	NULL
,	NULL
unstimulated	NULL
cells	NULL
;	NULL
column	NULL
3	NULL
,	NULL
stimulation	NULL
with	NULL
IL-18	NULL
(	NULL
50	NULL
U/ml	NULL
)	NULL
;	NULL
column	NULL
4	NULL
,	NULL
FLAP-transfected	NULL
unstimulated	NULL
cells	NULL
;	NULL
column	NULL
5	NULL
,	NULL
FLAP-transfected	NULL
cells	NULL
stimulated	NULL
with	NULL
IL-1B	NULL
(	NULL
50	NULL
U/ml	NULL
)	NULL
;	NULL
column	NULL
6	NULL
,	NULL
as	NULL
in	NULL
column	NULL
5	NULL
plus	NULL
NAC	NULL
(	NULL
10	NULL
mM	NULL
)	NULL
;	NULL
column	NULL
7	NULL
,	NULL
as	NULL
in	NULL
column	NULL
5	NULL
plus	NULL
NAC	NULL
(	NULL
20	NULL
mM	NULL
)	NULL
;	NULL
column	NULL
8	NULL
,	NULL
as	NULL
in	NULL
column	NULL
5	NULL
plus	NULL
PDTC	NULL
(	NULL
60	NULL
M	NULL
)	NULL
;	NULL
column	NULL
9	NULL
,	NULL
as	NULL
in	NULL
column	NULL
5	NULL
plus	NULL
PDTC	NULL
(	NULL
100	NULL
M	NULL
)	NULL
;	NULL
column	NULL
10	NULL
,	NULL
as	NULL
in	NULL
column	NULL
5	NULL
plus	NULL
MK886	NULL
(	NULL
0.5	NULL
M	NULL
)	NULL
;	NULL
column	NULL
11	NULL
,	NULL
as	NULL
in	NULL
column	NULL
5	NULL
plus	NULL
MK886	NULL
(	NULL
1	NULL
M	NULL
)	NULL
;	NULL
column	NULL
13	NULL
,	NULL
stimulation	NULL
with	NULL
IL-16	NULL
(	NULL
50	NULL
U/ml	NULL
)	NULL
;	NULL
column	NULL
14	NULL
,	NULL
as	NULL
in	NULL
column	NULL
13	NULL
plus	NULL
ETYA	NULL
(	NULL
35	NULL
M	NULL
)	NULL
;	NULL
column	NULL
15	NULL
,	NULL
as	NULL
in	NULL
column	NULL
13	NULL
plus	NULL
ETYA	NULL
(	NULL
65	NULL
aM	NULL
)	NULL
;	NULL
columns	NULL
12	NULL
and	NULL
16	NULL
,	NULL
stimulation	NULL
with	NULL
HO	NULL
,	NULL
(	NULL
250	NULL
wM	NULL
)	NULL
.	NULL

Asterisks	NULL
indicate	NULL
that	NULL
values	NULL
were	NULL
statistically	NULL
different	NULL
from	NULL
the	NULL
reference	NULL
values	NULL
(	NULL
A	NULL
)	NULL
.	NULL

Magnetic	NULL
cell	NULL
sorting	NULL
(	NULL
MACS	NULL
)	NULL
-selected	NULL
cells	NULL
were	NULL
further	NULL
purified	NULL
by	NULL
flow	NULL
RESULTS	NULL
cytometry	NULL
.	NULL

Briefly	NULL
,	NULL
cells	NULL
were	NULL
incubated	NULL
with	NULL
the	NULL
same	NULL
FITC-conjugated	NULL
anti	NULL
CD20	NULL
monoclonal	NULL
antibody	NULL
and	NULL
selected	NULL
by	NULL
using	NULL
a	NULL
flow	NULL
cell	NULL
sorter	NULL
(	NULL
FACStar	NULL
F	NULL
_	NULL
LAP	NULL
i	NULL
:	NULL
F	NULL
Plus	NULL
;	NULL
Becton	NULL
Dickinson	NULL
,	NULL
San	NULL
Jose	NULL
,	NULL
Calif.	NULL
)	NULL
with	NULL
a	NULL
100	NULL
mW	NULL
air-cooled	NULL
argon	NULL
laser	NULL
EXPreSSlon	NULL
of	NULL
5-LOX	NULL
and	NULL
F	NULL
in	NULL
cell	NULL
lines	NULL
.	NULL

The	NULL
expression	NULL
(	NULL
Spinnaker	NULL
1161	NULL
;	NULL
Spectra	NULL
Physics	NULL
,	NULL
Mountain	NULL
View	NULL
,	NULL
Calif.	NULL
)	NULL
and	NULL
the	NULL
CellQuest	NULL
9f	NULL
5	NULL
“	NULL
LOX	NULL
and	NULL
FLAP	NULL
pIOteins	NULL
was	NULL
analyzed	NULL
by	NULL
immun0b1	NULL
?	NULL

tting	NULL
software	NULL
(	NULL
Becton	NULL
Dickinson	NULL
)	NULL
for	NULL
Macintosh	NULL
Facstation	NULL
.	NULL

CD20-positive	NULL
cells	NULL
in	NULL
various	NULL
cell	NULL
lines	NULL
from	NULL
different	NULL
lineages	NULL
,	NULL
as	NULL
follows	NULL
(	NULL
Fig	NULL
.	NULL

1	NULL
)	NULL
:	NULL
(	NULL
1.2	NULL
x	NULL
1T	NULL
06115	NULL
)	NULL
(	NULL
Pfiz	NULL
,	NULL
>	NULL
90	NULL
%	NULL
)	NULL
were	NULL
stimulated	NULL
with	NULL
IL-1B	NULL
,	NULL
and	NULL
the	NULL
ROIs	NULL
were	NULL
monocytic	NULL
cells	NULL
(	NULL
HL-60	NULL
and	NULL
U937	NULL
)	NULL
,	NULL
lymphoid	NULL
B	NULL
and	NULL
T	NULL
cells	NULL
measured	NULL
,	NULL
as	NULL
described	NULL
.	NULL

_	NULL
r	NULL
:	NULL
r	NULL
Statistical	NULL
analysis	NULL
.	NULL

Data	NULL
are	NULL
presented	NULL
as	NULL
means	NULL
+	NULL
standard	NULL
deviations	NULL
(	NULL
SDs	NULL
)	NULL
.	NULL

(	NULL
Jurkat	NULL
’	NULL
EL-4	NULL
,	NULL
707/3	NULL
,	NULL
and	NULL
Rap	NULL
)	NULL
¥	NULL
ovarl.an	NULL
carcinoma	NULL
cells	NULL
Differences	NULL
between	NULL
measures	NULL
were	NULL
assessed	NULL
by	NULL
Student	NULL
's	NULL
¢	NULL
tests	NULL
for	NULL
unpaired	NULL
(	NULL
OVCAR	NULL
'	NULL
3	NULL
and	NULL
SKOV	NULL
'	NULL
3	NULL
)	NULL
’	NULL
breast	NULL
carcinoma	NULL
cells	NULL
(	NULL
MCF7	NULL
data	NULL
.	NULL

A	NULL
P	NULL
value	NULL
of	NULL
less	NULL
than	NULL
0.05	NULL
was	NULL
considered	NULL
significant	NULL
.	NULL

A/Z	NULL
)	NULL
,	NULL
and	NULL
colon	NULL
carcinoma	NULL
cells	NULL
(	NULL
HCT-116	NULL
,	NULL
HT-29	NULL
,	NULL
and	NULL
HTM-	NULL
1954	NULL
BONIZZI	NULL
ET	NULL
AL	NULL
.	NULL

A	NULL
24	NULL
I	NULL
>	NULL
Relative	NULL
CAT-Activity	NULL
3	NULL
a	NULL
Fd	NULL
C	NULL
tn	NULL
®	NULL
A	NULL
.S	NULL
4	NULL
&	NULL
@	NULL
1	NULL
2	NULL
3	NULL
4	NULL
50	NULL
6	NULL
708	NULL
9	NULL
10	NULL
11	NULL
12	NULL
13	NULL
14	NULL
FLAP	NULL
=o	NULL
n	NULL
t	NULL
e	NULL
odo	NULL
#	NULL
404	NULL
4	NULL
0	NULL
%	NULL
+o	NULL
ot	NULL
+	NULL
+	NULL
IL-18	NULL
soe	NULL
4	NULL
#	NULL
ode	NULL
ode	NULL
oo	NULL
400+	NULL
+o	NULL
+0	NULL
+	NULL
-	NULL
-	NULL
>	NULL
>	NULL
>	NULL
>	NULL
>	NULL
>	NULL
>	NULL
*	NULL
800k	NULL
0060+	NULL
N	NULL
P__	NULL
MK	NULL
ETYA	NULL
FIG	NULL
.	NULL

5	NULL
.	NULL

Transfection	NULL
of	NULL
the	NULL
FLAP	NULL
expression	NULL
vector	NULL
restored	NULL
ROI	NULL
production	NULL
and	NULL
ROI-dependent	NULL
NF-	NULL
«	NULL
B	NULL
activity	NULL
in	NULL
HCT-116	NULL
cells	NULL
.	NULL

(	NULL
A	NULL
)	NULL
HCT-116	NULL
cells	NULL
were	NULL
transfected	NULL
with	NULL
the	NULL
HIV-	NULL
«	NULL
kB-CAT	NULL
reporter	NULL
plasmid	NULL
alone	NULL
or	NULL
together	NULL
with	NULL
a	NULL
FLAP	NULL
expression	NULL
vector	NULL
,	NULL
and	NULL
CAT	NULL
activities	NULL
were	NULL
measured	NULL
in	NULL
unstimulated	NULL
cells	NULL
or	NULL
in	NULL
cells	NULL
stimulated	NULL
with	NULL
IL-186	NULL
for	NULL
6	NULL
h	NULL
(	NULL
50	NULL
U/ml	NULL
)	NULL
,	NULL
as	NULL
indicated	NULL
in	NULL
the	NULL
figure	NULL
.	NULL

The	NULL
IL-1§6	NULL
treatment	NULL
was	NULL
performed	NULL
in	NULL
the	NULL
absence	NULL
or	NULL
in	NULL
the	NULL
presence	NULL
of	NULL
either	NULL
the	NULL
FLAP	NULL
inhibitor	NULL
MK886	NULL
at	NULL
0.5	NULL
M	NULL
(	NULL
column	NULL
5	NULL
)	NULL
and	NULL
1	NULL
wM	NULL
(	NULL
column	NULL
6	NULL
)	NULL
or	NULL
the	NULL
5-LOX	NULL
inhibitor	NULL
ETYA	NULL
at	NULL
35	NULL
M	NULL
(	NULL
column	NULL
8	NULL
)	NULL
and	NULL
65	NULL
M	NULL
(	NULL
column	NULL
9	NULL
)	NULL
.	NULL

Each	NULL
column	NULL
represents	NULL
the	NULL
mean	NULL
of	NULL
three	NULL
independent	NULL
experiments	NULL
(	NULL
+	NULL
SD	NULL
)	NULL
.	NULL

Asterisks	NULL
indicate	NULL
that	NULL
values	NULL
were	NULL
statistically	NULL
different	NULL
from	NULL
the	NULL
reference	NULL
values	NULL
(	NULL
A	NULL
)	NULL
.	NULL

(	NULL
B	NULL
)	NULL
Formation	NULL
of	NULL
ROIs	NULL
in	NULL
HCT-116	NULL
cells	NULL
transiently	NULL
transfected	NULL
with	NULL
the	NULL
FLAP	NULL
expression	NULL
vector	NULL
.	NULL

Column	NULL
1	NULL
,	NULL
background	NULL
(	NULL
no	NULL
DFCH	NULL
probe	NULL
)	NULL
;	NULL
column	NULL
2	NULL
,	NULL
unstimu-lated	NULL
,	NULL
FLAP	NULL
transfected	NULL
cells	NULL
;	NULL
column	NULL
3	NULL
,	NULL
stimulation	NULL
with	NULL
IL-18	NULL
(	NULL
50	NULL
U/ml	NULL
)	NULL
;	NULL
column	NULL
4	NULL
,	NULL
as	NULL
in	NULL
column	NULL
3	NULL
plus	NULL
NAC	NULL
(	NULL
10	NULL
mM	NULL
)	NULL
;	NULL
column	NULL
5	NULL
,	NULL
as	NULL
in	NULL
column	NULL
3	NULL
plus	NULL
NAC	NULL
(	NULL
20	NULL
mM	NULL
)	NULL
;	NULL
column	NULL
6	NULL
,	NULL
as	NULL
in	NULL
column	NULL
3	NULL
plus	NULL
PDTC	NULL
(	NULL
60	NULL
M	NULL
)	NULL
;	NULL
column	NULL
7	NULL
,	NULL
as	NULL
in	NULL
column	NULL
3	NULL
plus	NULL
PDTC	NULL
(	NULL
100	NULL
mM	NULL
)	NULL
;	NULL
column	NULL
8	NULL
,	NULL
as	NULL
in	NULL
column	NULL
3	NULL
plus	NULL
MK886	NULL
(	NULL
0.5	NULL
uM	NULL
)	NULL
;	NULL
column	NULL
9	NULL
,	NULL
as	NULL
in	NULL
column	NULL
3	NULL
plus	NULL
MK886	NULL
(	NULL
1	NULL
M	NULL
)	NULL
;	NULL
column	NULL
11	NULL
,	NULL
stimulation	NULL
with	NULL
IL-18	NULL
(	NULL
50	NULL
U/ml	NULL
)	NULL
;	NULL
column	NULL
12	NULL
,	NULL
as	NULL
in	NULL
column	NULL
11	NULL
plus	NULL
ETYA	NULL
(	NULL
35	NULL
M	NULL
)	NULL
;	NULL
column	NULL
13	NULL
,	NULL
as	NULL
in	NULL
column	NULL
11	NULL
plus	NULL
ETYA	NULL
(	NULL
65	NULL
M	NULL
)	NULL
;	NULL
columns	NULL
10	NULL
and	NULL
14	NULL
,	NULL
stimulation	NULL
with	NULL
H	NULL
,	NULL
O	NULL
;	NULL
(	NULL
250	NULL
M	NULL
)	NULL
.	NULL

Asterisks	NULL
indicate	NULL
that	NULL
values	NULL
are	NULL
statistically	NULL
different	NULL
from	NULL
the	NULL
reference	NULL
values	NULL
(	NULL
A	NULL
)	NULL
.	NULL

29	NULL
)	NULL
(	NULL
Fig	NULL
.	NULL

1A	NULL
)	NULL
.	NULL

Using	NULL
an	NULL
antibody	NULL
directed	NULL
against	NULL
the	NULL
human	NULL
5-LOX	NULL
,	NULL
the	NULL
protein	NULL
was	NULL
detected	NULL
in	NULL
Raji	NULL
,	NULL
SKOV-3	NULL
,	NULL
HCT-116	NULL
,	NULL
HT-29	NULL
(	NULL
faint	NULL
band	NULL
)	NULL
,	NULL
and	NULL
HTM-29	NULL
cells	NULL
but	NULL
not	NULL
in	NULL
the	NULL
murine	NULL
cell	NULL
lines	NULL
.	NULL

Moreover	NULL
,	NULL
we	NULL
could	NULL
not	NULL
detect	NULL
any	NULL
5-LOX	NULL
expression	NULL
in	NULL
the	NULL
THP-1	NULL
monocytic	NULL
cells	NULL
(	NULL
data	NULL
not	NULL
shown	NULL
)	NULL
.	NULL

5-LOX	NULL
Mor	NULL
.	NULL

CELL	NULL
.	NULL

BioL	NULL
.	NULL

mRNA	NULL
expression	NULL
was	NULL
also	NULL
detected	NULL
by	NULL
reverse	NULL
transcription	NULL
(	NULL
RT	NULL
)	NULL
-PCR	NULL
in	NULL
the	NULL
murine	NULL
lymphoid	NULL
cell	NULL
lines	NULL
70Z	NULL
%	NULL
/3	NULL
and	NULL
EL-4	NULL
(	NULL
reference	NULL
7	NULL
and	NULL
data	NULL
not	NULL
shown	NULL
)	NULL
.	NULL

In	NULL
other	NULL
words	NULL
,	NULL
we	NULL
could	NULL
not	NULL
observe	NULL
any	NULL
5-LOX	NULL
expression	NULL
,	NULL
either	NULL
by	NULL
immunoblotting	NULL
or	NULL
by	NULL
RT-PCR	NULL
,	NULL
in	NULL
monocytic	NULL
cells	NULL
or	NULL
in	NULL
breast	NULL
or	NULL
ovarian	NULL
carcinoma	NULL
cells	NULL
.	NULL

Similarly	NULL
,	NULL
the	NULL
FLAP	NULL
protein	NULL
was	NULL
detected	NULL
by	NULL
Western	NULL
blotting	NULL
in	NULL
the	NULL
four	NULL
analyzed	NULL
lymphoid	NULL
cell	NULL
lines	NULL
(	NULL
Fig	NULL
.	NULL

1	NULL
)	NULL
.	NULL

Its	NULL
expression	NULL
was	NULL
high	NULL
in	NULL
Raji	NULL
cells	NULL
and	NULL
considerably	NULL
lower	NULL
in	NULL
Jurkat	NULL
cells	NULL
.	NULL

A	NULL
faint	NULL
and	NULL
more	NULL
slowly	NULL
migrating	NULL
specific	NULL
band	NULL
was	NULL
also	NULL
detected	NULL
with	NULL
the	NULL
human	NULL
antibody	NULL
in	NULL
the	NULL
murine	NULL
cell	NULL
lines	NULL
EL-4	NULL
and	NULL
70Z/3	NULL
.	NULL

The	NULL
expression	NULL
of	NULL
FLAP	NULL
was	NULL
not	NULL
observed	NULL
in	NULL
any	NULL
of	NULL
the	NULL
adenocarcinoma	NULL
cell	NULL
lines	NULL
.	NULL

Among	NULL
monocytic	NULL
cell	NULL
lines	NULL
,	NULL
FLAP	NULL
was	NULL
expressed	NULL
in	NULL
U937	NULL
and	NULL
THP-1	NULL
cells	NULL
but	NULL
not	NULL
in	NULL
HL-60	NULL
cells	NULL
(	NULL
Fig	NULL
.	NULL

1	NULL
and	NULL
data	NULL
not	NULL
shown	NULL
)	NULL
.	NULL

We	NULL
could	NULL
thus	NULL
conclude	NULL
that	NULL
only	NULL
the	NULL
lymphoid	NULL
cells	NULL
expressed	NULL
simultaneously	NULL
5-LOX	NULL
and	NULL
FLAP	NULL
proteins	NULL
and	NULL
could	NULL
therefore	NULL
demonstrate	NULL
5-LOX	NULL
enzymatic	NULL
activity	NULL
.	NULL

ROI	NULL
production	NULL
following	NULL
stimulation	NULL
.	NULL

We	NULL
previously	NULL
reported	NULL
that	NULL
IL-18B	NULL
stimulation	NULL
led	NULL
to	NULL
the	NULL
generation	NULL
of	NULL
ROIs	NULL
in	NULL
lymphoid	NULL
cells	NULL
but	NULL
not	NULL
in	NULL
epithelial	NULL
transformed	NULL
cells	NULL
(	NULL
6	NULL
)	NULL
.	NULL

In	NULL
order	NULL
to	NULL
determine	NULL
whether	NULL
ROI	NULL
production	NULL
was	NULL
due	NULL
to	NULL
5-LOX	NULL
activity	NULL
,	NULL
U937	NULL
,	NULL
Raji	NULL
,	NULL
MCF7	NULL
A/Z	NULL
,	NULL
and	NULL
HCT-116	NULL
cells	NULL
were	NULL
stimulated	NULL
with	NULL
IL-1§6	NULL
(	NULL
50	NULL
U/ml	NULL
!	NULL
)	NULL

for	NULL
15	NULL
min	NULL
and	NULL
analyzed	NULL
with	NULL
a	NULL
DFCH	NULL
probe	NULL
for	NULL
ROI	NULL
detection	NULL
(	NULL
Fig	NULL
.	NULL

2	NULL
)	NULL
.	NULL

Under	NULL
these	NULL
conditions	NULL
,	NULL
IL-1B	NULL
treatment	NULL
of	NULL
Raji	NULL
cells	NULL
led	NULL
to	NULL
the	NULL
production	NULL
of	NULL
ROIs	NULL
(	NULL
Fig	NULL
.	NULL

2A	NULL
;	NULL
compare	NULL
columns	NULL
2	NULL
and	NULL
3	NULL
)	NULL
.	NULL

As	NULL
expected	NULL
,	NULL
preincubation	NULL
of	NULL
Raji	NULL
cells	NULL
with	NULL
the	NULL
antioxidant	NULL
NAC	NULL
or	NULL
PDTC	NULL
abolished	NULL
ROI	NULL
accumulation	NULL
(	NULL
columns	NULL
4	NULL
to	NULL
7	NULL
)	NULL
.	NULL

Interestingly	NULL
,	NULL
preincubation	NULL
of	NULL
Raji	NULL
cells	NULL
prior	NULL
to	NULL
IL-1B	NULL
stimulation	NULL
with	NULL
MK886	NULL
,	NULL
a	NULL
specific	NULL
inhibitor	NULL
of	NULL
FLAP	NULL
(	NULL
40	NULL
)	NULL
(	NULL
columns	NULL
8	NULL
and	NULL
9	NULL
)	NULL
,	NULL
or	NULL
with	NULL
the	NULL
5-LOX	NULL
inhibitor	NULL
ETYA	NULL
(	NULL
columns	NULL
12	NULL
and	NULL
13	NULL
)	NULL
completely	NULL
abolished	NULL
or	NULL
markedly	NULL
decreased	NULL
ROI	NULL
production	NULL
,	NULL
confirming	NULL
that	NULL
5-LOX	NULL
activity	NULL
was	NULL
required	NULL
for	NULL
IL-1B-induced	NULL
intracellular	NULL
oxidative	NULL
stress	NULL
in	NULL
lymphoid	NULL
cells	NULL
.	NULL

As	NULL
a	NULL
positive	NULL
control	NULL
,	NULL
we	NULL
measured	NULL
ROI	NULL
production	NULL
in	NULL
H	NULL
,	NULL
O	NULL
,	NULL
-treated	NULL
cells	NULL
(	NULL
250	NULL
M	NULL
)	NULL
(	NULL
columns	NULL
10	NULL
and	NULL
14	NULL
)	NULL
;	NULL
MK886	NULL
did	NULL
not	NULL
influence	NULL
the	NULL
ROI	NULL
production	NULL
after	NULL
H	NULL
,	NULL
O	NULL
,	NULL
treatment	NULL
,	NULL
indicating	NULL
that	NULL
this	NULL
inhibitor	NULL
exerts	NULL
a	NULL
specific	NULL
action	NULL
(	NULL
data	NULL
not	NULL
shown	NULL
)	NULL
.	NULL

Stimulation	NULL
of	NULL
U937	NULL
or	NULL
THP-1	NULL
monocytic	NULL
cells	NULL
with	NULL
IL-18B	NULL
also	NULL
generated	NULL
ROIs	NULL
(	NULL
Fig	NULL
.	NULL

2B	NULL
and	NULL
C	NULL
;	NULL
compare	NULL
columns	NULL
2	NULL
and	NULL
3	NULL
)	NULL
.	NULL

Again	NULL
,	NULL
the	NULL
production	NULL
of	NULL
ROIs	NULL
was	NULL
completely	NULL
or	NULL
partially	NULL
abolished	NULL
by	NULL
preincubation	NULL
of	NULL
these	NULL
cells	NULL
with	NULL
the	NULL
antioxidant	NULL
NAC	NULL
or	NULL
PDTC	NULL
(	NULL
columns	NULL
4	NULL
to	NULL
7	NULL
)	NULL
.	NULL

Similar	NULL
data	NULL
were	NULL
obtained	NULL
with	NULL
HL60	NULL
cells	NULL
(	NULL
data	NULL
not	NULL
shown	NULL
)	NULL
.	NULL

However	NULL
,	NULL
contrasting	NULL
with	NULL
the	NULL
observation	NULL
made	NULL
with	NULL
Raji	NULL
cells	NULL
,	NULL
MK886	NULL
and	NULL
ETYA	NULL
failed	NULL
to	NULL
block	NULL
ROI	NULL
induction	NULL
in	NULL
monocytic	NULL
cells	NULL
(	NULL
columns	NULL
8	NULL
,	NULL
9	NULL
,	NULL
12	NULL
,	NULL
and	NULL
13	NULL
)	NULL
,	NULL
demonstrating	NULL
that	NULL
5-LOX	NULL
activity	NULL
was	NULL
not	NULL
responsible	NULL
for	NULL
this	NULL
production	NULL
.	NULL

Stimulation	NULL
of	NULL
HCT116	NULL
or	NULL
MCF7	NULL
A/Z	NULL
cells	NULL
with	NULL
IL-18	NULL
did	NULL
not	NULL
generate	NULL
any	NULL
significant	NULL
ROI	NULL
production	NULL
(	NULL
Fig	NULL
.	NULL

2D	NULL
and	NULL
E	NULL
,	NULL
;	NULL
compare	NULL
columns	NULL
2	NULL
,	NULL
without	NULL
IL-18	NULL
,	NULL
and	NULL
columns	NULL
3	NULL
,	NULL
in	NULL
the	NULL
presence	NULL
of	NULL
IL-1B	NULL
)	NULL
.	NULL

The	NULL
last	NULL
observation	NULL
confirmed	NULL
our	NULL
previously	NULL
reported	NULL
data	NULL
obtained	NULL
with	NULL
ovarian	NULL
carcinoma	NULL
OVCAR-3	NULL
cells	NULL
(	NULL
6	NULL
)	NULL
,	NULL
indicating	NULL
that	NULL
IL-1B	NULL
did	NULL
not	NULL
generate	NULL
any	NULL
oxidative	NULL
stress	NULL
in	NULL
epithelial	NULL
transformed	NULL
cells	NULL
.	NULL

Induction	NULL
of	NULL
NF-B	NULL
following	NULL
IL-1B	NULL
stimulation	NULL
.	NULL

Several	NULL
reports	NULL
stated	NULL
that	NULL
NF-kB	NULL
induction	NULL
following	NULL
a	NULL
number	NULL
of	NULL
stimuli	NULL
depended	NULL
on	NULL
ROI	NULL
production	NULL
(	NULL
50-52	NULL
)	NULL
.	NULL

However	NULL
,	NULL
we	NULL
reported	NULL
that	NULL
IL-1B	NULL
induced	NULL
NF-kB	NULL
in	NULL
adenocarcinoma	NULL
cells	NULL
independently	NULL
of	NULL
any	NULL
cellular	NULL
oxidative	NULL
stress	NULL
(	NULL
6	NULL
)	NULL
,	NULL
an	NULL
observation	NULL
confirmed	NULL
by	NULL
the	NULL
experiments	NULL
described	NULL
in	NULL
Fig	NULL
.	NULL

2	NULL
.	NULL

We	NULL
therefore	NULL
further	NULL
evaluated	NULL
the	NULL
role	NULL
of	NULL
5-LOX	NULL
activity	NULL
in	NULL
NF-kB	NULL
activation	NULL
after	NULL
IL-1B	NULL
stimulation	NULL
of	NULL
lymphoid	NULL
or	NULL
monocytic	NULL
cells	NULL
.	NULL

Stimulation	NULL
of	NULL
Raji	NULL
,	NULL
U937	NULL
,	NULL
or	NULL
THP-1	NULL
cells	NULL
with	NULL
IL-18	NULL
induced	NULL
nuclear	NULL
NF-kB	NULL
DNA-binding	NULL
activity	NULL
as	NULL
dem	NULL
Vor	NULL
.	NULL

19	NULL
,	NULL
1999	NULL
Emission	NULL
at	NULL
525	NULL
nm	NULL
B	NULL
B	NULL
wn	NULL
€	NULL
in	NULL
=	NULL
®	NULL
P	NULL
-	NULL
&	NULL
2	NULL
2	NULL
&	NULL
m	NULL
NF-	NULL
«	NULL
B	NULL
ACTIVATION	NULL
BY	NULL
REACTIVE	NULL
OXYGEN	NULL
INTERMEDIATES	NULL
-	NULL
1955	NULL
B	NULL
:	NULL
THP-1	NULL
+	NULL
FIG	NULL
.	NULL

6	NULL
.	NULL

NADPH	NULL
oxidase	NULL
inhibitors	NULL
blocked	NULL
ROI	NULL
production	NULL
induced	NULL
by	NULL
IL-1§	NULL
stimulation	NULL
in	NULL
monocytic	NULL
cells	NULL
.	NULL

Formation	NULL
of	NULL
ROIs	NULL
was	NULL
measured	NULL
by	NULL
using	NULL
a	NULL
DFCH	NULL
probe	NULL
in	NULL
U937	NULL
(	NULL
A	NULL
)	NULL
,	NULL
THP-1	NULL
(	NULL
B	NULL
)	NULL
,	NULL
and	NULL
Raji	NULL
(	NULL
C	NULL
)	NULL
cells	NULL
after	NULL
IL-18	NULL
stimulation	NULL
,	NULL
with	NULL
and	NULL
without	NULL
preincubation	NULL
in	NULL
the	NULL
presence	NULL
of	NULL
the	NULL
NADPH	NULL
oxidase	NULL
inhibitors	NULL
DPI	NULL
and	NULL
PAO	NULL
.	NULL

Columns	NULL
1	NULL
,	NULL
background	NULL
(	NULL
no	NULL
DFCH	NULL
probe	NULL
)	NULL
;	NULL
columns	NULL
2	NULL
,	NULL
unstimulated	NULL
cells	NULL
;	NULL
columns	NULL
3	NULL
,	NULL
stimulation	NULL
with	NULL
IL-1B	NULL
(	NULL
50	NULL
U/m	NULL
!	NULL
)	NULL

;	NULL
columns	NULL
4	NULL
,	NULL
as	NULL
in	NULL
columns	NULL
3	NULL
plus	NULL
PAO	NULL
(	NULL
30	NULL
ug/ml	NULL
)	NULL
;	NULL
columns	NULL
5	NULL
,	NULL
as	NULL
in	NULL
columns	NULL
3	NULL
plus	NULL
PAO	NULL
(	NULL
60	NULL
pg/ml	NULL
)	NULL
;	NULL
columns	NULL
7	NULL
,	NULL
stimulation	NULL
with	NULL
IL-1B	NULL
(	NULL
50	NULL
U/ml	NULL
)	NULL
;	NULL
columns	NULL
8	NULL
,	NULL
as	NULL
in	NULL
columns	NULL
7	NULL
plus	NULL
DPI	NULL
(	NULL
10	NULL
M	NULL
)	NULL
;	NULL
columns	NULL
9	NULL
,	NULL
as	NULL
in	NULL
columns	NULL
7	NULL
plus	NULL
DPI	NULL
(	NULL
30	NULL
M	NULL
)	NULL
;	NULL
columns	NULL
6	NULL
and	NULL
10	NULL
,	NULL
stimulation	NULL
with	NULL
H	NULL
,	NULL
O	NULL
;	NULL
(	NULL
250	NULL
M	NULL
)	NULL
.	NULL

Asterisks	NULL
indicate	NULL
that	NULL
values	NULL
are	NULL
statistically	NULL
different	NULL
from	NULL
the	NULL
reference	NULL
values	NULL
(	NULL
A	NULL
)	NULL
.	NULL

onstrated	NULL
by	NULL
EMSA	NULL
(	NULL
Fig	NULL
.	NULL

3A	NULL
,	NULL
B	NULL
,	NULL
and	NULL
C	NULL
)	NULL
.	NULL

Pretreatment	NULL
with	NULL
antioxidant	NULL
NAC	NULL
or	NULL
PDTC	NULL
completely	NULL
abolished	NULL
NF-	NULL
«	NULL
B	NULL
activation	NULL
in	NULL
the	NULL
three	NULL
cell	NULL
lines	NULL
.	NULL

However	NULL
,	NULL
pretreatment	NULL
with	NULL
the	NULL
FLAP	NULL
inhibitor	NULL
MK-886	NULL
or	NULL
the	NULL
5-LOX	NULL
inhibitor	NULL
ETYA	NULL
inhibited	NULL
IL-1B-dependent	NULL
NF-KB	NULL
activation	NULL
in	NULL
Raji	NULL
cells	NULL
(	NULL
Fig	NULL
.	NULL

3A	NULL
)	NULL
while	NULL
it	NULL
did	NULL
not	NULL
affect	NULL
this	NULL
induction	NULL
in	NULL
U937	NULL
or	NULL
THP-1	NULL
cells	NULL
(	NULL
Fig	NULL
.	NULL

3B	NULL
and	NULL
C	NULL
)	NULL
.	NULL

Similarly	NULL
,	NULL
antioxidants	NULL
,	NULL
MK-866	NULL
,	NULL
or	NULL
ETYA	NULL
failed	NULL
to	NULL
abolish	NULL
NF-	NULL
«	NULL
B	NULL
activation	NULL
by	NULL
IL-18	NULL
in	NULL
MCF7	NULL
A/Z	NULL
and	NULL
HCT-116	NULL
cells	NULL
(	NULL
Fig	NULL
.	NULL

3D	NULL
and	NULL
E	NULL
)	NULL
,	NULL
confirming	NULL
our	NULL
previous	NULL
observation	NULL
in	NULL
OVCAR-3	NULL
and	NULL
SKOV-3	NULL
epithelial	NULL
cells	NULL
(	NULL
6	NULL
,	NULL
7	NULL
)	NULL
.	NULL

These	NULL
data	NULL
thus	NULL
indicate	NULL
that	NULL
5-LOX	NULL
activity	NULL
plays	NULL
an	NULL
important	NULL
role	NULL
in	NULL
ROI	NULL
production	NULL
and	NULL
NF-	NULL
«	NULL
B	NULL
activation	NULL
in	NULL
lymphoid	NULL
cells	NULL
but	NULL
not	NULL
in	NULL
monocytic	NULL
or	NULL
epithelial	NULL
cells	NULL
.	NULL

Reconstitution	NULL
of	NULL
the	NULL
5-LOX/FLAP	NULL
pathway	NULL
in	NULL
adenocarcinoma	NULL
cells	NULL
.	NULL

In	NULL
order	NULL
to	NULL
confirm	NULL
the	NULL
data	NULL
obtained	NULL
with	NULL
EMSAs	NULL
,	NULL
MCF7	NULL
A/Z	NULL
cells	NULL
were	NULL
transfected	NULL
with	NULL
a	NULL
reporter	NULL
plasmid	NULL
containing	NULL
a	NULL
CAT	NULL
gene	NULL
driven	NULL
by	NULL
the	NULL
two	NULL
kB	NULL
sites	NULL
from	NULL
the	NULL
HIV	NULL
LTR	NULL
(	NULL
HIV-	NULL
«	NULL
kB-CAT	NULL
)	NULL
and	NULL
then	NULL
stimulated	NULL
with	NULL
IL-186	NULL
.	NULL

Such	NULL
a	NULL
treatment	NULL
induced	NULL
CAT	NULL
activity	NULL
three-	NULL
to	NULL
fourfold	NULL
over	NULL
the	NULL
basal	NULL
activity	NULL
observed	NULL
in	NULL
untreated	NULL
control	NULL
cells	NULL
(	NULL
Fig	NULL
.	NULL

4A	NULL
)	NULL
.	NULL

Cotransfection	NULL
of	NULL
the	NULL
FLAP	NULL
expression	NULL
vector	NULL
did	NULL
not	NULL
allow	NULL
any	NULL
further	NULL
induction	NULL
of	NULL
CAT	NULL
activity	NULL
following	NULL
stimulation	NULL
(	NULL
columns	NULL
3	NULL
and	NULL
4	NULL
)	NULL
.	NULL

Moreover	NULL
,	NULL
the	NULL
5-LOX	NULL
inhibitors	NULL
MK-886	NULL
and	NULL
ETYA	NULL
failed	NULL
to	NULL
block	NULL
IL-18	NULL
induction	NULL
of	NULL
NF-kB-dependent	NULL
transcription	NULL
in	NULL
either	NULL
FLAP	NULL
-expressing	NULL
(	NULL
Fig	NULL
.	NULL

4A	NULL
,	NULL
columns	NULL
5	NULL
,	NULL
6	NULL
,	NULL
8	NULL
,	NULL
and	NULL
9	NULL
)	NULL
or	NULL
nonexpressing	NULL
cells	NULL
(	NULL
data	NULL
not	NULL
shown	NULL
)	NULL
.	NULL

The	NULL
same	NULL
experiment	NULL
was	NULL
then	NULL
performed	NULL
in	NULL
MCF7	NULL
A/Z	NULL
cells	NULL
stably	NULL
transfected	NULL
with	NULL
a	NULL
5-LOX	NULL
expression	NULL
vector	NULL
(	NULL
MCF7	NULL
A/Z-LOX	NULL
)	NULL
.	NULL

In	NULL
these	NULL
cells	NULL
,	NULL
IL-1B	NULL
induced	NULL
NF-kB	NULL
transcriptional	NULL
activity	NULL
and	NULL
this	NULL
activity	NULL
was	NULL
not	NULL
modified	NULL
in	NULL
the	NULL
presence	NULL
of	NULL
MK886	NULL
(	NULL
Fig	NULL
.	NULL

4B	NULL
and	NULL
data	NULL
not	NULL
shown	NULL
)	NULL
.	NULL

Transient	NULL
transfection	NULL
of	NULL
MCF7	NULL
A/Z-LOX	NULL
cells	NULL
with	NULL
the	NULL
FLAP	NULL
expression	NULL
vector	NULL
led	NULL
to	NULL
a	NULL
small	NULL
increase	NULL
of	NULL
the	NULL
IL-1B-induced	NULL
CAT	NULL
activity	NULL
(	NULL
Fig	NULL
.	NULL

4B	NULL
,	NULL
column	NULL
4	NULL
)	NULL
.	NULL

In	NULL
the	NULL
presence	NULL
of	NULL
FLAP	NULL
,	NULL
treatment	NULL
of	NULL
MCF7	NULL
A/Z-LOX	NULL
cells	NULL
with	NULL
MK-886	NULL
or	NULL
ETYA	NULL
completely	NULL
abolished	NULL
IL-1B-dependent	NULL
transcriptional	NULL
activity	NULL
(	NULL
columns	NULL
5	NULL
,	NULL
6	NULL
,	NULL
8	NULL
,	NULL
and	NULL
9	NULL
)	NULL
.	NULL

Consistently	NULL
with	NULL
these	NULL
CAT	NULL
assays	NULL
,	NULL
transient	NULL
transfections	NULL
of	NULL
MCF7	NULL
A/Z	NULL
cells	NULL
with	NULL
the	NULL
FLAP	NULL
expression	NULL
vector	NULL
did	NULL
not	NULL
allow	NULL
any	NULL
generation	NULL
of	NULL
ROIs	NULL
,	NULL
even	NULL
after	NULL
IL-1B	NULL
stimulation	NULL
(	NULL
Fig	NULL
.	NULL

4C	NULL
;	NULL
compare	NULL
columns	NULL
2	NULL
and	NULL
3	NULL
)	NULL
.	NULL

However	NULL
,	NULL
transient	NULL
transfection	NULL
of	NULL
the	NULL
FLAP	NULL
expression	NULL
vector	NULL
in	NULL
MCF7	NULL
A/Z-LOX	NULL
cells	NULL
led	NULL
to	NULL
a	NULL
marked	NULL
increase	NULL
in	NULL
ROI	NULL
production	NULL
after	NULL
IL-18	NULL
treatment	NULL
(	NULL
Fig	NULL
.	NULL

4D	NULL
;	NULL
compare	NULL
columns	NULL
4	NULL
and	NULL
5	NULL
)	NULL
while	NULL
stable	NULL
expression	NULL
of	NULL
5-LOX	NULL
alone	NULL
was	NULL
not	NULL
sufficient	NULL
for	NULL
such	NULL
an	NULL
effect	NULL
(	NULL
columns	NULL
2	NULL
and	NULL
3	NULL
)	NULL
.	NULL

As	NULL
expected	NULL
,	NULL
NAC	NULL
,	NULL
PDTC	NULL
,	NULL
MK886	NULL
,	NULL
and	NULL
1956	NULL
BONIZZI	NULL
ET	NULL
AL	NULL
.	NULL

ro	NULL
P	NULL
©	NULL
pr	NULL
Pa0	NULL
_DPL	NULL
+	NULL
30ug	NULL
‘	NULL
+	NULL
30	NULL
uM|**	NULL
+	NULL
60	NULL
ug	NULL
+	NULL
10	NULL
uM	NULL
56	NULL
ZL	NULL
4	NULL
bd	NULL
+	NULL
+	NULL
60	NULL
ug	NULL
+	NULL
10	NULL
uM	NULL
+	NULL
30	NULL
uM	NULL
ILAB	NULL
|	NULL
.	NULL

,	NULL
oo	NULL
We	NULL
C	NULL
B	NULL
+	NULL
s	NULL
y	NULL
)	NULL
ba	NULL
hai	NULL
bl	NULL
Wad	NULL
FIG	NULL
.	NULL

7	NULL
.	NULL

NADPH	NULL
oxidase	NULL
inhibitors	NULL
blocked	NULL
NF-	NULL
«	NULL
B	NULL
activation	NULL
by	NULL
IL-1B	NULL
in	NULL
monocytic	NULL
cells	NULL
.	NULL

Nuclear	NULL
extracts	NULL
were	NULL
prepared	NULL
from	NULL
Raji	NULL
(	NULL
A	NULL
)	NULL
,	NULL
U937	NULL
(	NULL
B	NULL
)	NULL
,	NULL
THP-1	NULL
(	NULL
C	NULL
)	NULL
,	NULL
HCT116	NULL
(	NULL
D	NULL
)	NULL
,	NULL
or	NULL
MCF7	NULL
A/Z	NULL
(	NULL
E	NULL
)	NULL
cells	NULL
,	NULL
either	NULL
untreated	NULL
or	NULL
stimulated	NULL
with	NULL
IL-18	NULL
(	NULL
50	NULL
U/ml	NULL
)	NULL
.	NULL

The	NULL
same	NULL
cells	NULL
were	NULL
preincubated	NULL
for	NULL
1	NULL
h	NULL
prior	NULL
to	NULL
IL-18B	NULL
stimulation	NULL
with	NULL
increasing	NULL
concentrations	NULL
of	NULL
DPI	NULL
or	NULL
PAO	NULL
,	NULL
as	NULL
indicated	NULL
in	NULL
the	NULL
figure	NULL
.	NULL

These	NULL
extracts	NULL
were	NULL
analyzed	NULL
by	NULL
EMSA	NULL
for	NULL
binding	NULL
to	NULL
a	NULL
specific	NULL
kB	NULL
probe	NULL
.	NULL

ETYA	NULL
reduced	NULL
ROI	NULL
production	NULL
in	NULL
MCF7	NULL
A/Z	NULL
cells	NULL
transfected	NULL
stably	NULL
with	NULL
the	NULL
5-LOX	NULL
expression	NULL
vector	NULL
and	NULL
transiently	NULL
with	NULL
the	NULL
FLAP	NULL
expression	NULL
vector	NULL
(	NULL
columns	NULL
6	NULL
to	NULL
11	NULL
,	NULL
14	NULL
,	NULL
and	NULL
15	NULL
)	NULL
.	NULL

In	NULL
HCT-116	NULL
cells	NULL
,	NULL
which	NULL
express	NULL
the	NULL
5-LOX	NULL
enzyme	NULL
but	NULL
not	NULL
the	NULL
FLAP	NULL
protein	NULL
,	NULL
IL-1	NULL
stimulated	NULL
threefold	NULL
the	NULL
NF-kB-de-pendent	NULL
CAT	NULL
activity	NULL
(	NULL
Fig	NULL
.	NULL

5A	NULL
)	NULL
and	NULL
this	NULL
stimulation	NULL
was	NULL
not	NULL
blocked	NULL
by	NULL
MK886	NULL
(	NULL
data	NULL
not	NULL
shown	NULL
)	NULL
.	NULL

Again	NULL
,	NULL
after	NULL
cotransfection	NULL
of	NULL
the	NULL
FLAP	NULL
expression	NULL
vector	NULL
,	NULL
we	NULL
observed	NULL
a	NULL
small	NULL
increase	NULL
in	NULL
the	NULL
transcription	NULL
induced	NULL
by	NULL
IL-1B	NULL
(	NULL
column	NULL
4	NULL
)	NULL
,	NULL
an	NULL
effect	NULL
which	NULL
was	NULL
inhibited	NULL
by	NULL
preincubation	NULL
of	NULL
the	NULL
cells	NULL
with	NULL
MK886	NULL
(	NULL
columns	NULL
5	NULL
and	NULL
6	NULL
)	NULL
or	NULL
ETYA	NULL
(	NULL
columns	NULL
8	NULL
and	NULL
9	NULL
)	NULL
.	NULL

Similarly	NULL
,	NULL
transient	NULL
transfection	NULL
of	NULL
the	NULL
FLAP	NULL
expression	NULL
vector	NULL
in	NULL
HCT-116	NULL
cells	NULL
was	NULL
sufficient	NULL
to	NULL
allow	NULL
the	NULL
production	NULL
of	NULL
ROIs	NULL
after	NULL
IL-1B	NULL
stimulation	NULL
(	NULL
Fig	NULL
.	NULL

5B	NULL
)	NULL
,	NULL
a	NULL
production	NULL
which	NULL
was	NULL
inhibited	NULL
by	NULL
preincubation	NULL
with	NULL
NAC	NULL
,	NULL
PDTC	NULL
,	NULL
MK886	NULL
,	NULL
or	NULL
ETYA	NULL
.	NULL

We	NULL
can	NULL
thus	NULL
conclude	NULL
that	NULL
coexpression	NULL
of	NULL
5-LOX	NULL
and	NULL
FLAP	NULL
is	NULL
required	NULL
to	NULL
restore	NULL
the	NULL
5-LOX-dependent	NULL
pathway	NULL
leading	NULL
to	NULL
production	NULL
of	NULL
ROIs	NULL
and	NULL
consequent	NULL
NF-xB	NULL
activation	NULL
.	NULL

NADPH	NULL
oxidase	NULL
is	NULL
required	NULL
for	NULL
ROI	NULL
production	NULL
in	NULL
IL-1-treated	NULL
monocytic	NULL
cells	NULL
.	NULL

Monocytic	NULL
cells	NULL
such	NULL
as	NULL
U937	NULL
or	NULL
THP-1	NULL
cells	NULL
produce	NULL
ROIs	NULL
in	NULL
response	NULL
to	NULL
IL-1B	NULL
stimulation	NULL
but	NULL
do	NULL
not	NULL
express	NULL
5-LOX	NULL
.	NULL

They	NULL
must	NULL
therefore	NULL
rely	NULL
on	NULL
another	NULL
source	NULL
for	NULL
ROI	NULL
production	NULL
,	NULL
and	NULL
this	NULL
source	NULL
was	NULL
deemed	NULL
most	NULL
likely	NULL
to	NULL
be	NULL
NADPH	NULL
oxidase	NULL
.	NULL

We	NULL
first	NULL
investigated	NULL
whether	NULL
NADPH	NULL
oxidase	NULL
inhibitors	NULL
could	NULL
block	NULL
ROI	NULL
production	NULL
in	NULL
IL-1B-stimulated	NULL
monocytic	NULL
cells	NULL
.	NULL

As	NULL
already	NULL
shown	NULL
in	NULL
Fig	NULL
.	NULL

2	NULL
,	NULL
IL-1B	NULL
treatment	NULL
induced	NULL
ROIs	NULL
in	NULL
THP-1	NULL
and	NULL
U937	NULL
cells	NULL
(	NULL
Fig	NULL
.	NULL

6A	NULL
and	NULL
B	NULL
;	NULL
compare	NULL
columns	NULL
2	NULL
and	NULL
3	NULL
)	NULL
.	NULL

Preincubation	NULL
of	NULL
these	NULL
cells	NULL
with	NULL
DPI	NULL
or	NULL
PAO	NULL
inhibited	NULL
in	NULL
a	NULL
dose-dependent	NULL
manner	NULL
IL-1B-induced	NULL
ROI	NULL
production	NULL
(	NULL
Fig	NULL
.	NULL

6A	NULL
and	NULL
B	NULL
,	NULL
columns	NULL
4	NULL
,	NULL
5	NULL
,	NULL
8	NULL
,	NULL
and	NULL
9	NULL
)	NULL
.	NULL

Interestingly	NULL
,	NULL
preincubation	NULL
of	NULL
Raji	NULL
cells	NULL
with	NULL
the	NULL
same	NULL
NADPH	NULL
oxidase	NULL
inhibitors	NULL
did	NULL
not	NULL
block	NULL
ROI	NULL
production	NULL
(	NULL
Fig	NULL
.	NULL

6C	NULL
)	NULL
.	NULL

”	NULL
Eb	NULL
investigate	NULL
whether	NULL
NADPH	NULL
oxidase	NULL
was	NULL
involved	NULL
in	NULL
Mor	NULL
.	NULL

CELL	NULL
.	NULL

BioL	NULL
.	NULL

NF-kB	NULL
activation	NULL
by	NULL
IL-18B	NULL
,	NULL
nuclear	NULL
extracts	NULL
were	NULL
prepared	NULL
from	NULL
cells	NULL
preincubated	NULL
with	NULL
the	NULL
same	NULL
inhibitor	NULL
,	NULL
DPI	NULL
or	NULL
PAO	NULL
,	NULL
prior	NULL
to	NULL
IL-1B	NULL
stimulation	NULL
.	NULL

These	NULL
inhibitors	NULL
did	NULL
not	NULL
modify	NULL
NF-kB	NULL
activation	NULL
induced	NULL
by	NULL
IL-18	NULL
in	NULL
Raji	NULL
,	NULL
MCF7	NULL
A/Z	NULL
,	NULL
or	NULL
HCT-116	NULL
cells	NULL
,	NULL
as	NULL
demonstrated	NULL
on	NULL
EMSAs	NULL
(	NULL
Fig	NULL
.	NULL

7A	NULL
,	NULL
D	NULL
,	NULL
and	NULL
E	NULL
)	NULL
.	NULL

However	NULL
,	NULL
they	NULL
abolished	NULL
in	NULL
a	NULL
dose-dependent	NULL
manner	NULL
the	NULL
induction	NULL
of	NULL
NF-kB	NULL
in	NULL
U937	NULL
and	NULL
THP-1	NULL
monocytic	NULL
cells	NULL
(	NULL
Fig	NULL
.	NULL

7B	NULL
and	NULL
C	NULL
)	NULL
,	NULL
indicating	NULL
that	NULL
NADPH	NULL
oxidase	NULL
activity	NULL
was	NULL
required	NULL
for	NULL
the	NULL
IL-1B-dependent	NULL
signaling	NULL
pathway	NULL
leading	NULL
to	NULL
IxBa	NULL
degradation	NULL
in	NULL
these	NULL
cells	NULL
.	NULL

Rac	NULL
and	NULL
Cdc42	NULL
are	NULL
required	NULL
for	NULL
ROI	NULL
production	NULL
and	NULL
NF-KB	NULL
activation	NULL
in	NULL
IL-1f-treated	NULL
monocytic	NULL
cells	NULL
.	NULL

Rho	NULL
,	NULL
Racl	NULL
,	NULL
and	NULL
Cdc42	NULL
,	NULL
all	NULL
members	NULL
of	NULL
the	NULL
Ras	NULL
superfamily	NULL
of	NULL
GTPases	NULL
,	NULL
have	NULL
been	NULL
noted	NULL
to	NULL
play	NULL
a	NULL
role	NULL
in	NULL
several	NULL
transduction	NULL
processes	NULL
,	NULL
including	NULL
the	NULL
JNK/SAPK	NULL
and	NULL
MAPK	NULL
pathways	NULL
(	NULL
60	NULL
)	NULL
.	NULL

More	NULL
recently	NULL
,	NULL
it	NULL
has	NULL
been	NULL
reported	NULL
that	NULL
Rho	NULL
,	NULL
Racl	NULL
,	NULL
and	NULL
Cdc42	NULL
are	NULL
involved	NULL
in	NULL
NF-kB	NULL
induction	NULL
by	NULL
TNF-	NULL
«	NULL
or	NULL
bradykinin	NULL
(	NULL
45	NULL
,	NULL
46	NULL
)	NULL
.	NULL

The	NULL
NADPH	NULL
oxidase	NULL
component	NULL
p67°	NULL
``	NULL
``	NULL
*	NULL
associates	NULL
with	NULL
Cdc42/Rac	NULL
,	NULL
and	NULL
Racl	NULL
is	NULL
required	NULL
for	NULL
the	NULL
activation	NULL
of	NULL
NADPH	NULL
oxidase	NULL
(	NULL
1	NULL
,	NULL
5	NULL
,	NULL
21	NULL
)	NULL
.	NULL

Therefore	NULL
,	NULL
we	NULL
investigated	NULL
whether	NULL
these	NULL
GTPases	NULL
are	NULL
involved	NULL
in	NULL
IL-1B-induced	NULL
NF-	NULL
«	NULL
B	NULL
activation	NULL
in	NULL
adenocarcinoma	NULL
or	NULL
monocytic	NULL
cells	NULL
.	NULL

MCF7	NULL
A/Z	NULL
cells	NULL
were	NULL
cotransfected	NULL
with	NULL
the	NULL
HIV-	NULL
«	NULL
B-CAT	NULL
reporter	NULL
plasmid	NULL
together	NULL
with	NULL
expression	NULL
vectors	NULL
coding	NULL
for	NULL
wild-type	NULL
or	NULL
dominant-negative	NULL
RhoA	NULL
,	NULL
Racl	NULL
,	NULL
or	NULL
Cdc42	NULL
(	NULL
Fig	NULL
.	NULL

8A	NULL
)	NULL
.	NULL

Again	NULL
,	NULL
IL-1B	NULL
stimulation	NULL
induced	NULL
three-	NULL
to	NULL
four-fold	NULL
the	NULL
basal	NULL
CAT	NULL
activity	NULL
.	NULL

This	NULL
transcriptional	NULL
activation	NULL
was	NULL
not	NULL
modified	NULL
in	NULL
the	NULL
presence	NULL
of	NULL
wild-type	NULL
or	NULL
mutant	NULL
Rho	NULL
,	NULL
Rac1	NULL
,	NULL
or	NULL
Cdc42	NULL
proteins	NULL
.	NULL

Similarly	NULL
,	NULL
treatment	NULL
of	NULL
MCF7	NULL
A/Z	NULL
cells	NULL
with	NULL
TNF-a	NULL
«	NULL
or	NULL
arachidonic	NULL
acid	NULL
also	NULL
activated	NULL
NF-	NULL
«	NULL
B-dependent	NULL
transcription	NULL
of	NULL
the	NULL
CAT	NULL
reporter	NULL
gene	NULL
.	NULL

Again	NULL
,	NULL
the	NULL
expression	NULL
of	NULL
wild-type	NULL
or	NULL
mutant	NULL
GTPases	NULL
did	NULL
not	NULL
modify	NULL
this	NULL
induction	NULL
(	NULL
data	NULL
not	NULL
shown	NULL
)	NULL
.	NULL

We	NULL
thus	NULL
concluded	NULL
that	NULL
RhoA	NULL
,	NULL
Racl	NULL
,	NULL
and	NULL
Cdc42	NULL
are	NULL
not	NULL
required	NULL
for	NULL
NF-	NULL
«	NULL
B	NULL
activation	NULL
by	NULL
IL-1	NULL
,	NULL
TNF-a	NULL
,	NULL
or	NULL
arachidonic	NULL
acid	NULL
in	NULL
MCF7	NULL
A/Z	NULL
cells	NULL
.	NULL

In	NULL
monocytic	NULL
cells	NULL
(	NULL
THP	NULL
and	NULL
U937	NULL
)	NULL
,	NULL
however	NULL
,	NULL
while	NULL
transfection	NULL
of	NULL
expression	NULL
vectors	NULL
for	NULL
wild-type	NULL
RhoA	NULL
,	NULL
Racl	NULL
,	NULL
or	NULL
Cdcd42	NULL
did	NULL
not	NULL
modify	NULL
transcription	NULL
of	NULL
an	NULL
NF-	NULL
«	NULL
kB-dependent	NULL
reporter	NULL
plasmid	NULL
,	NULL
the	NULL
expression	NULL
of	NULL
the	NULL
Racl1	NULL
and	NULL
Cdc42	NULL
dominant-negative	NULL
mutants	NULL
almost	NULL
completely	NULL
inhibited	NULL
IL-1B-induced	NULL
NF-	NULL
«	NULL
B-dependent	NULL
gene	NULL
transcription	NULL
(	NULL
Fig	NULL
.	NULL

8B	NULL
and	NULL
C	NULL
)	NULL
.	NULL

In	NULL
order	NULL
to	NULL
demonstrate	NULL
that	NULL
Cdc42	NULL
and	NULL
Racl	NULL
dominant-negative	NULL
mutants	NULL
could	NULL
block	NULL
ROI	NULL
production	NULL
in	NULL
monocytic	NULL
cells	NULL
,	NULL
U937	NULL
cells	NULL
were	NULL
transiently	NULL
transfected	NULL
with	NULL
expression	NULL
vectors	NULL
coding	NULL
for	NULL
these	NULL
mutants	NULL
or	NULL
the	NULL
wild-type	NULL
enzymes	NULL
.	NULL

Since	NULL
the	NULL
transfection	NULL
efficiency	NULL
was	NULL
very	NULL
low	NULL
and	NULL
did	NULL
not	NULL
allow	NULL
the	NULL
detection	NULL
of	NULL
any	NULL
difference	NULL
in	NULL
ROI	NULL
production	NULL
,	NULL
these	NULL
cells	NULL
were	NULL
then	NULL
cotransfected	NULL
with	NULL
the	NULL
mentioned	NULL
plasmids	NULL
together	NULL
with	NULL
an	NULL
expression	NULL
vector	NULL
coding	NULL
for	NULL
the	NULL
CD20	NULL
antigen	NULL
.	NULL

Transfected	NULL
cells	NULL
were	NULL
purified	NULL
through	NULL
two	NULL
rounds	NULL
of	NULL
positive	NULL
selection	NULL
with	NULL
an	NULL
anti-CD20	NULL
monoclonal	NULL
antibody	NULL
,	NULL
first	NULL
by	NULL
MACS	NULL
and	NULL
then	NULL
by	NULL
flow	NULL
cytometry	NULL
.	NULL

Purified	NULL
transfected	NULL
cells	NULL
(	NULL
1.2	NULL
X	NULL
10°	NULL
cells	NULL
)	NULL
were	NULL
then	NULL
treated	NULL
with	NULL
IL-1	NULL
$	NULL
B	NULL
,	NULL
and	NULL
ROI	NULL
production	NULL
was	NULL
measured	NULL
as	NULL
described	NULL
above	NULL
.	NULL

Under	NULL
these	NULL
conditions	NULL
,	NULL
IL-16	NULL
stimulation	NULL
generated	NULL
ROIs	NULL
(	NULL
Fig	NULL
.	NULL

9	NULL
)	NULL
.	NULL

This	NULL
production	NULL
of	NULL
ROIs	NULL
was	NULL
not	NULL
modified	NULL
by	NULL
the	NULL
expression	NULL
of	NULL
wild-type	NULL
Cdc42	NULL
or	NULL
Racl	NULL
enzyme	NULL
,	NULL
while	NULL
it	NULL
was	NULL
significantly	NULL
reduced	NULL
by	NULL
the	NULL
two	NULL
dominant-negative	NULL
mutants	NULL
,	NULL
confirming	NULL
their	NULL
implied	NULL
roles	NULL
in	NULL
induced	NULL
ROI	NULL
production	NULL
in	NULL
monocytic	NULL
cells	NULL
.	NULL

DISCUSSION	NULL
The	NULL
signaling	NULL
pathways	NULL
leading	NULL
to	NULL
NF-kB	NULL
activation	NULL
following	NULL
cellular	NULL
stimulation	NULL
with	NULL
proinflammatory	NULL
cytokines	NULL
have	NULL
been	NULL
the	NULL
subject	NULL
of	NULL
many	NULL
investigations	NULL
but	NULL
remain	NULL
a	NULL
matter	NULL
of	NULL
Vor	NULL
.	NULL

19	NULL
,	NULL
1999	NULL
A	NULL
:	NULL
MCF7ZA/Z	NULL
Relative	NULL
CAT	NULL
Activity	NULL
IL-18	NULL
o	NULL
)	NULL
:	NULL
U937	NULL
Relative	NULL
CAT	NULL
Activity	NULL
Cedaz	NULL
g	NULL
§	NULL
2	NULL
@	NULL
+0	NULL
-	NULL
+	NULL
4	NULL
Rac	NULL
IL-1	NULL
$	NULL
~	NULL
+	NULL
&	NULL
9	NULL
E	NULL
~	NULL
V	NULL
+	NULL
NF-	NULL
«	NULL
B	NULL
ACTIVATION	NULL
BY	NULL
REACTIVE	NULL
OXYGEN	NULL
INTERMEDIATES	NULL
-	NULL
1957	NULL
B	NULL
:	NULL
THP-1	NULL
go	NULL
4	NULL
f	NULL
T	NULL
l	NULL
3	NULL
8s	NULL
&	NULL
V	NULL
1	NULL
+	NULL
1	NULL
+	NULL
+	NULL
+	NULL
FIG	NULL
.	NULL

8	NULL
.	NULL

GTPases	NULL
are	NULL
required	NULL
for	NULL
NF-xB	NULL
transcriptional	NULL
activity	NULL
in	NULL
monocytic	NULL
cells	NULL
.	NULL

MCF7	NULL
A/Z	NULL
(	NULL
A	NULL
)	NULL
,	NULL
THP-1	NULL
(	NULL
B	NULL
)	NULL
,	NULL
or	NULL
U937	NULL
(	NULL
C	NULL
)	NULL
cells	NULL
were	NULL
transfected	NULL
with	NULL
the	NULL
HIV-	NULL
«	NULL
B-CAT	NULL
reporter	NULL
plasmid	NULL
alone	NULL
or	NULL
together	NULL
with	NULL
expression	NULL
vectors	NULL
for	NULL
wild-type	NULL
or	NULL
dominant-negative	NULL
RhoA	NULL
,	NULL
Racl	NULL
,	NULL
and	NULL
Cde42	NULL
.	NULL

Cells	NULL
were	NULL
either	NULL
untreated	NULL
(	NULL
-	NULL
)	NULL
or	NULL
stimulated	NULL
with	NULL
IL-1B	NULL
(	NULL
+	NULL
)	NULL
for	NULL
6	NULL
h	NULL
,	NULL
and	NULL
CAT	NULL
activities	NULL
were	NULL
measured	NULL
.	NULL

Each	NULL
column	NULL
represents	NULL
the	NULL
mean	NULL
of	NULL
three	NULL
independent	NULL
experiments	NULL
(	NULL
+	NULL
SD	NULL
)	NULL
.	NULL

Asterisks	NULL
indicate	NULL
that	NULL
values	NULL
are	NULL
statistically	NULL
different	NULL
from	NULL
the	NULL
reference	NULL
values	NULL
(	NULL
A	NULL
)	NULL
.	NULL

discussion	NULL
.	NULL

The	NULL
recent	NULL
discovery	NULL
of	NULL
IxBa	NULL
kinases	NULL
IKK-B	NULL
,	NULL
and	NULL
IKK-y	NULL
)	NULL
and	NULL
their	NULL
activation	NULL
by	NULL
the	NULL
NIK	NULL
kinase	NULL
led	NULL
to	NULL
the	NULL
hypothesis	NULL
that	NULL
TNF-	NULL
«	NULL
or	NULL
IL-1B	NULL
receptors	NULL
are	NULL
connected	NULL
to	NULL
IkxBa	NULL
through	NULL
TRAF	NULL
adapter	NULL
proteins	NULL
,	NULL
NIK	NULL
and	NULL
IKKs	NULL
(	NULL
20	NULL
,	NULL
33	NULL
,	NULL
39	NULL
,	NULL
42	NULL
,	NULL
56	NULL
,	NULL
66	NULL
)	NULL
.	NULL

However	NULL
,	NULL
such	NULL
a	NULL
model	NULL
did	NULL
not	NULL
incorporate	NULL
the	NULL
results	NULL
of	NULL
previous	NULL
studies	NULL
indicating	NULL
the	NULL
role	NULL
of	NULL
other	NULL
signaling	NULL
intermediates	NULL
such	NULL
as	NULL
ROIs	NULL
,	NULL
ceramide	NULL
,	NULL
or	NULL
Rho	NULL
proteins	NULL
and	NULL
left	NULL
unidentified	NULL
other	NULL
members	NULL
of	NULL
the	NULL
large	NULL
signaling	NULL
complex	NULL
.	NULL

These	NULL
discrepancies	NULL
could	NULL
be	NULL
explained	NULL
by	NULL
cell	NULL
type	NULL
specificities	NULL
.	NULL

Indeed	NULL
,	NULL
most	NULL
of	NULL
the	NULL
studies	NULL
reported	NULL
so	NULL
far	NULL
investigated	NULL
a	NULL
single	NULL
cell	NULL
line	NULL
,	NULL
and	NULL
the	NULL
models	NULL
derived	NULL
from	NULL
such	NULL
experiments	NULL
might	NULL
not	NULL
be	NULL
confirmed	NULL
in	NULL
different	NULL
settings	NULL
.	NULL

We	NULL
previously	NULL
reported	NULL
that	NULL
ROIs	NULL
and	NULL
the	NULL
PKC	NULL
A/	NULL
.	NULL

isoform	NULL
play	NULL
a	NULL
cell-specific	NULL
role	NULL
in	NULL
NF-KB	NULL
activation	NULL
by	NULL
IL-1B8	NULL
or	NULL
TNF-a	NULL
(	NULL
6-8	NULL
)	NULL
.	NULL

In	NULL
this	NULL
study	NULL
,	NULL
we	NULL
explored	NULL
the	NULL
sources	NULL
of	NULL
ROIs	NULL
in	NULL
different	NULL
cell	NULL
types	NULL
and	NULL
their	NULL
roles	NULL
in	NULL
NF-KB	NULL
activation	NULL
by	NULL
IL-1B	NULL
.	NULL

At	NULL
least	NULL
three	NULL
different	NULL
pathways	NULL
that	NULL
lead	NULL
to	NULL
induction	NULL
of	NULL
nuclear	NULL
NF-kB	NULL
DNA-binding	NULL
activity	NULL
and	NULL
transactivation	NULL
of	NULL
a	NULL
reporter	NULL
gene	NULL
after	NULL
cellular	NULL
treatment	NULL
with	NULL
IL-18B	NULL
can	NULL
be	NULL
identified	NULL
(	NULL
Fig	NULL
.	NULL

10	NULL
)	NULL
.	NULL

Lymphoid	NULL
cells	NULL
,	NULL
such	NULL
as	NULL
Raji	NULL
or	NULL
70Z/3	NULL
cells	NULL
,	NULL
express	NULL
5-LOX	NULL
and	NULL
its	NULL
activating	NULL
protein	NULL
FLAP	NULL
,	NULL
and	NULL
5-LOX	NULL
enzymatic	NULL
activity	NULL
is	NULL
required	NULL
for	NULL
ROI	NULL
production	NULL
and	NULL
NF-kB	NULL
activation	NULL
following	NULL
stimulation	NULL
by	NULL
IL-18B	NULL
.	NULL

In	NULL
these	NULL
cells	NULL
,	NULL
the	NULL
ROIs	NULL
are	NULL
essential	NULL
for	NULL
IxBa	NULL
degradation	NULL
and	NULL
NF-xB	NULL
activation	NULL
(	NULL
6	NULL
)	NULL
but	NULL
it	NULL
is	NULL
not	NULL
known	NULL
whether	NULL
ROIs	NULL
can	NULL
directly	NULL
or	NULL
indirectly	NULL
activate	NULL
the	NULL
IKK	NULL
kinases	NULL
or	NULL
whether	NULL
other	NULL
IxBa	NULL
kinases	NULL
are	NULL
involved	NULL
.	NULL

Epithelial	NULL
cells	NULL
do	NULL
not	NULL
express	NULL
the	NULL
5-LOX/FLAP	NULL
enzymatic	NULL
complex	NULL
and	NULL
do	NULL
not	NULL
produce	NULL
ROIs	NULL
in	NULL
response	NULL
to	NULL
IL-1B	NULL
or	NULL
TNF-	NULL
«	NULL
.	NULL

Reconstitution	NULL
of	NULL
the	NULL
5-LOX/FLAP	NULL
system	NULL
in	NULL
these	NULL
cells	NULL
showed	NULL
that	NULL
,	NULL
despite	NULL
high	NULL
catalase	NULL
activity	NULL
(	NULL
7	NULL
)	NULL
,	NULL
this	NULL
enzymatic	NULL
activity	NULL
was	NULL
sufficient	NULL
to	NULL
restore	NULL
ROI	NULL
production	NULL
and	NULL
ROI-dependent	NULL
NF-	NULL
«	NULL
B	NULL
activation	NULL
.	NULL

In	NULL
other	NULL
words	NULL
,	NULL
once	NULL
the	NULL
5-LOX	NULL
pathway	NULL
is	NULL
functional	NULL
,	NULL
it	NULL
becomes	NULL
predominant	NULL
.	NULL

These	NULL
data	NULL
,	NULL
as	NULL
well	NULL
as	NULL
those	NULL
obtained	NULL
with	NULL
monocytic	NULL
and	NULL
lymphoid	NULL
cells	NULL
,	NULL
suggest	NULL
that	NULL
the	NULL
ROIs	NULL
might	NULL
activate	NULL
the	NULL
signalsome	NULL
.	NULL

In	NULL
the	NULL
absence	NULL
of	NULL
5-LOX	NULL
,	NULL
as	NULL
we	NULL
had	NULL
previously	NULL
reported	NULL
,	NULL
an	NULL
alternative	NULL
pathway	NULL
which	NULL
involves	NULL
the	NULL
activation	NULL
of	NULL
acid	NULL
sphingomyelinase	NULL
and	NULL
the	NULL
production	NULL
of	NULL
ceramide	NULL
could	NULL
be	NULL
essential	NULL
1958	NULL
BONIZZI	NULL
ET	NULL
AL	NULL
.	NULL

0,47	NULL
A	NULL
A	NULL
3	NULL
0,37	NULL
A	NULL
up	NULL
ed	NULL
Ld	NULL
8	NULL
0,21	NULL
A	NULL
.S	NULL
3	NULL
aA	NULL
m	NULL
0,11	NULL
s	NULL
a	NULL
-	NULL
a	NULL
IL-1B	NULL
=	NULL
-	NULL
+	NULL
+	NULL
+	NULL
+	NULL
+	NULL
FIG	NULL
.	NULL

9	NULL
.	NULL

GTPases	NULL
are	NULL
required	NULL
for	NULL
ROI	NULL
production	NULL
in	NULL
response	NULL
to	NULL
IL-1§	NULL
in	NULL
monocytic	NULL
cells	NULL
.	NULL

U937	NULL
cells	NULL
were	NULL
transfected	NULL
with	NULL
the	NULL
CD20	NULL
expression	NULL
vector	NULL
and	NULL
with	NULL
plasmids	NULL
coding	NULL
for	NULL
wild-type	NULL
(	NULL
Cdc42	NULL
and	NULL
Rac	NULL
)	NULL
or	NULL
dominant-negative	NULL
(	NULL
Cde42	NULL
``	NULL
and	NULL
Rac	NULL
``	NULL
)	NULL
Racl	NULL
and	NULL
Cdc42	NULL
.	NULL

CD20-expressing	NULL
transfected	NULL
cells	NULL
were	NULL
positively	NULL
selected	NULL
with	NULL
an	NULL
anti-CD20	NULL
monoclonal	NULL
antibody	NULL
through	NULL
MACS	NULL
and	NULL
flow	NULL
cytometry	NULL
cell	NULL
sorting	NULL
.	NULL

Selected	NULL
cells	NULL
were	NULL
either	NULL
untreated	NULL
(	NULL
-	NULL
)	NULL
or	NULL
stimulated	NULL
with	NULL
IL-1B	NULL
(	NULL
+	NULL
)	NULL
for	NULL
15	NULL
min	NULL
,	NULL
and	NULL
formation	NULL
of	NULL
ROIs	NULL
was	NULL
measured	NULL
by	NULL
using	NULL
a	NULL
DFCH	NULL
probe	NULL
.	NULL

Asterisks	NULL
indicate	NULL
that	NULL
values	NULL
are	NULL
statistically	NULL
different	NULL
from	NULL
the	NULL
reference	NULL
values	NULL
(	NULL
A	NULL
)	NULL
.	NULL

for	NULL
NF-	NULL
«	NULL
B	NULL
activation	NULL
by	NULL
IL-186	NULL
in	NULL
epithelial	NULL
cells	NULL
(	NULL
7	NULL
)	NULL
,	NULL
but	NULL
such	NULL
an	NULL
hypothesis	NULL
remains	NULL
to	NULL
be	NULL
confirmed	NULL
by	NULL
genetic	NULL
studies	NULL
.	NULL

Finally	NULL
,	NULL
monocytic	NULL
cells	NULL
(	NULL
THP-1	NULL
or	NULL
U937	NULL
cells	NULL
)	NULL
do	NULL
not	NULL
express	NULL
the	NULL
5-LOX	NULL
enzyme	NULL
but	NULL
produce	NULL
ROIs	NULL
in	NULL
response	NULL
to	NULL
IL-18	NULL
or	NULL
TNF-	NULL
«	NULL
.	NULL

In	NULL
these	NULL
cells	NULL
,	NULL
ROIs	NULL
are	NULL
generated	NULL
by	NULL
the	NULL
NADPH	NULL
oxidase	NULL
and	NULL
are	NULL
required	NULL
for	NULL
NF-	NULL
«	NULL
B	NULL
activation	NULL
by	NULL
proinflammatory	NULL
cytokines	NULL
.	NULL

Moreover	NULL
,	NULL
the	NULL
induction	NULL
of	NULL
NF-	NULL
«	NULL
B	NULL
by	NULL
IL-18	NULL
,	NULL
TNF-a	NULL
,	NULL
or	NULL
arachidonic	NULL
acid	NULL
in	NULL
monocytic	NULL
cells	NULL
also	NULL
requires	NULL
the	NULL
activity	NULL
of	NULL
small	NULL
GTPases	NULL
.	NULL

We	NULL
concluded	NULL
that	NULL
Rho	NULL
and	NULL
Rac	NULL
proteins	NULL
stimulated	NULL
ROI	NULL
production	NULL
through	NULL
NADPH	NULL
NADPH	NULL
oxidase	NULL
pl	NULL
£	NULL
3	NULL
?	NULL

~A	NULL
(	NULL
Ip	NULL
Q4	NULL
__	NULL
--	NULL
A__	NULL
FIG	NULL
.	NULL

10	NULL
.	NULL

Signaling	NULL
pathways	NULL
for	NULL
NF-	NULL
«	NULL
B	NULL
activation	NULL
by	NULL
IL-16B	NULL
.	NULL

Following	NULL
the	NULL
interaction	NULL
of	NULL
IL-1	NULL
with	NULL
the	NULL
type	NULL
1	NULL
IL-1	NULL
receptor	NULL
,	NULL
the	NULL
NIK-IKK	NULL
pathway	NULL
can	NULL
be	NULL
activated	NULL
through	NULL
the	NULL
MyD88	NULL
,	NULL
IRAK	NULL
,	NULL
and	NULL
TRAF6	NULL
signaling	NULL
proteins	NULL
.	NULL

Alterna-tively	NULL
,	NULL
Racl	NULL
and	NULL
Cdc42	NULL
can	NULL
activate	NULL
the	NULL
NADPH	NULL
oxidase	NULL
complex	NULL
and	NULL
induce	NULL
NF-	NULL
«	NULL
B	NULL
activity	NULL
through	NULL
the	NULL
production	NULL
of	NULL
ROIs	NULL
.	NULL

Other	NULL
pathways	NULL
involve	NULL
,	NULL
in	NULL
lymphoid	NULL
cells	NULL
,	NULL
the	NULL
cytoplasmic	NULL
phospholipase	NULL
A2	NULL
,	NULL
the	NULL
5-LOX	NULL
,	NULL
and	NULL
FLAP	NULL
complex	NULL
and	NULL
the	NULL
production	NULL
of	NULL
ROIs	NULL
or	NULL
,	NULL
in	NULL
epithelial	NULL
cells	NULL
,	NULL
the	NULL
acid	NULL
sphingomyelinase	NULL
(	NULL
SMase	NULL
)	NULL
and	NULL
the	NULL
production	NULL
of	NULL
ceramide	NULL
.	NULL

CPLA2	NULL
,	NULL
cytosolic	NULL
phospholipase	NULL
A2	NULL
.	NULL

Mor	NULL
.	NULL

CELL	NULL
.	NULL

BioL	NULL
.	NULL

oxidase	NULL
activation	NULL
in	NULL
macrophages/monocytes	NULL
.	NULL

As	NULL
for	NULL
lymphoid	NULL
cells	NULL
,	NULL
we	NULL
do	NULL
not	NULL
know	NULL
how	NULL
ROIs	NULL
are	NULL
connected	NULL
to	NULL
IxBa	NULL
kinases	NULL
.	NULL

These	NULL
data	NULL
thus	NULL
disclosed	NULL
two	NULL
distinct	NULL
,	NULL
cell-specific	NULL
sources	NULL
of	NULL
ROIs	NULL
,	NULL
which	NULL
are	NULL
each	NULL
required	NULL
for	NULL
NF-kB	NULL
activation	NULL
by	NULL
proinflammatory	NULL
cytokines	NULL
,	NULL
and	NULL
a	NULL
third	NULL
pathway	NULL
leading	NULL
to	NULL
NF-	NULL
«	NULL
B	NULL
activation	NULL
independently	NULL
of	NULL
ROI	NULL
production	NULL
(	NULL
Fig	NULL
.	NULL

10	NULL
)	NULL
.	NULL

Such	NULL
cell	NULL
specificity	NULL
might	NULL
be	NULL
explained	NULL
by	NULL
the	NULL
association	NULL
of	NULL
distinct	NULL
proteins	NULL
with	NULL
the	NULL
IL-1	NULL
receptor	NULL
.	NULL

Indeed	NULL
,	NULL
IL-1R	NULL
associates	NULL
with	NULL
TRAF6	NULL
,	NULL
My	NULL
D88	NULL
,	NULL
IRAK	NULL
,	NULL
and	NULL
IRAK-2	NULL
proteins	NULL
,	NULL
which	NULL
are	NULL
all	NULL
required	NULL
for	NULL
NF-	NULL
«	NULL
B	NULL
activation	NULL
(	NULL
14-16	NULL
,	NULL
31	NULL
,	NULL
44	NULL
,	NULL
61	NULL
)	NULL
.	NULL

Moreover	NULL
,	NULL
other	NULL
proteins	NULL
might	NULL
also	NULL
associate	NULL
with	NULL
this	NULL
receptor	NULL
.	NULL

It	NULL
is	NULL
possible	NULL
that	NULL
the	NULL
expression	NULL
of	NULL
each	NULL
of	NULL
these	NULL
receptor-associated	NULL
adapter	NULL
proteins	NULL
or	NULL
kinases	NULL
is	NULL
cell	NULL
specific	NULL
and	NULL
therefore	NULL
initiates	NULL
distinct	NULL
transduction	NULL
pathways	NULL
.	NULL

Indeed	NULL
,	NULL
it	NULL
has	NULL
been	NULL
shown	NULL
that	NULL
,	NULL
although	NULL
TRAF6	NULL
,	NULL
MyD88	NULL
,	NULL
IRAK	NULL
,	NULL
and	NULL
IRAK-2	NULL
mRNAs	NULL
could	NULL
be	NULL
detected	NULL
in	NULL
most	NULL
cell	NULL
types	NULL
and	NULL
organs	NULL
,	NULL
their	NULL
levels	NULL
of	NULL
expression	NULL
vary	NULL
considerably	NULL
(	NULL
15	NULL
,	NULL
16	NULL
,	NULL
28	NULL
,	NULL
44	NULL
)	NULL
.	NULL

It	NULL
would	NULL
be	NULL
most	NULL
interesting	NULL
to	NULL
determine	NULL
whether	NULL
different	NULL
proteins	NULL
are	NULL
associated	NULL
with	NULL
the	NULL
IL-1	NULL
type	NULL
I	NULL
receptor	NULL
in	NULL
lymphoid	NULL
,	NULL
monocytic	NULL
,	NULL
or	NULL
epithelial	NULL
cells	NULL
and	NULL
play	NULL
specific	NULL
,	NULL
cell	NULL
type-related	NULL
,	NULL
signaling	NULL
roles	NULL
.	NULL

These	NULL
signaling	NULL
pathways	NULL
leading	NULL
to	NULL
NF-	NULL
«	NULL
B	NULL
activation	NULL
might	NULL
be	NULL
related	NULL
to	NULL
distinct	NULL
IL-1	NULL
biological	NULL
activities	NULL
in	NULL
different	NULL
cell	NULL
types	NULL
.	NULL

The	NULL
nature	NULL
of	NULL
the	NULL
activated	NULL
NF-	NULL
«	NULL
xB	NULL
complexes	NULL
might	NULL
be	NULL
different	NULL
for	NULL
each	NULL
pathway	NULL
and	NULL
lead	NULL
to	NULL
the	NULL
transcription	NULL
of	NULL
distinct	NULL
target	NULL
genes	NULL
.	NULL

Each	NULL
pathway	NULL
is	NULL
also	NULL
controlled	NULL
differ-ently	NULL
.	NULL

For	NULL
instance	NULL
,	NULL
antioxidant	NULL
cellular	NULL
defenses	NULL
could	NULL
regulate	NULL
pathways	NULL
involving	NULL
ROI	NULL
production	NULL
while	NULL
distinct	NULL
phosphatases	NULL
could	NULL
dephosphorylate	NULL
kinase	NULL
substrates	NULL
and	NULL
specifically	NULL
regulate	NULL
signal	NULL
transduction	NULL
.	NULL

Finally	NULL
,	NULL
the	NULL
activation	NULL
of	NULL
distinct	NULL
pathways	NULL
leads	NULL
to	NULL
the	NULL
concomitant	NULL
activation	NULL
of	NULL
NF-kB	NULL
and	NULL
other	NULL
specific	NULL
transcription	NULL
factors	NULL
.	NULL

In	NULL
a	NULL
given	NULL
cellular	NULL
context	NULL
,	NULL
the	NULL
activation	NULL
of	NULL
a	NULL
specific	NULL
set	NULL
of	NULL
transcription	NULL
factors	NULL
,	NULL
including	NULL
NF-kB	NULL
,	NULL
certainly	NULL
regulates	NULL
the	NULL
expression	NULL
of	NULL
distinct	NULL
target	NULL
genes	NULL
and	NULL
thus	NULL
allows	NULL
an	NULL
appropriate	NULL
cellular	NULL
response	NULL
to	NULL
the	NULL
applied	NULL
stimulus	NULL
.	NULL

Further	NULL
experiments	NULL
are	NULL
required	NULL
in	NULL
order	NULL
to	NULL
identify	NULL
NF-	NULL
«	NULL
B	NULL
target	NULL
genes	NULL
specifically	NULL
induced	NULL
by	NULL
IL-1B	NULL
in	NULL
lymphoid	NULL
,	NULL
monocytic	NULL
,	NULL
or	NULL
epithelial	NULL
cells	NULL
and	NULL
to	NULL
determine	NULL
cell-specific	NULL
mechanisms	NULL
of	NULL
regulation	NULL
for	NULL
each	NULL
of	NULL
them	NULL
.	NULL

It	NULL
has	NULL
been	NULL
shown	NULL
that	NULL
IL-1B	NULL
can	NULL
exert	NULL
pro-	NULL
or	NULL
anti-apoptotic	NULL
activities	NULL
in	NULL
HeLa	NULL
and	NULL
L929	NULL
cells	NULL
(	NULL
27	NULL
)	NULL
.	NULL

Moreover	NULL
,	NULL
high	NULL
IL-1B	NULL
levels	NULL
have	NULL
been	NULL
measured	NULL
in	NULL
the	NULL
sera	NULL
of	NULL
patients	NULL
with	NULL
ovarian	NULL
adenocarcinomas	NULL
(	NULL
67	NULL
)	NULL
.	NULL

It	NULL
is	NULL
therefore	NULL
crucial	NULL
to	NULL
better	NULL
understand	NULL
the	NULL
role	NULL
of	NULL
IL-18	NULL
in	NULL
normal	NULL
and	NULL
transformed	NULL
epithelial	NULL
cells	NULL
and	NULL
to	NULL
identify	NULL
the	NULL
biochemical	NULL
pathways	NULL
mediating	NULL
its	NULL
biological	NULL
activities	NULL
.	NULL

ACKNOWLEDGMENTS	NULL
We	NULL
thank	NULL
J.	NULL
Evans	NULL
(	NULL
Merck	NULL
Frosst	NULL
Centre	NULL
for	NULL
Therapeutic	NULL
Research	NULL
,	NULL
Quebec	NULL
,	NULL
Canada	NULL
)	NULL
for	NULL
the	NULL
MK-886	NULL
inhibitor	NULL
,	NULL
for	NULL
the	NULL
5-LOX	NULL
and	NULL
FLAP	NULL
expression	NULL
vectors	NULL
,	NULL
and	NULL
for	NULL
the	NULL
FLAP	NULL
and	NULL
5-LOX	NULL
antibodies	NULL
,	NULL
L.	NULL
Cross	NULL
(	NULL
National	NULL
Institutes	NULL
of	NULL
Health	NULL
,	NULL
Bethesda	NULL
,	NULL
Md	NULL
.	NULL
)	NULL

for	NULL
the	NULL
RhoA	NULL
,	NULL
Racl	NULL
,	NULL
and	NULL
Cdcd42	NULL
constructs	NULL
,	NULL
and	NULL
Jim	NULL
Koh	NULL
(	NULL
Laboratory	NULL
of	NULL
Molecular	NULL
Oncology	NULL
,	NULL
Massachusetts	NULL
General	NULL
Hospital	NULL
and	NULL
Harvard	NULL
Medical	NULL
School	NULL
)	NULL
for	NULL
the	NULL
CD20	NULL
expression	NULL
plasmid	NULL
.	NULL

We	NULL
are	NULL
most	NULL
thankful	NULL
to	NULL
J.	NULL
Gielen	NULL
for	NULL
his	NULL
support	NULL
and	NULL
critical	NULL
comments	NULL
about	NULL
the	NULL
manuscript	NULL
,	NULL
to	NULL
O.	NULL
Giet	NULL
for	NULL
his	NULL
help	NULL
with	NULL
the	NULL
MACS	NULL
selection	NULL
,	NULL
and	NULL
to	NULL
F.	NULL
Bureau	NULL
for	NULL
statistical	NULL
analysis	NULL
.	NULL

M.-P.M.	NULL
and	NULL
V.B	NULL
.	NULL

are	NULL
research	NULL
associates	NULL
and	NULL
J.P.	NULL
is	NULL
a	NULL
research	NULL
director	NULL
at	NULL
the	NULL
National	NULL
Fund	NULL
for	NULL
Scientific	NULL
Research	NULL
(	NULL
Belgium	NULL
)	NULL
.	NULL

G.B	NULL
.	NULL

is	NULL
a	NULL
fellow	NULL
from	NULL
the	NULL
Biotechnology	NULL
Programme	NULL
,	NULL
European	NULL
Commis-sion	NULL
.	NULL

This	NULL
work	NULL
has	NULL
been	NULL
supported	NULL
by	NULL
grants	NULL
from	NULL
the	NULL
National	NULL
Fund	NULL
for	NULL
Scientific	NULL
Research	NULL
(	NULL
FNRS	NULL
,	NULL
Belgium	NULL
)	NULL
,	NULL
FNRS-Télévie	NULL
(	NULL
Belgium	NULL
)	NULL
,	NULL
the	NULL
Centre	NULL
Anti	NULL
Cancéreux	NULL
(	NULL
University	NULL
of	NULL
Liége	NULL
,	NULL
Liege	NULL
,	NULL
Belgium	NULL
)	NULL
,	NULL
and	NULL
the	NULL
EEC	NULL
Biomed	NULL
II	NULL
program	NULL
(	NULL
grant	NULL
BMH4-CT97-2387	NULL
)	NULL
.	NULL

Vor	NULL
.	NULL

19	NULL
,	NULL
1999	NULL
10	NULL
.	NULL

11	NULL
.	NULL

12	NULL
.	NULL

13	NULL
.	NULL

14	NULL
.	NULL

15	NULL
.	NULL

16	NULL
.	NULL

17	NULL
.	NULL

18	NULL
.	NULL

19	NULL
.	NULL

20	NULL
.	NULL

21	NULL
.	NULL

22	NULL
.	NULL

23	NULL
.	NULL

24	NULL
.	NULL

25	NULL
.	NULL

26	NULL
.	NULL

27	NULL
.	NULL

REFERENCES	NULL
.	NULL

Abo	NULL
,	NULL
A.	NULL
,	NULL
A.	NULL
Boyhan	NULL
,	NULL
I	NULL
.	NULL

West	NULL
,	NULL
A.	NULL
J.	NULL
Thrasher	NULL
,	NULL
and	NULL
A.	NULL
W.	NULL
Segal	NULL
.	NULL

1992	NULL
.	NULL

Recon-	NULL
stitution	NULL
of	NULL
neutrophil	NULL
NADPH	NULL
oxidase	NULL
activity	NULL
in	NULL
the	NULL
cell-free	NULL
system	NULL
by	NULL
four	NULL
components	NULL
:	NULL
p67-phox	NULL
,	NULL
p47-phox	NULL
,	NULL
p2iracl	NULL
and	NULL
cytochrome	NULL
b-245	NULL
.	NULL

J.	NULL
Biol	NULL
.	NULL

Chem	NULL
.	NULL

267:16767-16770.	NULL
.	NULL

Baldwin	NULL
,	NULL
A.	NULL
S.	NULL
1996	NULL
.	NULL

The	NULL
NF-kB	NULL
and	NULL
IxB	NULL
proteins	NULL
:	NULL
new	NULL
discoveries	NULL
and	NULL
insights	NULL
.	NULL

Annu	NULL
.	NULL

Rev	NULL
.	NULL

Immunol	NULL
.	NULL

14:649-681.	NULL
.	NULL

Barnes	NULL
,	NULL
P.	NULL
J.	NULL
,	NULL
and	NULL
M.	NULL
Karin	NULL
.	NULL

1997	NULL
.	NULL

Nuclear	NULL
factor-	NULL
«	NULL
B-a	NULL
pivotal	NULL
transcrip-	NULL
tion	NULL
factor	NULL
in	NULL
chronic	NULL
inflammatory	NULL
diseases	NULL
.	NULL

N.	NULL
Engl	NULL
.	NULL

J.	NULL
Med	NULL
.	NULL

336:1066-1071.	NULL
.	NULL

Beg	NULL
,	NULL
A	NULL
.	NULL

A.	NULL
,	NULL
T.	NULL
S.	NULL
Finco	NULL
,	NULL
P.	NULL
V.	NULL
Nantermet	NULL
,	NULL
and	NULL
A.	NULL
S.	NULL
Baldwin	NULL
,	NULL
Jr.	NULL
1993	NULL
.	NULL

Tumor	NULL
necrosis	NULL
factor	NULL
and	NULL
interleukin-1	NULL
lead	NULL
to	NULL
phosphorylation	NULL
and	NULL
loss	NULL
of	NULL
IxBa	NULL
:	NULL
a	NULL
mechanism	NULL
for	NULL
NF-xB	NULL
activation	NULL
.	NULL

Mol	NULL
.	NULL

Cell	NULL
.	NULL

Biol	NULL
.	NULL

13:3301-3310.	NULL
.	NULL

Bokoch	NULL
,	NULL
G.	NULL
M.	NULL
1995	NULL
.	NULL

Regulation	NULL
of	NULL
the	NULL
phagocyte	NULL
respiratory	NULL
burst	NULL
by	NULL
small	NULL
GTP-binding	NULL
proteins	NULL
.	NULL

Trends	NULL
Cell	NULL
Biol	NULL
.	NULL

5:109-113.	NULL
.	NULL

Bonizzi	NULL
,	NULL
G.	NULL
,	NULL
E.	NULL
Dejardin	NULL
,	NULL
B.	NULL
Piret	NULL
,	NULL
J.	NULL
Piette	NULL
,	NULL
M.-P.	NULL
Merville	NULL
,	NULL
and	NULL
V.	NULL
Bours	NULL
.	NULL

1996	NULL
.	NULL

IL-1§6	NULL
induces	NULL
NF-B	NULL
in	NULL
epithelial	NULL
cells	NULL
independently	NULL
of	NULL
the	NULL
production	NULL
of	NULL
reactive	NULL
oxygen	NULL
intermediates	NULL
.	NULL

Eur	NULL
.	NULL

J.	NULL
Biochem	NULL
.	NULL

242:544-549.	NULL
.	NULL

Bonizzi	NULL
,	NULL
G.	NULL
,	NULL
J.	NULL
Piette	NULL
,	NULL
M.-P.	NULL
Merville	NULL
,	NULL
and	NULL
V.	NULL
Bours	NULL
.	NULL

1997	NULL
.	NULL

Distinct	NULL
signal	NULL
transduction	NULL
pathways	NULL
mediate	NULL
nuclear	NULL
factor-	NULL
«	NULL
B	NULL
induction	NULL
by	NULL
IL-16	NULL
in	NULL
epithelial	NULL
and	NULL
lymphoid	NULL
cells	NULL
.	NULL

J.	NULL
Immunol	NULL
.	NULL

159:5264-5272.	NULL
.	NULL

Bonizzi	NULL
,	NULL
G.	NULL
,	NULL
S.	NULL
Schoonbroodt	NULL
,	NULL
J.	NULL
Piette	NULL
,	NULL
M.-P.	NULL
Merville	NULL
,	NULL
and	NULL
V.	NULL
Bours	NULL
.	NULL

Im-	NULL
plication	NULL
of	NULL
the	NULL
protein	NULL
kinase	NULL
C	NULL
A/	NULL
isoform	NULL
in	NULL
NF-	NULL
«	NULL
B	NULL
activation	NULL
by	NULL
IL-18	NULL
or	NULL
TNF-a	NULL
:	NULL
cell	NULL
type	NULL
specificities	NULL
.	NULL

Biochem	NULL
.	NULL

Pharmacol	NULL
.	NULL

,	NULL
in	NULL
press	NULL
.	NULL

.	NULL

Bours	NULL
,	NULL
V.	NULL
,	NULL
P.	NULL
R.	NULL
Burd	NULL
,	NULL
K.	NULL
Brown	NULL
,	NULL
J.	NULL
Villalobos	NULL
,	NULL
S.	NULL
Park	NULL
,	NULL
R.~P	NULL
.	NULL

Ryseck	NULL
,	NULL
R.	NULL
Bravo	NULL
,	NULL
K.	NULL
Kelly	NULL
,	NULL
and	NULL
U.	NULL
Siebenlist	NULL
.	NULL

1992	NULL
.	NULL

A	NULL
novel	NULL
mitogen-inducible	NULL
gene	NULL
product	NULL
related	NULL
to	NULL
p50/p105-NF-	NULL
«	NULL
B	NULL
participates	NULL
in	NULL
transactivation	NULL
through	NULL
a	NULL
xB	NULL
site	NULL
.	NULL

Mol	NULL
.	NULL

Cell	NULL
.	NULL

Biol	NULL
.	NULL

12:685-695	NULL
.	NULL

Bowie	NULL
,	NULL
A.	NULL
,	NULL
P.	NULL
N.	NULL
Moynagh	NULL
,	NULL
and	NULL
L.	NULL
A.	NULL
J.	NULL
O'Neill	NULL
.	NULL

1997	NULL
.	NULL

Lipid	NULL
peroxidation	NULL
is	NULL
involved	NULL
in	NULL
the	NULL
activation	NULL
of	NULL
NF-kB	NULL
by	NULL
tumor	NULL
necrosis	NULL
factor	NULL
but	NULL
not	NULL
interleukin-1	NULL
in	NULL
the	NULL
human	NULL
endothelial	NULL
cell	NULL
line	NULL
ECV304	NULL
.	NULL

J.	NULL
Biol	NULL
.	NULL

Chem	NULL
.	NULL

272	NULL
:	NULL
25941-25950	NULL
.	NULL

Brennan	NULL
,	NULL
P.	NULL
,	NULL
and	NULL
L.	NULL
A.	NULL
J.	NULL
O'Neill	NULL
.	NULL

1995	NULL
.	NULL

Effects	NULL
of	NULL
oxidants	NULL
and	NULL
antioxidants	NULL
on	NULL
nuclear	NULL
factor	NULL
xB	NULL
activation	NULL
in	NULL
three	NULL
different	NULL
cell	NULL
lines	NULL
:	NULL
evidence	NULL
against	NULL
a	NULL
universal	NULL
hypothesis	NULL
involving	NULL
oxygen	NULL
radicals	NULL
.	NULL

Biochim	NULL
.	NULL

Biophys	NULL
.	NULL

Acta	NULL
1260:167-175	NULL
.	NULL

Brown	NULL
,	NULL
K.	NULL
,	NULL
S.	NULL
Gerstberger	NULL
,	NULL
L.	NULL
Carlson	NULL
,	NULL
G.	NULL
Franzoso	NULL
,	NULL
and	NULL
U.	NULL
Siebenlist	NULL
.	NULL

1995	NULL
.	NULL

Control	NULL
of	NULL
IxB-a	NULL
proteolysis	NULL
by	NULL
site-specific	NULL
,	NULL
signal-induced	NULL
phosphorylation	NULL
.	NULL

Science	NULL
267:1485-1488	NULL
.	NULL

Brown	NULL
,	NULL
K.	NULL
,	NULL
S.	NULL
Park	NULL
,	NULL
T.	NULL
Kanno	NULL
,	NULL
G.	NULL
Franzoso	NULL
,	NULL
and	NULL
U.	NULL
Siebenlist	NULL
.	NULL

1993	NULL
.	NULL

Mutual	NULL
regulation	NULL
of	NULL
the	NULL
transcriptional	NULL
activator	NULL
NF-	NULL
«	NULL
B	NULL
and	NULL
its	NULL
inhibitor	NULL
,	NULL
IxB-	NULL
«	NULL
.	NULL

Proc	NULL
.	NULL

Natl	NULL
.	NULL

Acad	NULL
.	NULL

Sci	NULL
.	NULL

USA	NULL
90:2532-2536	NULL
.	NULL

Burns	NULL
,	NULL
K.	NULL
,	NULL
F.	NULL
Martinon	NULL
,	NULL
C.	NULL
Esslinger	NULL
,	NULL
H.	NULL
Pabl	NULL
,	NULL
P.	NULL
Schneider	NULL
,	NULL
J.-L.	NULL
Bodmer	NULL
,	NULL
F.	NULL
Di	NULL
Marco	NULL
,	NULL
L.	NULL
French	NULL
,	NULL
and	NULL
J.	NULL
Tschopp	NULL
.	NULL

1998	NULL
.	NULL

MyD88	NULL
,	NULL
an	NULL
adapter	NULL
protein	NULL
involved	NULL
in	NULL
interleukin-1	NULL
signaling	NULL
.	NULL

J.	NULL
Biol	NULL
.	NULL

Chem	NULL
.	NULL

273:12203-12209	NULL
.	NULL

Cao	NULL
,	NULL
Z.	NULL
,	NULL
W.	NULL
J.	NULL
Henzel	NULL
,	NULL
and	NULL
X.	NULL
Gao	NULL
.	NULL

1996	NULL
.	NULL

IRAK	NULL
:	NULL
a	NULL
kinase	NULL
associated	NULL
with	NULL
the	NULL
interleukin-1	NULL
receptor	NULL
.	NULL

Science	NULL
271:1128-1131	NULL
.	NULL

Cao	NULL
,	NULL
Z.	NULL
,	NULL
J.	NULL
Xiong	NULL
,	NULL
M.	NULL
Takeuchi	NULL
,	NULL
T.	NULL
Kurama	NULL
,	NULL
and	NULL
D.	NULL
V.	NULL
Goeddel	NULL
.	NULL

1996	NULL
.	NULL

TRAF6	NULL
is	NULL
a	NULL
signal	NULL
transducer	NULL
for	NULL
interleukin-1	NULL
.	NULL

Nature	NULL
383:443-446	NULL
.	NULL

Chen	NULL
,	NULL
Z.	NULL
J.	NULL
,	NULL
L.	NULL
Parent	NULL
,	NULL
and	NULL
T.	NULL
Maniatis	NULL
.	NULL

1996	NULL
.	NULL

Site-specific	NULL
phosphorylation	NULL
of	NULL
IxBa	NULL
by	NULL
a	NULL
novel	NULL
ubiquitination-dependent	NULL
protein	NULL
kinase	NULL
activity	NULL
.	NULL

Cell	NULL
84:853-862	NULL
.	NULL

Coso	NULL
,	NULL
O	NULL
.	NULL

A.	NULL
,	NULL
M.	NULL
Chiarello	NULL
,	NULL
J.	NULL
C.	NULL
Yu	NULL
,	NULL
H.	NULL
Teramoto	NULL
,	NULL
P.	NULL
Crespo	NULL
,	NULL
N.	NULL
Xu	NULL
,	NULL
T.	NULL
Miki	NULL
,	NULL
and	NULL
J.	NULL
S.	NULL
Gutkind	NULL
.	NULL

1995	NULL
.	NULL

The	NULL
small	NULL
GTP-binding	NULL
proteins	NULL
Racl	NULL
and	NULL
Cdc42	NULL
regulate	NULL
the	NULL
activity	NULL
of	NULL
the	NULL
JNK/SAPK	NULL
signaling	NULL
pathway	NULL
.	NULL

Cell	NULL
81:1137-1148	NULL
.	NULL

Diaz-Meco	NULL
,	NULL
M.	NULL
T.	NULL
,	NULL
E.	NULL
Berra	NULL
,	NULL
M.	NULL
M.	NULL
Municio	NULL
,	NULL
L.	NULL
Sanz	NULL
,	NULL
J.	NULL
Lozano	NULL
,	NULL
I.	NULL
Dominguez	NULL
,	NULL
V.	NULL
Diaz-Golpe	NULL
,	NULL
M.	NULL
T.	NULL
Lain	NULL
de	NULL
Lera	NULL
,	NULL
J.	NULL
Alcami	NULL
,	NULL
C.	NULL
V.	NULL
Paya	NULL
,	NULL
F.	NULL
Arenzana-Seisdedos	NULL
,	NULL
J.-L.	NULL
Virelizier	NULL
,	NULL
and	NULL
J.	NULL
Moscat	NULL
.	NULL

1993	NULL
.	NULL

A	NULL
dominant	NULL
negative	NULL
protein	NULL
kinase	NULL
C	NULL
{	NULL
subspecies	NULL
blocks	NULL
NF-B	NULL
activation	NULL
.	NULL

Mol	NULL
.	NULL

Cell	NULL
.	NULL

Biol	NULL
.	NULL

13:4770-4775	NULL
.	NULL

DiDonato	NULL
,	NULL
J	NULL
.	NULL

A.	NULL
,	NULL
M.	NULL
Hayakawa	NULL
,	NULL
D.	NULL
M.	NULL
Rothwarf	NULL
,	NULL
E.	NULL
Zandi	NULL
,	NULL
and	NULL
M.	NULL
Karin	NULL
.	NULL

1997	NULL
.	NULL

A	NULL
cytokine-responsive	NULL
IxB	NULL
kinase	NULL
that	NULL
activates	NULL
the	NULL
transcriptional	NULL
factor	NULL
NF-kB	NULL
.	NULL

Nature	NULL
388:548-554	NULL
.	NULL

Diekmann	NULL
,	NULL
D.	NULL
,	NULL
A.	NULL
Abo	NULL
,	NULL
C.	NULL
Johnston	NULL
,	NULL
A.	NULL
W.	NULL
Segal	NULL
,	NULL
and	NULL
A	NULL
.	NULL

Hall	NULL
.	NULL

1994	NULL
.	NULL

Interaction	NULL
of	NULL
Rac	NULL
with	NULL
p67phox	NULL
and	NULL
regulation	NULL
of	NULL
phagocytic	NULL
NADPH	NULL
activity	NULL
.	NULL

Science	NULL
265:531-533	NULL
.	NULL

Dinarello	NULL
,	NULL
C.	NULL
A	NULL
.	NULL

1996	NULL
.	NULL

Biologic	NULL
basis	NULL
for	NULL
interleukin-1	NULL
in	NULL
disease	NULL
.	NULL

Blood	NULL
87:2095-2147	NULL
.	NULL

Dixon	NULL
,	NULL
R.	NULL
A.	NULL
F.	NULL
,	NULL
R.	NULL
E.	NULL
Diehl	NULL
,	NULL
E.	NULL
Opas	NULL
,	NULL
E.	NULL
Rands	NULL
,	NULL
P.	NULL
J.	NULL
Vickers	NULL
,	NULL
J.	NULL
F.	NULL
Evans	NULL
,	NULL
J.	NULL
W.	NULL
Gillard	NULL
,	NULL
and	NULL
D.	NULL
K.	NULL
Miller	NULL
.	NULL

1990	NULL
.	NULL

Requirement	NULL
of	NULL
a	NULL
5-lipoxygenase-activating	NULL
protein	NULL
for	NULL
leukotriene	NULL
synthesis	NULL
.	NULL

Nature	NULL
343:282-284	NULL
.	NULL

Dominguez	NULL
,	NULL
L	NULL
,	NULL
L.	NULL
Sanz	NULL
,	NULL
F.	NULL
Arenzana-Seisdedos	NULL
,	NULL
M.	NULL
T.	NULL
Diaz-Meco	NULL
,	NULL
J.-L.	NULL
Virelizier	NULL
,	NULL
and	NULL
J.	NULL
Moscat	NULL
.	NULL

1993	NULL
.	NULL

Inhibition	NULL
of	NULL
protein	NULL
kinase	NULL
C	NULL
{	NULL
subspecies	NULL
blocks	NULL
the	NULL
activation	NULL
of	NULL
an	NULL
NF-	NULL
«	NULL
B-like	NULL
activity	NULL
in	NULL
Xenopus	NULL
laevis	NULL
oocytes	NULL
.	NULL

Mol	NULL
.	NULL

Cell	NULL
.	NULL

Biol	NULL
.	NULL

13:1290-1295	NULL
.	NULL

Finco	NULL
,	NULL
T.	NULL
S.	NULL
,	NULL
and	NULL
A.	NULL
S.	NULL
J.	NULL
Baldwin	NULL
.	NULL

1993	NULL
.	NULL

B	NULL
site-dependent	NULL
induction	NULL
of	NULL
gene	NULL
expression	NULL
by	NULL
diverse	NULL
inducers	NULL
of	NULL
nuclear	NULL
factor	NULL
«	NULL
B	NULL
requires	NULL
Raf-1	NULL
.	NULL

J.	NULL
Biol	NULL
.	NULL

Chem	NULL
.	NULL

268:17676-17679	NULL
.	NULL

Franzoso	NULL
,	NULL
G.	NULL
,	NULL
V.	NULL
Bours	NULL
,	NULL
S.	NULL
Park	NULL
,	NULL
M.	NULL
Tomita-Yamaguchi	NULL
,	NULL
K.	NULL
Kelly	NULL
,	NULL
and	NULL
U.	NULL
Siebenlist	NULL
.	NULL

1992	NULL
.	NULL

The	NULL
candidate	NULL
oncoprotein	NULL
Bcl-3	NULL
is	NULL
an	NULL
antagonist	NULL
of	NULL
p50/	NULL
NF-	NULL
«	NULL
B-mediated	NULL
inhibition	NULL
.	NULL

Nature	NULL
359:339-342	NULL
.	NULL

Friedlander	NULL
,	NULL
R.	NULL
M.	NULL
,	NULL
V.	NULL
Gagliardini	NULL
,	NULL
R.	NULL
J.	NULL
Rotello	NULL
,	NULL
and	NULL
J.	NULL
Yuan	NULL
.	NULL

1996	NULL
.	NULL

Functional	NULL
role	NULL
of	NULL
interleukin	NULL
16	NULL
(	NULL
IL-18	NULL
)	NULL
in	NULL
IL-1B-converting	NULL
enzyme-mediated	NULL
NF-	NULL
«	NULL
B	NULL
ACTIVATION	NULL
BY	NULL
REACTIVE	NULL
OXYGEN	NULL
INTERMEDIATES	NULL
28	NULL
.	NULL

29	NULL
.	NULL

30	NULL
.	NULL

31	NULL
.	NULL

32	NULL
.	NULL

33	NULL
.	NULL

34	NULL
.	NULL

35	NULL
.	NULL

36	NULL
.	NULL

37	NULL
.	NULL

38	NULL
.	NULL

39	NULL
.	NULL

40	NULL
.	NULL

41	NULL
.	NULL

42	NULL
.	NULL

43	NULL
.	NULL

44	NULL
.	NULL

45	NULL
.	NULL

46	NULL
.	NULL

47	NULL
.	NULL

48	NULL
.	NULL

49	NULL
.	NULL

50	NULL
.	NULL

51	NULL
.	NULL

52	NULL
.	NULL

53	NULL
.	NULL

1959	NULL
apoptosis	NULL
.	NULL

J.	NULL
Exp	NULL
.	NULL

Med	NULL
.	NULL

184:717-724	NULL
.	NULL

Hardiman	NULL
,	NULL
G.	NULL
,	NULL
F.	NULL
L.	NULL
Rock	NULL
,	NULL
S.	NULL
Balasubramanian	NULL
,	NULL
R.	NULL
A.	NULL
Kastelein	NULL
,	NULL
and	NULL
J.	NULL
F.	NULL
Bazan	NULL
.	NULL

1996	NULL
.	NULL

Molecular	NULL
characterization	NULL
and	NULL
modular	NULL
analysis	NULL
of	NULL
human	NULL
MyD88	NULL
.	NULL

Oncogene	NULL
13:2467-2475	NULL
.	NULL

Harrison	NULL
,	NULL
K.	NULL
A.	NULL
,	NULL
and	NULL
R.	NULL
C.	NULL
Murphy	NULL
.	NULL

1995	NULL
.	NULL

Isolcukotrienes	NULL
are	NULL
biologically	NULL
active	NULL
free	NULL
radical	NULL
products	NULL
of	NULL
lipid	NULL
peroxidation	NULL
.	NULL

J.	NULL
Biol	NULL
.	NULL

Chem	NULL
.	NULL

270:17273-17278	NULL
.	NULL

Huang	NULL
,	NULL
J.	NULL
,	NULL
X.	NULL
Gao	NULL
,	NULL
and	NULL
Z.	NULL
Cao	NULL
.	NULL

1997	NULL
.	NULL

Recruitment	NULL
of	NULL
IRAK	NULL
to	NULL
the	NULL
interleukin	NULL
1	NULL
receptor	NULL
complex	NULL
requires	NULL
interleukin	NULL
1	NULL
receptor	NULL
accessory	NULL
protein	NULL
.	NULL

Proc	NULL
.	NULL

Natl	NULL
.	NULL

Acad	NULL
.	NULL

Sci	NULL
.	NULL

USA	NULL
94:12829-12832	NULL
.	NULL

Kanakaraj	NULL
,	NULL
P.	NULL
,	NULL
P.	NULL
H.	NULL
Schafer	NULL
,	NULL
D.	NULL
E.	NULL
Cavender	NULL
,	NULL
Y.	NULL
Wu	NULL
,	NULL
K.	NULL
Ngo	NULL
,	NULL
P.	NULL
F.	NULL
Grealish	NULL
,	NULL
S.	NULL
A.	NULL
Wadsworth	NULL
,	NULL
P.	NULL
A.	NULL
Peterson	NULL
,	NULL
J.	NULL
J.	NULL
Sickierka	NULL
,	NULL
C.	NULL
A.	NULL
Harris	NULL
,	NULL
and	NULL
W.-P.	NULL
Fung-Leung	NULL
.	NULL

1998	NULL
.	NULL

Interleukin	NULL
(	NULL
IL	NULL
)	NULL
-1	NULL
receptor-associated	NULL
kinase	NULL
(	NULL
IRAK	NULL
)	NULL
requirement	NULL
for	NULL
optimal	NULL
induction	NULL
of	NULL
multiple	NULL
IL-1	NULL
signaling	NULL
pathways	NULL
and	NULL
IL-6	NULL
production	NULL
.	NULL

J.	NULL
Exp	NULL
.	NULL

Med	NULL
.	NULL

187:2073-2079	NULL
.	NULL

Kolesnick	NULL
,	NULL
R.	NULL
,	NULL
and	NULL
D.	NULL
W.	NULL
Golde	NULL
.	NULL

1994	NULL
.	NULL

The	NULL
sphingomyelin	NULL
pathway	NULL
in	NULL
tumor	NULL
necrosis	NULL
factor	NULL
and	NULL
interleukin-1	NULL
signaling	NULL
.	NULL

Cell	NULL
77:325-328	NULL
.	NULL

Lee	NULL
,	NULL
F.	NULL
S.	NULL
,	NULL
J.	NULL
Hagler	NULL
,	NULL
Z.	NULL
J.	NULL
Chen	NULL
,	NULL
and	NULL
T.	NULL
Maniatis	NULL
.	NULL

1997	NULL
.	NULL

Activation	NULL
of	NULL
the	NULL
IxBa	NULL
kinase	NULL
complex	NULL
by	NULL
MEKK1	NULL
,	NULL
a	NULL
kinase	NULL
of	NULL
the	NULL
JNK	NULL
pathway	NULL
.	NULL

Cell	NULL
88	NULL
:	NULL
213-222	NULL
.	NULL

Lee	NULL
,	NULL
S.	NULL
,	NULL
K.	NULL
A.	NULL
Felts	NULL
,	NULL
G.	NULL
C.	NULL
N.	NULL
Parry	NULL
,	NULL
L.	NULL
M.	NULL
Armacost	NULL
,	NULL
and	NULL
R.	NULL
R.	NULL
Cobb	NULL
.	NULL

1997	NULL
.	NULL

Inhibition	NULL
of	NULL
5-lipoxygenase	NULL
blocks	NULL
IL-1B-induced	NULL
vascular	NULL
adhesion	NULL
mole-cule-1	NULL
gene	NULL
expression	NULL
in	NULL
human	NULL
endothelial	NULL
cells	NULL
.	NULL

J.	NULL
Immunol	NULL
.	NULL

158:3401-3407	NULL
.	NULL

Legrand-Poels	NULL
,	NULL
S.	NULL
,	NULL
D.	NULL
Vaira	NULL
,	NULL
J.	NULL
Pincemail	NULL
,	NULL
A	NULL
.	NULL

Van	NULL
de	NULL
Vorst	NULL
,	NULL
and	NULL
J.	NULL
Pictte	NULL
.	NULL

1990	NULL
.	NULL

Activation	NULL
of	NULL
human	NULL
immunodeficiency	NULL
virus	NULL
type	NULL
1	NULL
by	NULL
an	NULL
oxidative	NULL
stress	NULL
.	NULL

AIDS	NULL
Res	NULL
.	NULL

Hum	NULL
.	NULL

Retroviruses	NULL
6:1389-1397	NULL
.	NULL

Lewis	NULL
,	NULL
R.	NULL
A.	NULL
,	NULL
K.	NULL
F.	NULL
Austen	NULL
,	NULL
and	NULL
R.	NULL
J.	NULL
Soberman	NULL
.	NULL

1990	NULL
.	NULL

Leukotrienes	NULL
and	NULL
other	NULL
products	NULL
of	NULL
the	NULL
5-lipoxygenase	NULL
pathway	NULL
.	NULL

N.	NULL
Engl	NULL
.	NULL

J.	NULL
Med	NULL
.	NULL

323:645-655	NULL
.	NULL

Los	NULL
,	NULL
M.	NULL
,	NULL
H.	NULL
Schenk	NULL
,	NULL
K.	NULL
Hexel	NULL
,	NULL
P.	NULL
A.	NULL
Baeuerle	NULL
,	NULL
W.	NULL
Droge	NULL
,	NULL
and	NULL
K.	NULL
Schulze-Osthoff	NULL
.	NULL

1995	NULL
.	NULL

IL-2	NULL
gene	NULL
expression	NULL
and	NULL
NF-kB	NULL
activation	NULL
through	NULL
CD28	NULL
requires	NULL
reactive	NULL
oxygen	NULL
production	NULL
by	NULL
5-lipoxygenase	NULL
.	NULL

EMBO	NULL
J	NULL
.	NULL

14:3731-3740	NULL
.	NULL

Machleidt	NULL
,	NULL
T.	NULL
,	NULL
K.	NULL
Wieg	NULL
T.	NULL
Henkel	NULL
,	NULL
S.	NULL
Schiitze	NULL
,	NULL
P.	NULL
Baeuerle	NULL
,	NULL
and	NULL
M.	NULL
Krionke	NULL
.	NULL

1994	NULL
.	NULL

Sphingomyelinase	NULL
activates	NULL
proteolytic	NULL
IxB-	NULL
«	NULL
degradation	NULL
in	NULL
a	NULL
cell-free	NULL
system	NULL
.	NULL

J.	NULL
Biol	NULL
.	NULL

Chem	NULL
.	NULL

269:13760-13765	NULL
.	NULL

Malinin	NULL
,	NULL
N.	NULL
L.	NULL
,	NULL
M.	NULL
P.	NULL
Boldin	NULL
,	NULL
A.	NULL
V.	NULL
Kovalenko	NULL
,	NULL
and	NULL
D.	NULL
Wallach	NULL
.	NULL

1997	NULL
.	NULL

MAP3K-related	NULL
kinase	NULL
involved	NULL
in	NULL
NF-	NULL
«	NULL
B	NULL
induction	NULL
by	NULL
TNF	NULL
,	NULL
CD95	NULL
and	NULL
IL-1	NULL
.	NULL

Nature	NULL
385:540-544	NULL
.	NULL

Mancini	NULL
,	NULL
J	NULL
.	NULL

A.	NULL
,	NULL
P.	NULL
Prasit	NULL
,	NULL
M.	NULL
G.	NULL
Coppolino	NULL
,	NULL
P.	NULL
Charleson	NULL
,	NULL
S.	NULL
Leger	NULL
,	NULL
J.	NULL
F.	NULL
Evans	NULL
,	NULL
J.	NULL
W.	NULL
Gillard	NULL
,	NULL
and	NULL
P.	NULL
J.	NULL
Vickers	NULL
.	NULL

1991	NULL
.	NULL

5-Lipoxygenase-activating	NULL
protein	NULL
is	NULL
the	NULL
target	NULL
of	NULL
a	NULL
novel	NULL
hybrid	NULL
of	NULL
two	NULL
classes	NULL
of	NULL
leukotriene	NULL
biosyn-thesis	NULL
inhibitors	NULL
.	NULL

Mol	NULL
.	NULL

Pharmacol	NULL
.	NULL

41:267-272	NULL
.	NULL

Maniatis	NULL
,	NULL
T.	NULL
1997	NULL
.	NULL

Catalysis	NULL
by	NULL
a	NULL
multiprotein	NULL
IxB	NULL
kinase	NULL
complex	NULL
.	NULL

Science	NULL
278:818-819	NULL
.	NULL

Mercurio	NULL
,	NULL
F.	NULL
,	NULL
H.	NULL
Zhu	NULL
,	NULL
B.	NULL
W.	NULL
Murray	NULL
,	NULL
A.	NULL
Shevchenko	NULL
,	NULL
B.	NULL
L.	NULL
Bennet	NULL
,	NULL
J.	NULL
W.	NULL
Li	NULL
,	NULL
D.	NULL
B	NULL
.	NULL

Young	NULL
,	NULL
M.	NULL
Barbosa	NULL
,	NULL
M.	NULL
Mann	NULL
,	NULL
A.	NULL
Manning	NULL
,	NULL
and	NULL
A.	NULL
Rao	NULL
.	NULL

1997	NULL
.	NULL

IKK-1	NULL
and	NULL
IKK-2	NULL
:	NULL
cytokine-activated	NULL
IxB	NULL
kinases	NULL
essential	NULL
for	NULL
NF-	NULL
«	NULL
B	NULL
activation	NULL
.	NULL

Science	NULL
278:860-865	NULL
.	NULL

Miller	NULL
,	NULL
D.	NULL
K.	NULL
,	NULL
J.	NULL
W.	NULL
Gillard	NULL
,	NULL
P.	NULL
J.	NULL
Vickers	NULL
,	NULL
S.	NULL
Sadowski	NULL
,	NULL
C.	NULL
Léveillé	NULL
,	NULL
J	NULL
.	NULL

A.	NULL
Mancini	NULL
,	NULL
P.	NULL
Charleson	NULL
,	NULL
R.	NULL
A.	NULL
F.	NULL
Dixon	NULL
,	NULL
H.	NULL
A.	NULL
W.	NULL
Ford-Hutchinson	NULL
,	NULL
and	NULL
R.	NULL
Fortin	NULL
.	NULL

1990	NULL
.	NULL

Identification	NULL
and	NULL
isolation	NULL
of	NULL
a	NULL
membrane	NULL
protein	NULL
necessary	NULL
for	NULL
leukotriene	NULL
production	NULL
.	NULL

Nature	NULL
343:278-281	NULL
.	NULL

Muzio	NULL
,	NULL
M.	NULL
,	NULL
J.	NULL
Ni	NULL
,	NULL
P.	NULL
Feng	NULL
,	NULL
and	NULL
V.	NULL
M.	NULL
Dixit	NULL
.	NULL

1997	NULL
.	NULL

IRAK	NULL
(	NULL
Pelle	NULL
)	NULL
family	NULL
member	NULL
IRAK-2	NULL
and	NULL
MyD88	NULL
as	NULL
proximal	NULL
mediators	NULL
of	NULL
IL-1	NULL
signaling	NULL
.	NULL

Science	NULL
278:1612-1615	NULL
.	NULL

Pan	NULL
,	NULL
Z.	NULL
K.	NULL
,	NULL
R.	NULL
D.	NULL
Ye	NULL
,	NULL
S.	NULL
C.	NULL
Christiansen	NULL
,	NULL
M.	NULL
A.	NULL
Jagels	NULL
,	NULL
G.	NULL
M.	NULL
Bokoch	NULL
,	NULL
and	NULL
B.	NULL
L.	NULL
Zuraw	NULL
.	NULL

1998	NULL
.	NULL

Role	NULL
of	NULL
the	NULL
Rho	NULL
GTPase	NULL
in	NULL
bradykinin-stimulated	NULL
nu-clear-kB	NULL
activation	NULL
and	NULL
IL-16	NULL
gene	NULL
expression	NULL
in	NULL
cultured	NULL
epithelial	NULL
cells	NULL
.	NULL

J.	NULL
Immunol	NULL
.	NULL

160:3038-3045	NULL
.	NULL

Perona	NULL
,	NULL
R.	NULL
,	NULL
S.	NULL
Montaner	NULL
,	NULL
L.	NULL
Saniger	NULL
,	NULL
I.	NULL
Sanchez-Perez	NULL
,	NULL
R.	NULL
Bravo	NULL
,	NULL
and	NULL
J.	NULL
C.	NULL
Lacal	NULL
.	NULL

1997	NULL
.	NULL

Activation	NULL
of	NULL
the	NULL
nuclear	NULL
factor-	NULL
«	NULL
B	NULL
by	NULL
Rho	NULL
,	NULL
CDC42	NULL
and	NULL
Rac-1	NULL
proteins	NULL
.	NULL

Genes	NULL
Dev	NULL
.	NULL

11:463-475	NULL
.	NULL

Régnier	NULL
,	NULL
C.	NULL
H.	NULL
,	NULL
H.	NULL
Y	NULL
.	NULL

Song	NULL
,	NULL
X.	NULL
Gao	NULL
,	NULL
D.	NULL
V.	NULL
Goeddel	NULL
,	NULL
Z.	NULL
Cao	NULL
,	NULL
and	NULL
M.	NULL
Rothe	NULL
.	NULL

1997	NULL
.	NULL

Identification	NULL
and	NULL
characterization	NULL
of	NULL
an	NULL
IxB	NULL
kinase	NULL
.	NULL

Cell	NULL
90:373-383	NULL
.	NULL

Reid	NULL
,	NULL
G.	NULL
K.	NULL
,	NULL
S.	NULL
Kargman	NULL
,	NULL
P.	NULL
J.	NULL
Vickers	NULL
,	NULL
J	NULL
.	NULL

A.	NULL
Mancini	NULL
,	NULL
C.	NULL
Léveillé	NULL
,	NULL
D.	NULL
Ethier	NULL
,	NULL
D.	NULL
K.	NULL
Miller	NULL
,	NULL
J.	NULL
W.	NULL
Gillard	NULL
,	NULL
R.	NULL
A.	NULL
F.	NULL
Dixon	NULL
,	NULL
and	NULL
J.	NULL
F.	NULL
Evans	NULL
.	NULL

1990	NULL
.	NULL

Correlation	NULL
between	NULL
expression	NULL
of	NULL
5-lipoxygenase-activating	NULL
protein	NULL
,	NULL
5-lipoxygenase	NULL
and	NULL
cellular	NULL
leukotriene	NULL
synthesis	NULL
.	NULL

J.	NULL
Biol	NULL
.	NULL

Chem	NULL
.	NULL

265:19818-19823	NULL
.	NULL

Rothwarf	NULL
,	NULL
D.	NULL
M.	NULL
,	NULL
E.	NULL
Zandi	NULL
,	NULL
G.	NULL
Natoli	NULL
,	NULL
and	NULL
M.	NULL
Karin	NULL
.	NULL

1998	NULL
.	NULL

IKK-y	NULL
is	NULL
an	NULL
essential	NULL
regulatory	NULL
subunit	NULL
of	NULL
the	NULL
IxB	NULL
kinase	NULL
complex	NULL
.	NULL

Nature	NULL
395:297-300	NULL
.	NULL

Schreck	NULL
,	NULL
R.	NULL
,	NULL
K.	NULL
Albermann	NULL
,	NULL
and	NULL
P.	NULL
A.	NULL
Baeuerle	NULL
.	NULL

1992	NULL
.	NULL

Nuclear	NULL
factor	NULL
kappa	NULL
B	NULL
:	NULL
an	NULL
oxidative	NULL
stress-responsive	NULL
transcription	NULL
factor	NULL
of	NULL
eukaryotic	NULL
cells	NULL
(	NULL
a	NULL
review	NULL
)	NULL
.	NULL

Free	NULL
Radic	NULL
.	NULL

Res	NULL
.	NULL

Commun	NULL
.	NULL

17:221-227	NULL
.	NULL

Schreck	NULL
,	NULL
R.	NULL
,	NULL
B.	NULL
Meier	NULL
,	NULL
D.	NULL
N.	NULL
Mannel	NULL
,	NULL
W.	NULL
Droge	NULL
,	NULL
and	NULL
P.	NULL
A.	NULL
Baeuerle	NULL
.	NULL

1992	NULL
.	NULL

Dithiocarbamates	NULL
as	NULL
potent	NULL
inhibitors	NULL
of	NULL
nuclear	NULL
factor	NULL
kappa	NULL
B	NULL
activation	NULL
in	NULL
intact	NULL
cells	NULL
.	NULL

J.	NULL
Exp	NULL
.	NULL

Med	NULL
.	NULL

175:1181-1194	NULL
.	NULL

Schreck	NULL
,	NULL
R.	NULL
,	NULL
P.	NULL
Rieber	NULL
,	NULL
and	NULL
P.	NULL
A.	NULL
Baeuerle	NULL
.	NULL

1991	NULL
.	NULL

Reactive	NULL
oxygen	NULL
intermediates	NULL
as	NULL
apparently	NULL
widely	NULL
used	NULL
messengers	NULL
in	NULL
the	NULL
activation	NULL
of	NULL
the	NULL
NF-kappa	NULL
B	NULL
transcription	NULL
factor	NULL
and	NULL
HIV-1	NULL
.	NULL

EMBO	NULL
J	NULL
.	NULL

10:2247-2258	NULL
.	NULL

Schiitze	NULL
,	NULL
S.	NULL
,	NULL
K.	NULL
Potthoff	NULL
,	NULL
T.	NULL
Machleidt	NULL
,	NULL
D.	NULL
Berkovic	NULL
,	NULL
K.	NULL
Wiegmann	NULL
,	NULL
and	NULL
M.	NULL
Krionke	NULL
.	NULL

1992	NULL
.	NULL

TNF	NULL
activates	NULL
NF-	NULL
«	NULL
B	NULL
by	NULL
phosphatidylcholine-specific	NULL
phospholipase	NULL
C-induced	NULL
``	NULL
acidic	NULL
``	NULL
sphingomyelin	NULL
breakdown	NULL
.	NULL

Cell	NULL
71:765-776	NULL
.	NULL

1960	NULL
54	NULL
.	NULL

55	NULL
.	NULL

56	NULL
.	NULL

57	NULL
.	NULL

58	NULL
.	NULL

59	NULL
.	NULL

60	NULL
.	NULL

61	NULL
.	NULL

BONIZZI	NULL
ET	NULL
AL	NULL
.	NULL

Segal	NULL
,	NULL
A.	NULL
W.	NULL
,	NULL
and	NULL
A.	NULL
Abo	NULL
.	NULL

1993	NULL
.	NULL

The	NULL
biochemical	NULL
basis	NULL
of	NULL
the	NULL
NADPH	NULL
oxidase	NULL
of	NULL
phagocytes	NULL
.	NULL

Trends	NULL
Biochem	NULL
.	NULL

Sci	NULL
.	NULL

18:43-47	NULL
.	NULL

Siebenlist	NULL
,	NULL
U.	NULL
,	NULL
G.	NULL
Franzoso	NULL
,	NULL
and	NULL
K.	NULL
Brown	NULL
.	NULL

1994	NULL
.	NULL

Structure	NULL
,	NULL
regulation	NULL
,	NULL
and	NULL
function	NULL
of	NULL
NF-kB	NULL
.	NULL

Annu	NULL
.	NULL

Rev	NULL
.	NULL

Cell	NULL
Biol	NULL
.	NULL

10:405-455	NULL
.	NULL

Song	NULL
,	NULL
H.	NULL
Y.	NULL
,	NULL
C.	NULL
H.	NULL
Regnier	NULL
,	NULL
C.	NULL
J.	NULL
Kirschning	NULL
,	NULL
D.	NULL
V.	NULL
Goeddel	NULL
,	NULL
and	NULL
M.	NULL
Rothe	NULL
.	NULL

1997	NULL
.	NULL

Tumor	NULL
necrosis	NULL
factor	NULL
(	NULL
TNF	NULL
)	NULL
-mediated	NULL
kinase	NULL
cascades	NULL
:	NULL
bifurcation	NULL
of	NULL
nuclear	NULL
factor-	NULL
«	NULL
B	NULL
and	NULL
c-jun	NULL
N-terminal	NULL
kinase	NULL
(	NULL
JINK/SAPK	NULL
)	NULL
pathways	NULL
at	NULL
TNF	NULL
receptor-associated	NULL
factor	NULL
2	NULL
.	NULL

Proc	NULL
.	NULL

Natl	NULL
.	NULL

Acad	NULL
.	NULL

Sci	NULL
.	NULL

USA	NULL
94:9792-9796	NULL
.	NULL

Sulciner	NULL
,	NULL
D.	NULL
J.	NULL
,	NULL
K.	NULL
Irani	NULL
,	NULL
Z.~X	NULL
.	NULL

Yu	NULL
,	NULL
V.	NULL
J.	NULL
Ferrans	NULL
,	NULL
P.	NULL
Goldschmidt-Clermont	NULL
,	NULL
and	NULL
T.	NULL
Finkel	NULL
.	NULL

1996.	NULL
racl	NULL
regulates	NULL
a	NULL
cytokine-stimulated	NULL
,	NULL
redox-dependent	NULL
pathway	NULL
necessary	NULL
for	NULL
NF-	NULL
«	NULL
B	NULL
activation	NULL
.	NULL

Mol	NULL
.	NULL

Cell	NULL
.	NULL

Biol	NULL
.	NULL

16:7115-7121	NULL
.	NULL

Traenckner	NULL
,	NULL
E.	NULL
B.-M.	NULL
,	NULL
H.	NULL
L.	NULL
Pabl	NULL
,	NULL
T.	NULL
Henkel	NULL
,	NULL
K.	NULL
N.	NULL
Schmidt	NULL
,	NULL
S.	NULL
Wilk	NULL
,	NULL
and	NULL
P.	NULL
A.	NULL
Baeuerle	NULL
.	NULL

1995	NULL
.	NULL

Phosphorylation	NULL
of	NULL
human	NULL
IxB-	NULL
«	NULL
on	NULL
serines	NULL
32	NULL
and	NULL
36	NULL
controls	NULL
IxB-	NULL
«	NULL
proteolysis	NULL
and	NULL
NF-kB	NULL
activation	NULL
in	NULL
response	NULL
to	NULL
diverse	NULL
stimuli	NULL
.	NULL

EMBO	NULL
J	NULL
.	NULL

14:2876-2883	NULL
.	NULL

Traenckner	NULL
,	NULL
E.	NULL
B.-M.	NULL
,	NULL
S.	NULL
Wilk	NULL
,	NULL
and	NULL
P.	NULL
A.	NULL
Baeverle	NULL
.	NULL

1994	NULL
.	NULL

A	NULL
proteasome	NULL
inhibitor	NULL
prevents	NULL
activation	NULL
of	NULL
NF-	NULL
«	NULL
B	NULL
and	NULL
stabilizes	NULL
a	NULL
newly	NULL
phosphorylated	NULL
form	NULL
of	NULL
IxB-	NULL
«	NULL
that	NULL
is	NULL
still	NULL
bound	NULL
to	NULL
NF-	NULL
«	NULL
B	NULL
.	NULL

EMBO	NULL
J	NULL
.	NULL

13:5433-5441	NULL
.	NULL

Van	NULL
Elst	NULL
,	NULL
L.	NULL
,	NULL
and	NULL
C.	NULL
D'Souza-Schorey	NULL
.	NULL

1997	NULL
.	NULL

Rho	NULL
GTPases	NULL
and	NULL
signaling	NULL
networks	NULL
.	NULL

Genes	NULL
Dev	NULL
.	NULL

11:2295-2322	NULL
.	NULL

Wesche	NULL
,	NULL
H.	NULL
,	NULL
W.	NULL
J.	NULL
Henzel	NULL
,	NULL
W.	NULL
Shillinglaw	NULL
,	NULL
S.	NULL
Li	NULL
,	NULL
and	NULL
Z.	NULL
Cao	NULL
.	NULL

1997	NULL
.	NULL

MyD88	NULL
:	NULL
an	NULL
adapter	NULL
that	NULL
recruits	NULL
IRAK	NULL
to	NULL
the	NULL
IL-1	NULL
receptor	NULL
complex	NULL
.	NULL

Immunity	NULL
7:837-847	NULL
.	NULL

62	NULL
.	NULL

63	NULL
.	NULL

64	NULL
.	NULL

65	NULL
.	NULL

66	NULL
.	NULL

67	NULL
.	NULL

Mor	NULL
.	NULL

CELL	NULL
.	NULL

BioL	NULL
.	NULL

Wesche	NULL
,	NULL
H.	NULL
,	NULL
C.	NULL
Korherr	NULL
,	NULL
M.	NULL
Kracht	NULL
,	NULL
W.	NULL
Falk	NULL
,	NULL
K.	NULL
Resch	NULL
,	NULL
and	NULL
M.	NULL
U.	NULL
Martin	NULL
.	NULL

1997	NULL
.	NULL

The	NULL
interleukin-1	NULL
receptor	NULL
accessory	NULL
protein	NULL
(	NULL
IL-1RAcP	NULL
)	NULL
is	NULL
essential	NULL
for	NULL
IL-l-induced	NULL
activation	NULL
of	NULL
interleukin-1	NULL
receptor	NULL
associated	NULL
kinase	NULL
(	NULL
IRAK	NULL
)	NULL
and	NULL
stress-activated	NULL
protein	NULL
kinases	NULL
(	NULL
SAP	NULL
kinases	NULL
)	NULL
.	NULL

J.	NULL
Biol	NULL
.	NULL

Chem	NULL
.	NULL

2727727-7731	NULL
.	NULL

Woods	NULL
,	NULL
J.	NULL
W.	NULL
,	NULL
J.	NULL
F.	NULL
Evans	NULL
,	NULL
D.	NULL
Ethier	NULL
,	NULL
S.	NULL
Scott	NULL
,	NULL
P.	NULL
J.	NULL
Vickers	NULL
,	NULL
L.	NULL
Hearn	NULL
,	NULL
J	NULL
.	NULL

A.	NULL
Heiben	NULL
,	NULL
S.	NULL
Charleson	NULL
,	NULL
and	NULL
I.	NULL
I	NULL
.	NULL

Singer	NULL
.	NULL

1993	NULL
.	NULL

5-Lipoxygenase	NULL
and	NULL
5-lipoxygenase-activating	NULL
protein	NULL
are	NULL
localized	NULL
in	NULL
the	NULL
nuclear	NULL
envelope	NULL
of	NULL
activated	NULL
human	NULL
leukocytes	NULL
.	NULL

J.	NULL
Exp	NULL
.	NULL

Med	NULL
.	NULL

178:1935-1946	NULL
.	NULL

Worenicz	NULL
,	NULL
J.	NULL
D.	NULL
,	NULL
X.	NULL
Gao	NULL
,	NULL
Z.	NULL
Cao	NULL
,	NULL
M.	NULL
Rothe	NULL
,	NULL
and	NULL
D.	NULL
V.	NULL
Goeddel	NULL
.	NULL

1997	NULL
.	NULL

IxB	NULL
kinase-B	NULL
:	NULL
NF-	NULL
«	NULL
B	NULL
activation	NULL
and	NULL
complex	NULL
formation	NULL
with	NULL
IxB	NULL
kinase-	NULL
«	NULL
and	NULL
NIK	NULL
.	NULL

Science	NULL
278:866-869	NULL
.	NULL

Yamin	NULL
,	NULL
T.	NULL
T.	NULL
,	NULL
and	NULL
D.	NULL
K.	NULL
Miller	NULL
,	NULL
1997	NULL
.	NULL

The	NULL
interleukin-1	NULL
receptor-associated	NULL
kinase	NULL
is	NULL
degraded	NULL
by	NULL
proteasomes	NULL
following	NULL
its	NULL
phosphorylation	NULL
.	NULL

J.	NULL
Biol	NULL
.	NULL

Chem	NULL
.	NULL

272:21540-21547	NULL
.	NULL

Zandi	NULL
,	NULL
E.	NULL
,	NULL
D.	NULL
M.	NULL
Rothwarf	NULL
,	NULL
M.	NULL
Delhasse	NULL
,	NULL
M.	NULL
Hayakawa	NULL
,	NULL
and	NULL
M.	NULL
Karin	NULL
.	NULL

1997	NULL
.	NULL

The	NULL
IxB	NULL
kinase	NULL
complex	NULL
(	NULL
IKK	NULL
)	NULL
contains	NULL
two	NULL
kinase	NULL
subunits	NULL
,	NULL
IKKe	NULL
and	NULL
IKKB	NULL
,	NULL
necessary	NULL
for	NULL
IxB	NULL
phosphorylation	NULL
and	NULL
NF-	NULL
«	NULL
B	NULL
activation	NULL
.	NULL

Cell	NULL
91	NULL
:	NULL
243-252	NULL
.	NULL

Zeisler	NULL
,	NULL
H.	NULL
,	NULL
C.	NULL
Tempfer	NULL
,	NULL
E.	NULL
A.	NULL
Joura	NULL
,	NULL
G.	NULL
Sliutz	NULL
,	NULL
H.	NULL
Koebl	NULL
,	NULL
O.	NULL
Wagner	NULL
,	NULL
and	NULL
C.	NULL
Kainz	NULL
.	NULL

1998	NULL
.	NULL

Serum	NULL
interleukin	NULL
1	NULL
in	NULL
ovarian	NULL
cancer	NULL
patients	NULL
.	NULL

Eur	NULL
.	NULL

J	NULL
.	NULL

Cancer	NULL
34:931-933	NULL
.	NULL

